Name	MOA	Target	Phase
abacavir	nucleoside reverse transcriptase inhibitor		Launched
abemaciclib	CDK inhibitor	CDK4, CDK6	Launched
abiraterone	androgen biosynthesis inhibitor	CYP11B1, CYP17A1	Launched
abiraterone-acetate	androgen biosynthesis inhibitor	CYP17A1	Launched
acamprosate	glutamate receptor antagonist	GABRA1, GABRA2, GABRA3, GABRA4, GABRA5, GABRA6, GABRB1, GABRB2, GABRB3, GABRD, GABRE, GABRG1, GABRG2, GABRG3, GABRP, GABRQ, GRIN1, GRIN2A, GRIN2B, GRIN2C, GRIN2D, GRIN3A, GRIN3B, GRM5	Launched
acarbose	glucosidase inhibitor	AMY2A, GAA, MGAM, SI	Launched
acebutolol	adrenergic receptor antagonist	ADRB1, ADRB2	Launched
aceclofenac	prostanoid receptor antagonist	PTGS2	Launched
acemetacin	cyclooxygenase inhibitor	PTGS1, PTGS2	Launched
acenocoumarol	vitamin K antagonist	VKORC1	Launched
acepromazine	dopamine receptor antagonist	ADRA1A, ADRA1B, DRD1, DRD2, HTR1A, HTR2A	Launched
acetazolamide	carbonic anhydrase inhibitor	AQP1, CA1, CA12, CA14, CA2, CA3, CA4, CA7	Launched
acetohexamide	ATP channel blocker	ABCC8, KCNJ1, KCNJ10, KCNJ11	Launched
acetohydroxamic-acid	urease inhibitor	MMP12	Launched
acetophenazine	dopamine receptor antagonist	DRD1, DRD2	Launched
acetyl-farnesyl-cysteine	methyltransferase inhibitor	PPARG	Launched
acexamic-acid	5 alpha reductase inhibitor	GAST	Launched
acipimox	cholesterol inhibitor	HCAR2	Launched
acitazanolast	mediator release inhibitor		Launched
aclarubicin	topoisomerase inhibitor	TOP1, TOP2A	Launched
aclidinium	acetylcholine receptor antagonist	CHRM1, CHRM2, CHRM3, CHRM4, CHRM5	Launched
acriflavine	hypoxia inducible factor inhibitor	HIF1A	Launched
acriflavinium	hypoxia inducible factor inhibitor	HIF1A	Launched
acrivastine	histamine receptor antagonist	HRH1	Launched
ACT-132577	endothelin receptor antagonist	EDNRA, EDNRB	Launched
actinomycin-d	RNA polymerase inhibitor		Launched
acyclovir	DNA polymerase inhibitor	PNP	Launched
adefovir	DNA polymerase inhibitor		Launched
adefovir-dipivoxil	DNA polymerase inhibitor		Launched
ademetionine	methyltransferase stimulant, phosphodiesterase inhibitor	AMD1, CBS, COMT, GNMT, MAT1A, MAT2A	Launched
adiphenine	acetylcholine receptor antagonist	CHRNA1	Launched
afatinib	EGFR inhibitor	EGFR, ERBB2, ERBB4	Launched
afloqualone	acetylcholine receptor antagonist		Launched
agomelatine	melatonin receptor agonist, serotonin receptor antagonist	HTR2A, HTR2B, HTR2C, MTNR1A, MTNR1B	Launched
AGP-103	membrane permeability inhibitor		Launched
ajmaline	sodium channel blocker	SCN5A	Launched
alacepril	angiotensin converting enzyme inhibitor	ACE	Launched
alarelin	gonadotropin releasing factor hormone receptor antagonist	GNRH1	Launched
albendazole	tubulin polymerization inhibitor	TUBA1A, TUBB, TUBB4B	Launched
alcaftadine	histamine receptor antagonist	HRH1	Launched
alclofenac	cyclooxygenase inhibitor	PTGS1	Launched
alectinib	ALK tyrosine kinase receptor inhibitor	ALK, MET	Launched
alendronate	bone resorption inhibitor	ATP6V1A, FDPS, PTPN4, PTPRE, PTPRS	Launched
alfuzosin	adrenergic receptor antagonist	ADRA1A, ADRA1B, ADRA1D, KCNH2	Launched
aliskiren-hemifumarate	renin inhibitor	REN	Launched
alizapride	dopamine receptor antagonist	DRD2	Launched
allopurinol	xanthine oxidase inhibitor	XDH	Launched
alogliptin	dipeptidyl peptidase inhibitor	DPP4	Launched
alprenolol	adrenergic receptor antagonist	ADRB1, ADRB2, HTR1A	Launched
altretamine	DNA synthesis inhibitor		Launched
alvimopan	opioid receptor antagonist	OPRD1, OPRK1, OPRM1	Launched
amantadine	glutamate receptor antagonist	DRD2, GRIN2A, GRIN2B, GRIN2C, GRIN2D, GRIN3A	Launched
ambenonium	cholinesterase inhibitor	ACHE	Launched
ambrisentan	endothelin receptor antagonist	EDNRA, EDNRB	Launched
ambroxol	sodium channel blocker	CYP3A4	Launched
amdinocillin	bacterial cell wall synthesis inhibitor		Launched
amfenac	cyclooxygenase inhibitor	PTGS1, PTGS2	Launched
amifampridine	potassium channel blocker		Launched
amikacin	bacterial 30S ribosomal subunit inhibitor		Launched
amiloride	sodium channel blocker	AOC1, ASIC1, ASIC2, ASIC3, PKD2, PKD2L1, PLAU, SCNN1A, SCNN1B, SCNN1D, SCNN1G, SLC9A1, TRPC7, TRPV2	Launched
aminocaproic-acid	plasminogen activator inhibitor	LPA, PLAT, PLG	Launched
aminoglutethimide	glucocorticoid receptor antagonist	CYP11A1, CYP19A1	Launched
aminopentamide	acetylcholine receptor antagonist	CHRM1	Launched
aminophylline	adenosine receptor antagonist	ADORA1, ADORA2A, ADORA2B, ADORA3, HDAC2, PDE3A, PDE3B, PDE4A, PDE4B, PDE4C, PDE4D	Launched
aminosalicylate	cyclooxygenase inhibitor	ALOX5, CHUK, PLA2G2E, PTGS1, PTGS2	Launched
amiodarone	potassium channel blocker	ADRB1, CACNA1H, CACNA2D2, KCNA7, KCNH2	Launched
amisulpride	dopamine receptor antagonist	DRD2, DRD3, HTR2A, HTR7	Launched
amitriptyline	norepinephrine inhibitor, norepinephrine reuptake inhibitor, serotonin receptor antagonist, serotoninâ€“norepinephrine reuptake inhibitor (SNRI)	ADRA1A, ADRA1B, ADRA1D, ADRA2A, ADRB1, ADRB2, ADRB3, CHRM1, CHRM2, CHRM3, CHRM4, CHRM5, HRH1, HRH2, HRH4, HTR1A, HTR1B, HTR1D, HTR2A, HTR2C, HTR6, HTR7, KCNA1, KCND2, KCND3, KCNQ2, KCNQ3, NTRK1, NTRK2, OPRD1, OPRK1, OPRM1, SIGMAR1, SLC6A2, SLC6A4	Launched
amlodipine	calcium channel blocker	CA1, CACNA1B, CACNA1C, CACNA1D, CACNA1F, CACNA1S, CACNA2D1, CACNA2D3, CACNB1, CACNB2, SMPD1	Launched
ammonium-glycyrrhizinate	thrombin inhibitor	HSD11B1, HSD11B2, SLCO1B1, SLCO1B3	Launched
amorolfine	membrane integrity inhibitor		Launched
amoxapine	norepinephrine reputake inhibitor	ADRA1A, ADRA1B, ADRA1D, ADRA2A, ADRA2B, ADRA2C, CHRM1, CHRM2, CHRM3, CHRM4, CHRM5, DRD1, DRD2, DRD3, DRD4, DRD5, GABRA1, GABRA2, GABRA3, GABRA4, GABRA5, GABRA6, GABRB1, GABRB2, GABRB3, GABRD, GABRE, GABRG1, GABRG2, GABRG3, GABRP, GABRQ, HRH1, HRH4, HTR1A, HTR1B, HTR2A, HTR2B, HTR2C, HTR3A, HTR6, HTR7, SLC6A2, SLC6A3, SLC6A4	Launched
amoxicillin	penicillin binding protein inhibitor	CYP2C19, SLC15A1, SLC15A2, SLC22A6	Launched
amperozide	dopamine receptor antagonist	FAAH, HTR2A	Launched
ampicillin	bacterial cell wall synthesis inhibitor		Launched
ampiroxicam	cyclooxygenase inhibitor	PTGS1, PTGS2	Launched
amprenavir	HIV protease inhibitor		Launched
amprolium	thiamine uptake blocker		Launched
amrinone	phosphodiesterase inhibitor	PDE3A, PDE3B, PDE4B, TNF	Launched
amrubicin	topoisomerase inhibitor	TOP2A, TOP2B	Launched
amsacrine	topoisomerase inhibitor	KCNH2, TOP2A	Launched
amtolmetin-guacil	cyclooxygenase inhibitor	PTGS1, PTGS2	Launched
anagliptin	dipeptidyl peptidase inhibitor	DPP4	Launched
anagrelide	phosphodiesterase inhibitor	PDE3A	Launched
anastrozole	aromatase inhibitor	CYP19A1	Launched
anecortave-acetate	angiogenesis inhibitor		Launched
anidulafungin	fungal 1,3-beta-D-glucan synthase inhibitor		Launched
anisindione	vitamin K antagonist	GGCX	Launched
anisotropine	acetylcholine receptor antagonist	CHRM1, CHRM2, CHRM3	Launched
anthralin	DNA synthesis inhibitor		Launched
apalutamide	androgen receptor antagonist		Launched
apixaban	coagulation factor inhibitor	F10	Launched
apramycin	bacterial 30S ribosomal subunit inhibitor		Launched
apremilast	phosphodiesterase inhibitor	PDE4A, PDE4B, PDE4C, PDE4D	Launched
aprepitant	tachykinin antagonist	TACR1	Launched
aprindine	voltage-gated sodium channel blocker	CALM1, SCN5A	Launched
arbidol	cytochrome P450 inhibitor	CYP3A4	Launched
argatroban	thrombin inhibitor	F2	Launched
arglabin	farnesyltransferase inhibitor	FNTA, NFKB1	Launched
aripiprazole	serotonin receptor agonist, serotonin receptor antagonist	ADRA1A, ADRA1B, ADRA2A, ADRA2B, ADRA2C, CHRM1, CHRM2, CHRM3, CHRM4, CHRM5, DRD1, DRD2, DRD3, DRD4, DRD5, HRH1, HTR1A, HTR1B, HTR1D, HTR1E, HTR2A, HTR2C, HTR3A, HTR6, HTR7	Launched
arotinolol	adrenergic receptor antagonist	ADRB3	Launched
artemisinin	DNA synthesis inhibitor	CYP2B6	Launched
artesunate	DNA synthesis inhibitor		Launched
asenapine	dopamine receptor antagonist, serotonin receptor antagonist	ADRA1A, ADRA2A, ADRA2B, ADRA2C, ADRB1, ADRB2, DRD1, DRD2, DRD3, DRD4, HRH1, HRH2, HTR1A, HTR1B, HTR1D, HTR1E, HTR2A, HTR2B, HTR2C, HTR5A, HTR6, HTR7	Launched
aspirin	cyclooxygenase inhibitor	AKR1C1, ASIC3, EDNRA, HSPA5, IKBKB, NFKB1, NFKB2, NFKBIA, PRKAA1, PRKAA2, PRKAB1, PRKAB2, PRKAG1, PRKAG2, PRKAG3, PTGS1, PTGS2, RPS6KA3, TP53	Launched
atazanavir	HIV protease inhibitor		Launched
atenolol-(+/-)	adrenergic receptor antagonist	ADRB1, ADRB2	Launched
atipamezole	adrenergic receptor antagonist		Launched
atomoxetine	norepinephrine transporter inhibitor	GRIN1, GRIN2A, GRIN2B, GRIN2C, GRIN2D, GRIN3A, GRIN3B, SLC6A2, SLC6A3, SLC6A4	Launched
atorvastatin	HMGCR inhibitor	AHR, DPP4, HMGCR	Launched
atosiban	oxytocin receptor antagonist	AVPR1A, AVPR1B, AVPR2, OXTR	Launched
atovaquone	mitochondrial electron transport inhibitor	DHODH	Launched
atracurium	acetylcholine receptor antagonist	CHRNA2	Launched
atropine	acetylcholine receptor antagonist	CHRM1, CHRM2, CHRM3, CHRM4, CHRM5	Launched
auranofin	NFkB pathway inhibitor	IKBKB, PRDX5, TRPA1	Launched
aurothioglucose	PKC inhibitor	PRKCI	Launched
avanafil	phosphodiesterase inhibitor	PDE5A	Launched
avibactam	beta lactamase inhibitor		Launched
avobenzone	UV blocker	TYR	Launched
axitinib	PDGFR tyrosine kinase receptor inhibitor, VEGFR inhibitor	CSF1, FLT1, FLT4, KDR, PLK4	Launched
azacitidine	DNA methyltransferase inhibitor	DNMT1, DNMT3A	Launched
azaperone	dopamine receptor antagonist	DRD2, DRD3	Launched
azasetron	serotonin receptor antagonist	HTR3A, HTR3B	Launched
azatadine	histamine receptor antagonist	HRH1	Launched
azathioprine	dehydrogenase inhibitor	HPRT1, IMPDH1, PPAT	Launched
azelaic-acid	tyrosinase inhibitor	AKR1D1, SRD5A2, TYR	Launched
azelastine	histamine receptor antagonist	HRH1	Launched
azelnidipine	calcium channel blocker	CACNA1C	Launched
azilsartan	angiotensin receptor antagonist	AGTR1, AGTR2	Launched
azilsartan-medoxomil	angiotensin receptor antagonist	AGTR1, AGTR2	Launched
azithromycin	bacterial 50S ribosomal subunit inhibitor	MLNR	Launched
azlocillin	bacterial cell wall synthesis inhibitor		Launched
azosemide	electrolyte reabsorption inhibitor	SLC12A1, SLC12A2	Launched
aztreonam	bacterial cell wall synthesis inhibitor		Launched
bacampicillin	bacterial cell wall synthesis inhibitor		Launched
bacitracin	bacterial cell wall synthesis inhibitor	A2M, IDE	Launched
bacitracin-zinc	bacterial cell wall synthesis inhibitor		Launched
baicalin	beta glucuronidase inhibitor	PREP	Launched
balofloxacin	bacterial DNA gyrase inhibitor		Launched
balsalazide	cyclooxygenase inhibitor	ALOX5, PPARG, PTGS1, PTGS2	Launched
barnidipine	calcium channel blocker		Launched
bedaquiline	ATPase inhibitor		Launched
bekanamycin	bacterial 30S ribosomal subunit inhibitor		Launched
belinostat	HDAC inhibitor	HDAC1, HDAC10, HDAC11, HDAC2, HDAC3, HDAC4, HDAC5, HDAC6, HDAC7, HDAC8, HDAC9	Launched
benazepril	angiotensin converting enzyme inhibitor	ACE	Launched
bendamustine	DNA inhibitor		Launched
bendazac	cyclooxygenase inhibitor	PTGS1, PTGS2	Launched
bendroflumethiazide	sodium/potassium/chloride transporter inhibitor	CA1, CA2, CA4, KCNMA1, SLC12A1, SLC12A3	Launched
benidipine	calcium channel blocker	CACNA1C, CACNA1G	Launched
benperidol	dopamine receptor antagonist	DRD2	Launched
benserazide	DOPA decarboxylase inhibitor	DDC	Launched
benzbromarone	chloride channel blocker	ABCC1	Launched
benzethonium	sodium channel blocker	SCN10A	Launched
benznidazole	DNA synthesis inhibitor		Launched
benzocaine	sodium channel blocker	SCN10A	Launched
benzthiazide	carbonic anhydrase inhibitor	CA1, CA12, CA2, CA4, CA9, SLC12A3	Launched
benztropine-mesylate	acetylcholine receptor antagonist	CHRM1, HRH1, SLC6A3	Launched
benzydamine	prostanoid receptor antagonist		Launched
benzyl-benzoate	lipase inhibitor	LIPE	Launched
benzylpenicillin	penicillin binding protein inhibitor		Launched
bepotastine	histamine receptor antagonist	HRH1	Launched
bepridil	calcium channel blocker	ATP1A1, CACNA1A, CACNA1H, CACNA2D2, CALM1, KCNQ1, KCNQ4, PDE1A, PDE1B, TNNC1	Launched
besifloxacin	bacterial DNA gyrase inhibitor		Launched
betahistine	histamine receptor agonist, histamine receptor antagonist	HRH1, HRH3	Launched
betamipron	panipenem uptake inhibitor		Launched
betaxolol	adrenergic receptor antagonist	ADRB1, ADRB2	Launched
betrixaban	coagulation factor inhibitor	KCNH2	Launched
bevantolol	adrenergic receptor antagonist	ADRA1A, ADRB1, ADRB2	Launched
biapenem	bacterial cell wall synthesis inhibitor		Launched
bicalutamide	androgen receptor antagonist	AR	Launched
bicyclol	NFkB pathway inhibitor	HSPA1A, HSPB1	Launched
bifonazole	sterol demethylase inhibitor	CYP2B6	Launched
bilastine	histamine receptor antagonist	HRH1	Launched
biperiden	acetylcholine receptor antagonist	CHRM1, CHRM2, CHRM3, CHRM4, CHRM5, CHRNA2	Launched
bismuth-subgallate	nitric oxide synthase inhibitor	NOS1	Launched
bisoprolol	adrenergic receptor antagonist	ADRB1, ADRB2	Launched
bivalirudin	thrombin inhibitor	F2	Launched
bleomycin	DNA synthesis inhibitor	LIG1, LIG3	Launched
blonanserin	dopamine receptor antagonist, serotonin receptor antagonist	DRD2, HTR2A	Launched
boceprevir	HCV inhibitor	CMA1, CTSA, CTSF, CTSK, CTSL, CTSS	Launched
bopindolol	adrenergic receptor antagonist	ADRB1, ADRB2, ADRB3, HTR1A, HTR1B	Launched
bortezomib	NFkB pathway inhibitor, proteasome inhibitor	PSMA1, PSMA2, PSMA3, PSMA4, PSMA5, PSMA6, PSMA7, PSMA8, PSMB1, PSMB10, PSMB11, PSMB2, PSMB3, PSMB4, PSMB5, PSMB6, PSMB7, PSMB8, PSMB9, PSMD1, PSMD2, RELA	Launched
bosentan	endothelin receptor antagonist	EDNRA, EDNRB	Launched
bosutinib	Abl kinase inhibitor, Bcr-Abl kinase inhibitor, src inhibitor	ABL1, BCR, CAMK1D, CAMK2G, CDK2, FRK, FYN, HCK, LYN, MAP2K1, MAP2K2, MAP3K2, MAP4K5, SRC, STK10, STK24, STK4, TNK2, TXK	Launched
bretylium	norepinephrine inhibitor	ATP1A1	Launched
brigatinib	ALK tyrosine kinase receptor inhibitor, EGFR inhibitor	ALK, EGFR	Launched
brinzolamide	carbonic anhydrase inhibitor	CA1, CA12, CA14, CA2, CA4, CA5A, CA7	Launched
brivaracetam	voltage-gated sodium channel blocker	SV2A	Launched
brivudine	DNA directed DNA polymerase inhibitor		Launched
bromantan	dopamine reuptake inhibitor, serotonin reuptake inhibitor		Launched
bromopride	dopamine receptor antagonist	DRD2	Launched
bromperidol	dopamine receptor antagonist	DRD2	Launched
brompheniramine	histamine receptor antagonist	CHRM1, CHRM2, CHRM3, CHRM4, CHRM5, HRH1	Launched
buclizine	histamine receptor antagonist	CHRM1, HRH1	Launched
budipine	glutamate receptor antagonist	GRIN1	Launched
buflomedil	adrenergic receptor antagonist, calcium channel blocker	ADRA1A	Launched
bumetanide	solute carrier family member inhibitor	CFTR, GPR35, SLC12A1, SLC12A2, SLC12A4, SLC12A5	Launched
bunazosin	adrenergic receptor antagonist	ADRA1A	Launched
bupivacaine	sodium channel blocker	KCNA5, PTGER1, SCN10A, SCN4A	Launched
bupranolol	adrenergic receptor antagonist	ADRB1, ADRB2, ADRB3	Launched
bupropion	dopamine uptake inhibitor	CHRNA3, SLC6A2, SLC6A3	Launched
busulfan	DNA inhibitor		Launched
butalbital	GABA receptor antagonist	CHRNA4, CHRNA7, GABRA1, GABRA2, GABRA3, GABRA4, GABRA5, GABRA6, GABRB1, GABRB2, GABRB3, GABRD, GABRE, GABRG1, GABRG2, GABRG3, GABRP, GABRQ, GRIA2, GRIK2	Launched
butenafine	fungal squalene epoxidase inhibitor	SQLE	Launched
butoconazole	bacterial cell wall synthesis inhibitor		Launched
butorphanol-(+)-tartrate	opioid receptor agonist, opioid receptor antagonist	OPRD1, OPRK1, OPRM1	Launched
butylphthalide	potassium channel antagonist	KCNK2	Launched
butylscopolamine-bromide	cholinergic receptor antagonist		Launched
cabazitaxel	microtubule inhibitor	TUBA4A, TUBB, TUBB1	Launched
cabozantinib	RET tyrosine kinase inhibitor, VEGFR inhibitor	KDR, MET	Launched
cadralazine	adrenergic receptor antagonist		Launched
caffeine	adenosine receptor antagonist, phosphodiesterase inhibitor	ADORA1, ADORA2A, ADORA2B, ADORA3, ATM, ITPR1, ITPR2, ITPR3, PDE10A, PDE11A, PDE1A, PDE1B, PDE1C, PDE2A, PDE3A, PDE3B, PDE4A, PDE4B, PDE4C, PDE4D, PDE5A, PDE6A, PDE6B, PDE6C, PDE7A, PDE7B, PDE8A, PDE8B, PDE9A, PIK3CA, PIK3CB, PIK3CD, PRKDC, RYR1, RYR2, RYR3	Launched
camostat-mesilate	protease inhibitor	PRSS1	Launched
canagliflozin	sodium/glucose cotransporter inhibitor	SLC5A1, SLC5A2	Launched
candesartan	angiotensin receptor antagonist	AGTR1	Launched
candesartan-cilextil	angiotensin receptor antagonist	AGTR1, AGTR2	Launched
candicidin	fungal ergosterol inhibitor		Launched
cantharidin	protein phosphatase inhibitor		Launched
capecitabine	DNA synthesis inhibitor, thymidylate synthase inhibitor	TYMS	Launched
capreomycin	protein synthesis inhibitor		Launched
captopril	angiotensin converting enzyme inhibitor	ACE, LTA4H, MMP2, MMP9	Launched
caramiphen	cholinergic receptor antagonist	CHRM1, CHRM2	Launched
carazolol	adrenergic receptor antagonist	ADRB1, ADRB2, ADRB3	Launched
carbaril	acetylcholinesterase inhibitor		Launched
carbendazim	microtubule inhibitor, tubulin polymerization inhibitor	TP53, TUBB	Launched
carbenicillin	bacterial cell wall synthesis inhibitor		Launched
carbenoxolone	11-beta hydroxysteroid dehydrogenase inhibitor	GJA1, GJA10, GJA3, GJA4, GJA5, GJA8, GJA9, GJB1, GJB2, GJB3, GJB4, GJB5, GJB6, GJB7, GJC1, GJC2, GJC3, GJD2, GJD3, GJD4, GJE1, HSD11B1, PANX1, PANX2, PANX3	Launched
carbetapentane	acetylcholine receptor antagonist	CHRM2	Launched
carbidopa	aromatic L-amino acid decarboxylase inhibitor	DDC	Launched
carbinoxamine	histamine receptor antagonist	HRH1	Launched
carboplatin	DNA alkylating agent, DNA inhibitor		Launched
carfilzomib	proteasome inhibitor	PSMA1, PSMA2, PSMA3, PSMA4, PSMA5, PSMA6, PSMA7, PSMA8, PSMB1, PSMB10, PSMB11, PSMB2, PSMB3, PSMB4, PSMB5, PSMB6, PSMB7, PSMB8, PSMB9	Launched
cariprazine	dopamine receptor antagonist	DRD2, DRD3	Launched
carisoprodol	acetylcholine receptor antagonist	CYP2C19	Launched
carmofur	thymidylate synthase inhibitor	TYMS	Launched
carmustine	DNA alkylating agent, DNA inhibitor	GSR	Launched
caroverine	glutamate receptor antagonist, calcium channel blocker		Launched
carprofen	cyclooxygenase inhibitor	PTGS1, PTGS2	Launched
carteolol	adrenergic receptor antagonist	ADRB1, ADRB2	Launched
carumonam	bacterial cell wall synthesis inhibitor		Launched
carvedilol	adrenergic receptor antagonist	ADRA1A, ADRA1B, ADRA1D, ADRA2A, ADRA2B, ADRA2C, ADRB1, ADRB2, ADRB3, GJA1, HIF1A, KCNH2, NDUFC2, NPPB, SELE, VCAM1, VEGFA	Launched
caspofungin	fungal 1,3-beta-D-glucan synthase inhibitor, bacterial cell wall synthesis inhibitor		Launched
caspofungin-acetate	fungal 1,3-beta-D-glucan synthase inhibitor		Launched
cefaclor	bacterial cell wall synthesis inhibitor		Launched
cefadroxil	bacterial cell wall synthesis inhibitor	SLC15A1, SLC15A2, SLC22A6, SLC22A8	Launched
cefalonium	bacterial cell wall synthesis inhibitor		Launched
cefamandole	bacterial cell wall synthesis inhibitor		Launched
cefamandole-nafate	bacterial cell wall synthesis inhibitor		Launched
cefathiamidine	bacterial cell wall synthesis inhibitor		Launched
cefazolin	bacterial cell wall synthesis inhibitor	PON1	Launched
cefcapene-pivoxil	bacterial cell wall synthesis inhibitor		Launched
cefdinir	bacterial cell wall synthesis inhibitor	MPO	Launched
cefditoren-pivoxil	bacterial cell wall synthesis inhibitor		Launched
cefepime	bacterial cell wall synthesis inhibitor		Launched
cefetamet	bacterial cell wall synthesis inhibitor		Launched
cefetamet-pivoxil	bacterial cell wall synthesis inhibitor		Launched
cefixime	bacterial cell wall synthesis inhibitor		Launched
cefmenoxime	bacterial cell wall synthesis inhibitor		Launched
cefmetazole	bacterial cell wall synthesis inhibitor		Launched
cefminox	bacterial cell wall synthesis inhibitor		Launched
cefodizime	bacterial cell wall synthesis inhibitor		Launched
cefonicid	bacterial cell wall synthesis inhibitor		Launched
cefoperazone	bacterial cell wall synthesis inhibitor		Launched
ceforanide	penicillin binding protein inhibitor		Launched
cefoselis	bacterial cell wall synthesis inhibitor		Launched
cefotaxime	bacterial cell wall synthesis inhibitor		Launched
cefotetan	bacterial cell wall synthesis inhibitor		Launched
cefotiam	bacterial cell wall synthesis inhibitor		Launched
cefotiam-cilexetil	bacterial cell wall synthesis inhibitor		Launched
cefoxitin	bacterial cell wall synthesis inhibitor		Launched
cefozopran	bacterial cell wall synthesis inhibitor		Launched
cefpiramide	bacterial cell wall synthesis inhibitor		Launched
cefpirome	bacterial cell wall synthesis inhibitor		Launched
cefpodoxime	bacterial cell wall synthesis inhibitor		Launched
cefprozil	bacterial cell wall synthesis inhibitor		Launched
cefradine	bacterial cell wall synthesis inhibitor	CYP3A4	Launched
cefsulodin	bacterial cell wall synthesis inhibitor		Launched
ceftaroline-fosamil	bacterial cell wall synthesis inhibitor		Launched
ceftazidime	bacterial cell wall synthesis inhibitor		Launched
ceftibuten	bacterial cell wall synthesis inhibitor		Launched
ceftiofur	bacterial cell wall synthesis inhibitor		Launched
ceftizoxim	bacterial cell wall synthesis inhibitor		Launched
ceftriaxone	bacterial cell wall synthesis inhibitor		Launched
cefuroxime	bacterial cell wall synthesis inhibitor		Launched
cefuroxime-axetil	bacterial cell wall synthesis inhibitor		Launched
celecoxib	cyclooxygenase inhibitor	CA12, PDPK1, PTGS2	Launched
celiprolol	adrenergic receptor antagonist	ADRA2A, ADRB1, ADRB2	Launched
cephalexin	bacterial cell wall synthesis inhibitor		Launched
cephalothin	bacterial cell wall synthesis inhibitor		Launched
cephapirin	bacterial cell wall synthesis inhibitor		Launched
cephradine	bacterial cell wall synthesis inhibitor		Launched
ceritinib	ALK tyrosine kinase receptor inhibitor	ALK, FLT3, IGF1R, INSR, TSSK1B	Launched
cerulenin	fatty acid synthase inhibitor	FASN	Launched
cetirizine	histamine receptor antagonist	HRH1	Launched
cetrorelix	gonadotropin releasing factor hormone receptor antagonist	GNRHR, LHCGR	Launched
chenodeoxycholic-acid	11-beta hydroxysteroid dehydrogenase inhibitor, FXR agonist	HSD11B1, NR1H4	Launched
chidamide	HDAC inhibitor	HDAC10, HDAC3	Launched
chlorambucil	DNA inhibitor		Launched
chloramphenicol	bacterial 50S ribosomal subunit inhibitor	CD55	Launched
chloramphenicol-palmitate	protein synthesis inhibitor		Launched
chloramphenicol-sodium-succinate	protein synthesis inhibitor		Launched
chlorcyclizine	histamine receptor antagonist	HRH1	Launched
chlorhexidine	membrane integrity inhibitor		Launched
chlormadinone-acetate	5 alpha reductase inhibitor	PGR	Launched
chlormidazole	fungal lanosterol demethylase inhibitor		Launched
chloroprocaine	sodium channel blocker	ATP1A1, CHRNA10, GRIN3A, HTR3A, SCN10A, SLC6A3	Launched
chloropyramine	histamine receptor antagonist	HRH1	Launched
chloroxine	opioid receptor antagonist	OPRK1	Launched
chloroxylenol	ATP synthase inhibitor		Launched
chlorphenamine	histamine receptor antagonist	HRH1, SLC6A2, SLC6A3, SLC6A4	Launched
chlorproguanil	dihydrofolate reductase inhibitor	DHFR	Launched
chlorpromazine	dopamine receptor antagonist	ADRA1A, ADRA1B, ADRA1D, ADRA2A, ADRA2B, ADRA2C, CALM1, CHRM1, CHRM3, DRD1, DRD2, DRD3, DRD4, DRD5, HRH1, HRH4, HTR1A, HTR2A, HTR2B, HTR2C, HTR6, HTR7, KCNH2, ORM1, ORM2, SMPD1, TRPC5	Launched
chlorpropamide	ATP channel blocker	ABCC8, KCNJ10, KCNJ11	Launched
chlorprothixene	dopamine receptor antagonist	CHRM1, CHRM2, CHRM3, CHRM4, CHRM5, DRD1, DRD2, DRD3, HRH1, HTR2A, HTR2B, HTR2C	Launched
chlorpyrifos	acetylcholinesterase inhibitor	ACHE	Launched
chlortetracycline	protein synthesis inhibitor		Launched
chlorthalidone	carbonic anhydrase inhibitor	CA1, CA12, CA14, CA4, CA7, SLC12A1, SLC12A3	Launched
chlorzoxazone	bacterial 30S ribosomal subunit inhibitor	KCNMA1, KCNN4	Launched
cibenzoline	sodium channel blocker		Launched
ciclopirox	membrane integrity inhibitor	ATP1A1	Launched
cidofovir	DNA polymerase inhibitor		Launched
cilastatin	dehydropeptidase inhibitor	DPEP1	Launched
cilazapril	angiotensin converting enzyme inhibitor	ACE	Launched
cilnidipine	calcium channel blocker	CACNA1B	Launched
cilostazol	phosphodiesterase inhibitor	PDE3A, PDE3B	Launched
cimetidine	histamine receptor antagonist	HRH2, SLC29A4, SLC47A1, SLC47A2	Launched
cimetropium	acetylcholine receptor antagonist	CHRM1	Launched
cinchocaine	sodium channel blocker	CALM1, SCN10A, SCN5A	Launched
cinnarazine	calcium channel blocker		Launched
cinoxacin	topoisomerase inhibitor		Launched
ciprofloxacin	bacterial DNA gyrase inhibitor	TOP2A	Launched
cisatracurium	acetylcholine receptor antagonist	CHRNA2	Launched
cisplatin	DNA alkylating agent, DNA synthesis inhibitor	XIAP	Launched
citalopram	selective serotonin reuptake inhibitor (SSRI)	SLC6A2, SLC6A4	Launched
cladribine	adenosine deaminase inhibitor, ribonucleotide reductase inhibitor	ADA, PNP, POLA1, POLE, POLE2, POLE3, POLE4, RRM1, RRM2, RRM2B	Launched
clarithromycin	bacterial 50S ribosomal subunit inhibitor	CYP3A4	Launched
clavulanate	beta lactamase inhibitor		Launched
clebopride	dopamine receptor antagonist	ACHE, DRD2	Launched
clemastine	histamine receptor antagonist	HRH1	Launched
clemizole	HCV inhibitor		Launched
cleviprex	calcium channel blocker	CACNA1C, CACNA1D, CACNA1F, CACNA1S	Launched
clevudine	DNA polymerase inhibitor		Launched
clidinium	acetylcholine receptor antagonist	CHRM1, CHRM3	Launched
clindamycin	protein synthesis inhibitor		Launched
clindamycin-palmitate	bacterial 50S ribosomal subunit inhibitor		Launched
clindamycin-phosphate	protein synthesis inhibitor		Launched
clinofibrate	lipase clearing factor inhibitor	LPL	Launched
clodronic-acid	bone resorption inhibitor	SLC25A4, SLC25A5, SLC25A6	Launched
clofarabine	ribonucleotide reductase inhibitor	POLA1, POLD1, POLE, RRM1, RRM2, RRM2B	Launched
clofazimine	GK0582 inhibitor		Launched
clofedanol	histamine receptor antagonist	HRH1	Launched
clofoctol	protein synthesis inhibitor		Launched
clomethiazole	GABA receptor antagonist, GABA receptor modulator	GABRA1	Launched
clomifene	estrogen receptor antagonist	ESR1	Launched
clomipramine	serotonin transporter (SERT) inhibitor	GSTP1, HTR2A, HTR2B, HTR2C, SLC6A2, SLC6A3, SLC6A4	Launched
clonixin-lysinate	cyclooxygenase inhibitor		Launched
clopamide	sodium/chloride cotransporter inhibitor		Launched
clopidogrel	purinergic receptor antagonist	P2RY12	Launched
cloranolol	adrenergic receptor antagonist	ADRB1, ADRB2, ADRB3	Launched
clorotepine	dopamine receptor antagonist, adrenergic receptor antagonist	ADRA1A, ADRA1B, ADRA1D, DRD2, HRH1, HTR2C, HTR6	Launched
clorsulon	glycolysis inhibitor		Launched
closantel	chitinase inhibitor, NFkB pathway inhibitor		Launched
clotrimazole	cytochrome P450 inhibitor, imidazoline receptor ligand	CYP3A4, KCNN4, NR1I2, NR1I3, TRPM2, TRPM4, TRPM8	Launched
cloxacillin	bacterial cell wall synthesis inhibitor		Launched
clozapine	dopamine receptor antagonist, serotonin receptor antagonist	ADRA1A, ADRA1B, ADRA1D, ADRA2A, ADRA2B, ADRA2C, CALY, CHRM1, CHRM2, CHRM3, CHRM4, CHRM5, DRD1, DRD2, DRD3, DRD4, DRD5, HRH1, HRH4, HTR1A, HTR1B, HTR1D, HTR1E, HTR1F, HTR2A, HTR2B, HTR2C, HTR3A, HTR5A, HTR6, HTR7	Launched
cobicistat	cytochrome P450 inhibitor	CYP3A4, CYP3A43, CYP3A5, CYP3A7	Launched
cobimetinib	MEK inhibitor		Launched
colchicine	microtubule inhibitor	GLRA1, GLRA2, TUBA1A, TUBA1B, TUBA1C, TUBA3C, TUBA3D, TUBA3E, TUBA4A, TUBB, TUBB1, TUBB2A, TUBB2B, TUBB3, TUBB4A, TUBB4B, TUBB6, TUBB8	Launched
conivaptan	vasopressin receptor antagonist	AVPR1A, AVPR2	Launched
copanlisib	PI3K inhibitor	PIK3CA, PIK3CB, PIK3CD, PIK3CG	Launched
coumarin	vitamin K antagonist	CA1, CA12, CA14, CA2, CA4, CA6, CA9, CYP2A6	Launched
crizotinib	ALK tyrosine kinase receptor inhibitor	ALK, MET	Launched
croconazole	bacterial cell wall synthesis inhibitor		Launched
curcumin	cyclooxygenase inhibitor, histone acetyltransferase inhibitor, lipoxygenase inhibitor, NFkB pathway inhibitor	APP, CA1, CA12, CA14, CA2, CA4, CA6, CA9, CYP3A4, DNMT3B, EP300, MMP13, MMP9, NOS2, PTGS1, PTGS2, XDH	Launched
cyamemazine	serotonin receptor antagonist	HTR1A, HTR2A, HTR2C, HTR7	Launched
cyclandelate	calcium channel blocker	CACNA2D1, CES1	Launched
cyclopentolate	acetylcholine receptor antagonist	CHRM1	Launched
cycloserine-(d)	bacterial cell wall synthesis inhibitor	GRIN1	Launched
cyclosporin-a	calcineurin inhibitor	PPP3CA	Launched
cyclosporine	calcineurin inhibitor	ABCB11, CAMLG, FPR1, PPIA, PPIF, PPP3R2, SLC10A1, SLCO1B1, SLCO1B3	Launched
cyclovalone	breast cancer resistance protein inhibitor	ABCG2	Launched
cyproheptadine	histamine receptor antagonist	ADRA1A, ADRA1B, ADRA1D, CHRM1, CHRM2, CHRM3, HRH1, HTR2A, HTR2C, HTR6, HTR7	Launched
cyproterone	androgen receptor antagonist	AR	Launched
cyproterone-acetate	androgen receptor antagonist	ADORA1, AR	Launched
cysteamine	tissue transglutaminase inhibitor	NPY2R, SST	Launched
cytarabine	ribonucleotide reductase inhibitor	POLA1, POLB, POLD1, POLE	Launched
dabigatran	thrombin inhibitor	F2	Launched
dabigatran-etexilate	thrombin inhibitor	F2	Launched
dabrafenib	RAF inhibitor	BRAF, LIMK1, NEK11, RAF1, SIK1	Launched
daclatasvir	HCV inhibitor		Launched
dactinomycin	RNA polymerase inhibitor	POLR2A	Launched
dalbavancin	bacterial cell wall synthesis inhibitor	PNLIP	Launched
dalfampridine	potassium channel blocker	KCNA1, KCNA10, KCNA2, KCNA3, KCNA4, KCNA5, KCNA6, KCNA7, KCNB1, KCNB2, KCNC1, KCNC2, KCNC3, KCNC4, KCND1, KCND2, KCND3, KCNF1, KCNG1, KCNG2, KCNG3, KCNG4, KCNH1, KCNH2, KCNH3, KCNH4, KCNH5, KCNH6, KCNH7, KCNH8, KCNJ13, KCNJ5, KCNQ1, KCNQ2, KCNQ3, KCNQ4, KCNQ5, KCNS1, KCNS2, KCNS3, KCNV1, KCNV2	Launched
danazol	estrogen receptor antagonist, progesterone receptor agonist	AR, CCL2, ESR1, GNRHR, GNRHR2, PGR	Launched
danofloxacin	bacterial DNA gyrase inhibitor		Launched
dantrolene	calcium channel blocker	RYR1, RYR3	Launched
dapagliflozin	sodium/glucose cotransporter inhibitor	SLC5A1, SLC5A2	Launched
dapiprazole	adrenergic receptor antagonist	ADRA1A, ADRA1B, ADRA1D	Launched
dapoxetine	selective serotonin reuptake inhibitor (SSRI)	HTR1A, HTR1B, HTR2C, SLC6A4	Launched
daptomycin	bacterial cell wall synthesis inhibitor		Launched
darifenacin	acetylcholine receptor antagonist	CHRM1, CHRM2, CHRM3, CHRM4, CHRM5	Launched
darunavir	HIV protease inhibitor	CYP3A4	Launched
dasabuvir	HCV inhibitor		Launched
dasatinib	Bcr-Abl kinase inhibitor, ephrin inhibitor, KIT inhibitor, PDGFR tyrosine kinase receptor inhibitor, src inhibitor, tyrosine kinase inhibitor	ABL1, ABL2, BLK, EPHA2, FGR, FRK, FYN, HCK, KIT, LCK, LYN, PDGFRB, SRC, SRMS, STAT5B, YES1	Launched
daunorubicin	RNA synthesis inhibitor, topoisomerase inhibitor	TOP2A, TOP2B	Launched
debrisoquin	adrenergic neuron blocker	SLC6A2	Launched
decitabine	DNA methyltransferase inhibitor	DNMT1, DNMT3A	Launched
degarelix	gonadotropin releasing factor hormone receptor antagonist	GNRHR	Launched
delamanid	bacterial cell wall synthesis inhibitor		Launched
delapril	angiotensin converting enzyme inhibitor	ACE	Launched
delavirdine	non-nucleoside reverse transcriptase inhibitor	CYP3A4	Launched
demecarium	acetylcholinesterase inhibitor	ACHE, BCHE	Launched
demeclocycline	bacterial 30S ribosomal subunit inhibitor		Launched
dequalinium	PKC inhibitor	KCNN1, KCNN3	Launched
deracoxib	cyclooxygenase inhibitor	PTGS2	Launched
deserpidine	angiotensin converting enzyme inhibitor	ACE, SLC18A2	Launched
deslanoside	Na/K-ATPase inhibitor	ATP1A1, ATP1A2, ATP1A3, ATP1A4, ATP1B1, ATP1B2, ATP1B3, FXYD2	Launched
desloratadine	histamine receptor antagonist	HRH1	Launched
desvenlafaxine	serotoninâ€“norepinephrine reuptake inhibitor (SNRI)	SLC6A2, SLC6A3, SLC6A4	Launched
dexchlorpheniramine	histamine receptor antagonist		Launched
dexlansoprazole	ATPase inhibitor	ATP4A, ATP4B	Launched
dexrazoxane	chelating agent, topoisomerase inhibitor	TOP2A, TOP2B	Launched
dextroamphetamine	monoamine oxidase inhibitor	ADRA1A, ADRA1B, SLC18A2, SLC6A2, SLC6A3, TAAR1	Launched
dextromethorphan	glutamate receptor antagonist, sigma receptor agonist	CHRNA2, CHRNA3, CHRNA4, CHRNA7, CHRNB2, CHRNB4, CYBA, CYBB, GRIN3A, NCF1, NCF2, NCF4, OPRD1, OPRK1, OPRM1, PGRMC1, RAC1, RAC2, SIGMAR1, SLC6A2, SLC6A4	Launched
diacerein	interleukin inhibitor	IL1B	Launched
diaveridine	dihydrofolate reductase inhibitor		Launched
dibekacin	bacterial 30S ribosomal subunit inhibitor		Launched
dichlorvos	acetylcholinesterase inhibitor		Launched
diclofenac	cyclooxygenase inhibitor	AKR1C3, ALOX5, ASIC1, ASIC3, KCNQ2, KCNQ3, PLA2G2A, PPARG, PTGS1, PTGS2, SCN4A	Launched
diclofenamide	carbonic anhydrase inhibitor	CA1, CA12, CA2, CA4, CA7	Launched
dicloxacillin	bacterial cell wall synthesis inhibitor		Launched
dicoumarol	NADPH inhibitor	CRYZ, NQO1, VKORC1	Launched
dicycloverine	acetylcholine receptor antagonist	CHRM1, CHRM2, CHRM3	Launched
didanosine	nucleoside reverse transcriptase inhibitor	PNP	Launched
didox	ribonucleotide reductase inhibitor	RRM1	Launched
diethylcarbamazine	lipoxygenase inhibitor	ALOX5, PTGS1	Launched
difenpiramide	cyclooxygenase inhibitor, prostaglandin inhibitor		Launched
difloxacin	bacterial DNA gyrase inhibitor		Launched
diflunisal	prostanoid receptor antagonist	PTGS1, PTGS2	Launched
diftalone	cyclooxygenase inhibitor		Launched
digitoxin	ATPase inhibitor	ATP1A1	Launched
digoxin	ATPase inhibitor	ATP1A1	Launched
dihydroergocristine	adrenergic receptor antagonist, prolactin inhibitor	ADRA1A, ADRB1, DRD1, DRD2, DRD3, DRD4, DRD5, HTR1A, HTR2A, HTR3A, HTR4, HTR5A, HTR6, HTR7	Launched
dilazep	adenosine reuptake inhibitor	SLC29A1	Launched
diloxanide	protein synthesis inhibitor		Launched
diltiazem	calcium channel blocker	CACNA1C, CACNA1S, CACNA2D1, CACNG1, HTR3A, KCNA5	Launched
dimenhydrinate	histamine receptor antagonist	HRH1	Launched
dimetindene	histamine receptor antagonist, cholinergic receptor antagonist	CHRM2, HRH1	Launched
dimetridazole	bacterial DNA inhibitor		Launched
dimpylate	acetylcholinesterase inhibitor	ACHE	Launched
diphemanil	acetylcholine receptor antagonist	CHRM3	Launched
diphenhydramine	histamine receptor antagonist	HRH1	Launched
diphenylpyraline	dopamine uptake inhibitor	HRH1, SLC6A3	Launched
DIPT	dopamine reuptake inhibitor, serotonin reuptake inhibitor	HTR1A, HTR2A, HTR2C	Launched
dipyridamole	phosphodiesterase inhibitor	ADA, PDE10A, PDE1A, PDE1B, PDE1C, PDE2A, PDE3A, PDE3B, PDE4A, PDE4B, PDE4C, PDE4D, PDE5A, PDE6A, PDE6B, PDE6C, PDE6D, PDE6G, PDE6H, PDE7A, PDE7B, PDE8A, PDE8B, PDE9A, SLC29A1	Launched
dirithromycin	bacterial 50S ribosomal subunit inhibitor		Launched
disopyramide	sodium channel blocker	CHRM1, CHRM2, CHRM3, KCND2, KCND3, KCNH2, SCN5A	Launched
disulfiram	aldehyde dehydrogenase inhibitor, DNA methyltransferase inhibitor, TRPV agonist	ALDH2, DBH	Launched
dithranol	DNA synthesis inhibitor		Launched
docetaxel	tubulin polymerization inhibitor	BCL2, MAP2, MAP4, MAPT, NR1I2, TUBB, TUBB1	Launched
docosanol	lipase clearing factor inhibitor	TLR7	Launched
dolasetron	serotonin receptor antagonist	HTR3A	Launched
dolutegravir	HIV integrase inhibitor	CYP3A4, CYP3A5, CYP3A7, POU2F2, UGT1A1	Launched
domperidone	dopamine receptor antagonist	DRD2, DRD3	Launched
donepezil	acetylcholinesterase inhibitor	ACHE, HTR2A	Launched
doripenem	bacterial cell wall synthesis inhibitor	DPEP1	Launched
dorzolamide	carbonic anhydrase inhibitor	CA1, CA12, CA14, CA2, CA4, CA7	Launched
dosulepin	norepinephrine reuptake inhibitor, serotoninâ€“norepinephrine reuptake inhibitor (SNRI), tricyclic antidepressant	CHRM1, CHRM2, CHRM3, CHRM4, CHRM5, HRH1, SLC6A2, SLC6A4	Launched
doxapram	potassium channel blocker	KCNK3, KCNK9	Launched
doxazosin	adrenergic receptor antagonist	ADRA1A, ADRA1B, ADRA1D, KCNH2, KCNH6, KCNH7	Launched
doxepin	histamine receptor antagonist	ADRA1A, ADRA1B, ADRA1D, ADRA2A, ADRA2B, ADRA2C, CHRM1, CHRM2, CHRM3, CHRM4, CHRM5, DRD2, HRH1, HRH2, HRH4, HTR1A, HTR2A, HTR2B, HTR2C, HTR6, KCNH2, SLC6A2, SLC6A4	Launched
doxifluridine	thymidylate synthase inhibitor	TYMS	Launched
doxofylline	adenosine receptor antagonist	ADORA1, PDE4A, PDE4B, PDE4C, PDE4D	Launched
doxorubicin	topoisomerase inhibitor	TOP2A	Launched
doxycycline	metalloproteinase inhibitor	MMP8	Launched
doxycycline-hyclate	bacterial 30S ribosomal subunit inhibitor		Launched
doxylamine	histamine receptor antagonist	CHRM1, HRH1	Launched
dronedarone	adrenergic receptor antagonist	ADRA1A, ADRA1B, ADRA1D, ADRA2A, ADRA2B, ADRA2C, ADRB1, CACNA1C, CACNA1D, CACNA1F, CACNA1S, CACNB1, CACNB2, CACNB3, CACNB4, KCNA5, KCNH2, KCNK2, SCN1A	Launched
droperidol	dopamine receptor antagonist	ADRA1A, DRD2, DRD3, DRD4, HTR2A	Launched
drospirenone	mineralocorticoid receptor antagonist	AR, NR3C2, PGR	Launched
drotaverine	phosphodiesterase inhibitor	CACNA1C, PDE4A	Launched
droxicam	cyclooxygenase inhibitor	PTGS1	Launched
duloxetine	norepinephrine reuptake inhibitor, serotoninâ€“norepinephrine reuptake inhibitor (SNRI)	HTR2A, HTR2C, HTR6, SLC6A2, SLC6A3, SLC6A4	Launched
dutasteride	5 alpha reductase inhibitor	SRD5A1, SRD5A2	Launched
dyclonine	sodium channel blocker	SCN10A, SCN5A	Launched
dyphylline	adenosine receptor antagonist, phosphodiesterase inhibitor	ADORA1, ADORA2A, PDE3A, PDE4A, PDE4B, PDE4C, PDE4D, PDE7A, PDE7B	Launched
ebastine	histamine receptor antagonist	CYP3A4, HRH1	Launched
ecabet	gastrin inhibitor, urease inhibitor	NOXO1	Launched
econazole	lanosterol demethylase inhibitor, sterol demethylase inhibitor	CYP51A1, NPY1R, NPY2R, TRPM2, TRPV5	Launched
edoxaban	coagulation factor inhibitor	F10	Launched
edoxudine	DNA directed DNA polymerase inhibitor		Launched
edrophonium	acetylcholinesterase inhibitor	ACHE, BCHE	Launched
efavirenz	HIV protease inhibitor	CYP1A2, CYP2B6, CYP2C19, CYP2C9, CYP2D6, CYP3A4	Launched
efinaconazole	lanosterol demethylase inhibitor	CYP51A1	Launched
eflornithine	ornithine decarboxylase inhibitor	ARG2, ODC1	Launched
efonidipine-monoethanolate	L-type calcium channel blocker, T-type calcium channel blocker	CACNA1C, CACNA1G	Launched
elbasvir	HCV inhibitor		Launched
eliglustat	Glycosyl transferase inhibitor	UGCG	Launched
elvitegravir	HIV integrase inhibitor		Launched
emedastine	histamine receptor antagonist	HRH1	Launched
emorfazone	antiinflammatory agent, cyclooxygenase inhibitor		Launched
empagliflozin	sodium/glucose cotransporter inhibitor	SLC5A1, SLC5A2	Launched
emtricitabine	nucleoside reverse transcriptase inhibitor		Launched
enalapril	angiotensin converting enzyme inhibitor	ACE	Launched
enalaprilat	angiotensin converting enzyme inhibitor	ACE	Launched
enasidenib	isocitrate dehydrogenase inhibitor	IDH1	Launched
enflurane	membrane permeability inhibitor	ATP2C1, ATP5D, GABRA1, GABRA2, GABRA3, GABRA4, GABRA5, GABRA6, GABRB1, GABRB2, GABRB3, GABRD, GABRE, GABRG1, GABRG2, GABRG3, GABRP, GABRQ, GLRA1, GLRB, GRIA1, KCNA1, KCNK10, KCNK18, KCNK2, KCNK3, KCNK9, KCNN4	Launched
enilconazole	sterol demethylase inhibitor	CYP19A1, CYP1A2, CYP2B6, CYP2C9, CYP2J2, CYP3A4, CYP3A5, NR1I2, PPARA, PTGER2	Launched
enocitabine	DNA synthesis inhibitor	CMPK1, RRM1, TYMS	Launched
enoxacin	topoisomerase inhibitor	TOP2A	Launched
enoximone	phosphodiesterase inhibitor	PDE3A	Launched
enrofloxacin	bacterial DNA gyrase inhibitor		Launched
entacapone	catechol O methyltransferase inhibitor	COMT	Launched
entecavir	DNA replication inhibitor, nucleoside reverse transcriptase inhibitor		Launched
enzalutamide	androgen receptor antagonist	AR	Launched
epalrestat	aldose reductase inhibitor	AKR1B1	Launched
eperisone	acetylcholine receptor antagonist	CYP2J2	Launched
epinastine	histamine receptor antagonist	ADRA1A, ADRA2A, HRH1, HRH2, HTR2A, HTR7	Launched
epirizole	cyclooxygenase inhibitor	PTGS1, PTGS2	Launched
epirubicin	topoisomerase inhibitor	CHD1, TOP2A	Launched
eplerenone	cytochrome P450 inhibitor	NR3C2	Launched
epomediol	cholesterol inhibitor	CYP7A1	Launched
eprobemide	monoamine oxidase inhibitor	MAOA	Launched
eprosartan	angiotensin receptor antagonist	AGTR1	Launched
eptifibatide	platelet aggregation inhibitor	ITGA2B, ITGB3	Launched
ergotamine	adrenergic receptor antagonist	ADRA1A, ADRA1B, ADRA1D, ADRA2A, ADRA2B, DRD1, DRD2, DRD5, HTR1A, HTR1B, HTR1D, HTR1E, HTR1F, HTR2A, HTR2B, HTR2C, HTR5A, HTR6, SLC6A2	Launched
erlotinib	EGFR inhibitor	EGFR, NR1I2	Launched
ertapenem	bacterial cell wall synthesis inhibitor		Launched
ertugliflozin	sodium/glucose cotransporter inhibitor	SLC5A2	Launched
erythromycin	NFkB pathway inhibitor	MLNR	Launched
erythromycin-estolate	bacterial 50S ribosomal subunit inhibitor	ABCB1, ALB, CYP3A4, CYP51A1, KCNH2, MLNR, SLC47A1	Launched
erythromycin-ethylsuccinate	cytochrome P450 inhibitor, protein synthesis inhibitor	ABCB1, ALB, CYP3A4, CYP51A1, KCNH2, MLNR, SLC47A1	Launched
escitalopram	selective serotonin reuptake inhibitor (SSRI)	ADRA1A, CHRM1, HRH1, SLC6A2, SLC6A3, SLC6A4	Launched
eslicarbazepine-acetate	sodium channel blocker	SCN10A, SCN11A, SCN1A, SCN2A, SCN3A, SCN4A, SCN5A, SCN7A, SCN8A, SCN9A	Launched
esmolol	adrenergic receptor antagonist	ADRB1	Launched
esomeprazole	ATPase inhibitor	ATP4A	Launched
estramustine-phosphate	DNA synthesis inhibitor, microtubule inhibitor	ESR1, ESR2, MAP1A, MAP2	Launched
etacrynic-acid	sodium/potassium/chloride transporter inhibitor	ATP1A1, SLC12A1	Launched
etafenone	calcium channel blocker		Launched
ethambutol	bacterial cell wall synthesis inhibitor		Launched
ethaverine	calcium channel blocker		Launched
ethionamide	mycolic synthesis inhibitor		Launched
ethoxzolamide	carbonic anhydrase inhibitor	CA1, CA12, CA13, CA14, CA2, CA3, CA4, CA5A, CA5B, CA6, CA7, CA9	Launched
ethylenediaminetetraacetic-acid	PKC inhibitor		Launched
etidronic-acid	bone resorption inhibitor	ATP6V1A, PTPRS	Launched
etodolac	cyclooxygenase inhibitor	PTGS1, PTGS2, RXRA	Launched
etofenamate	cyclooxygenase inhibitor	PTGS1, PTGS2	Launched
etofylline	adenosine receptor antagonist	ADORA1	Launched
etofylline-clofibrate	platelet aggregation inhibitor	PPARA	Launched
etoposide	topoisomerase inhibitor	TOP2A, TOP2B	Launched
etoposide-phosphate	topoisomerase inhibitor	TOP2A	Launched
etoricoxib	cyclooxygenase inhibitor	PTGS2	Launched
etravirine	non-nucleoside reverse transcriptase inhibitor	CYP2C19, CYP2C9, CYP3A4	Launched
eucalyptol	acetylcholinesterase inhibitor	ACHE	Launched
eugenol	androgen receptor antagonist	AR	Launched
everolimus	mTOR inhibitor	MTOR	Launched
exalamide	membrane permeability inhibitor		Launched
exemestane	aromatase inhibitor	CYP19A1	Launched
ezetimibe	cholesterol inhibitor, Niemann-Pick C1-like 1 protein antagonist	ANPEP, NPC1L1, SOAT1	Launched
fadrozole	aromatase inhibitor	CYP11B1, CYP19A1	Launched
famciclovir	DNA polymerase inhibitor		Launched
famotidine	histamine receptor antagonist	HRH2	Launched
faropenem	lactamase inhibitor		Launched
faropenem-medoxomil	lactamase inhibitor		Launched
fasudil	rho associated kinase inhibitor	PKIA, PRKACA, ROCK1, ROCK2	Launched
febuxostat	xanthine oxidase inhibitor	XDH	Launched
felbamate	glutamate receptor antagonist	GRIN1, GRIN2A, GRIN2B, GRIN2C, GRIN2D, GRIN3A, GRIN3B	Launched
felbinac	cyclooxygenase inhibitor	CTSL	Launched
felbinac-ethyl	cyclooxygenase inhibitor	PTGS1, PTGS2	Launched
felodipine	calcium channel blocker	CACNA1C, CACNA1D, CACNA1F, CACNA1H, CACNA1S, CACNA2D1, CACNA2D2, CACNB2, CALM1, CFTR, NR3C2, PDE1A, PDE1B, TNNC1, TNNC2	Launched
fenbendazole	tubulin polymerization inhibitor	TUBB	Launched
fenbufen	cyclooxygenase inhibitor	PTGS1, PTGS2	Launched
fenofibric-acid	cytochrome P450 inhibitor	CLCN1, PPARA	Launched
fenoprofen	prostaglandin inhibitor	PTGS1, PTGS2, SLC5A8	Launched
fenoverine	acetylcholine receptor antagonist		Launched
fenthion	cholinesterase inhibitor		Launched
fentiazac	cyclooxygenase inhibitor	PTGS1, PTGS2	Launched
fenticonazole	bacterial cell wall synthesis inhibitor		Launched
fesoterodine	acetylcholine receptor antagonist	CHRM1, CHRM2, CHRM3, CHRM4, CHRM5	Launched
fexofenadine	histamine receptor antagonist	HRH1	Launched
fidaxomicin	RNA polymerase inhibitor		Launched
fimasartan	angiotensin receptor antagonist	AGTR1	Launched
finafloxacin	bacterial DNA gyrase inhibitor		Launched
finasteride	5 alpha reductase inhibitor	AKR1D1, SRD5A1, SRD5A2	Launched
fipronil	chloride channel blocker, GABA gated chloride channel blocker		Launched
firocoxib	cyclooxygenase inhibitor	PTGS2	Launched
flavoxate	acetylcholine receptor antagonist	CHRM1, CHRM2	Launched
flecainide	sodium channel blocker	KCNA5, KCNA7, SCN4A, SCN5A	Launched
fleroxacin	topoisomerase inhibitor		Launched
floctafenine	cyclooxygenase inhibitor	PTGS1, PTGS2	Launched
flopropione	serotonin receptor antagonist	HTR1A	Launched
florfenicol	protein synthesis inhibitor		Launched
floxuridine	DNA synthesis inhibitor	TYMS	Launched
flubendazole	tubulin polymerization inhibitor	TUBB	Launched
flucloxacillin	bacterial cell wall synthesis inhibitor		Launched
fluconazole	sterol demethylase inhibitor	CYP51A1	Launched
fludarabine	ribonucleotide reductase inhibitor	ADA, RRM1, RRM2	Launched
fludarabine-phosphate	ribonucleotide reductase inhibitor	DCK, POLA1, POLD1, POLE, RRM1, RRM2, RRM2B	Launched
flumazenil	benzodiazepine receptor antagonist	GABRA1, GABRA2, GABRA3, GABRA4, GABRA5, GABRA6, GABRB1, GABRB2, GABRB3, GABRD, GABRE, GABRG1, GABRG2, GABRG3, GABRP, GABRQ	Launched
flumequine	topoisomerase inhibitor		Launched
flunarizine	calcium channel blocker	CACNA1G, CACNA1H, CACNA1I, CALM1, HRH1	Launched
flunisolide	cytochrome P450 inhibitor	NR3C1	Launched
flunixin-meglumin	prostanoid receptor antagonist		Launched
fluoxetine	selective serotonin reuptake inhibitor (SSRI)	ANO1, HTR2B, SLC6A4	Launched
flupentixol	dopamine receptor antagonist	ADRA1A, CHRM1, DRD1, DRD2, DRD3, DRD5, HTR2A	Launched
fluphenazine	dopamine receptor antagonist	CALM1, DRD1, DRD2, DRD5, HRH1, HTR2A, HTR6, HTR7	Launched
fluphenazine-decanoate	dopamine receptor antagonist	DRD2, HTR1B, HTR4	Launched
flupirtine	glutamate receptor antagonist	ADRA2A, KCNQ1, KCNQ2	Launched
flurbiprofen-(+/-)	cyclooxygenase inhibitor	PTGS1, PTGS2	Launched
flurbiprofen-(S)-(+)	cyclooxygenase inhibitor	PTGS1, PTGS2	Launched
fluspirilene	dopamine receptor antagonist	CACNG1, DRD2, HRH1, HTR1A, HTR1D, HTR1E, HTR2A	Launched
flutamide	androgen receptor antagonist	AHR, AR	Launched
flutrimazole	sterol demethylase inhibitor		Launched
fluvastatin	HMGCR inhibitor	HMGCR	Launched
fluvoxamine	selective serotonin reuptake inhibitor (SSRI)	SLC6A4	Launched
fomepizole	alcohol dehydrogenase inhibitor	ADH1A, ADH1B, ADH1C, AKR1A1, CAT	Launched
formestane	aromatase inhibitor	CYP19A1	Launched
fosamprenavir	HIV protease inhibitor		Launched
fosaprepitant-dimeglumine	tachykinin antagonist	TACR1	Launched
foscarnet	DNA polymerase inhibitor		Launched
fosfomycin	bacterial cell wall synthesis inhibitor		Launched
fosfosal	phosphodiesterase inhibitor	PTGS1, PTGS2	Launched
fosinopril	angiotensin converting enzyme inhibitor	ACE	Launched
fosinoprilat	angiotensin converting enzyme inhibitor	ACE	Launched
fosphenytoin	sodium channel blocker	SCN5A	Launched
fostamatinib	SYK inhibitor	SYK	Launched
fotemustine	thioredoxin inhibitor	TXNRD1	Launched
ftorafur	thymidylate synthase inhibitor	TYMS	Launched
fulvestrant	estrogen receptor antagonist	ESR1, ESR2, GPER1	Launched
fumagillin	methionine aminopeptidase inhibitor	METAP2	Launched
furaltadone	bacterial DNA inhibitor		Launched
furazolidone	bacterial DNA inhibitor		Launched
fusidic-acid	bacterial 30S ribosomal subunit inhibitor		Launched
gabapentin	calcium channel blocker	ADORA1, CACNA1A, CACNA1B, CACNA1C, CACNA1D, CACNA1E, CACNA1F, CACNA1G, CACNA1H, CACNA1I, CACNA1S, CACNA2D1, CACNA2D2, CACNA2D3, CACNA2D4, CACNB1, CACNB2, CACNB3, CACNB4, CACNG1, CACNG2, CACNG3, CACNG4, CACNG5, CACNG6, CACNG7, CACNG8, GRIN1, GRIN2A, GRIN2B, GRIN2C, GRIN2D, GRIN3A, GRIN3B	Launched
gabexate	serine protease inhibitor	PRSS1, TPSAB1	Launched
galantamine	acetylcholinesterase inhibitor	ACHE, BCHE, CHRNA1, CHRNA10, CHRNA2, CHRNA3, CHRNA4, CHRNA5, CHRNA6, CHRNA7, CHRNA9, CHRNB1, CHRNB2, CHRNB3, CHRNB4, CHRND, CHRNE, CHRNG	Launched
gallamine-triethiodide	acetylcholine receptor antagonist	ACHE, CHRM2, CHRNA1, CHRNA2	Launched
gallopamil	L-type calcium channel blocker	ATP2A2	Launched
ganciclovir	DNA polymerase inhibitor		Launched
garenoxacin	topoisomerase inhibitor	TOP2A	Launched
gefitinib	EGFR inhibitor	EGFR	Launched
gemcitabine	ribonucleotide reductase inhibitor	CMPK1, RRM1, RRM2, TYMS	Launched
gemifloxacin	bacterial DNA gyrase inhibitor		Launched
gentamycin	bacterial 50S ribosomal subunit inhibitor	HSPA8, LRP2	Launched
gestrinone	progesterone receptor antagonist	AR, ESR1, PGR	Launched
gimeracil	dihydropyrimidine dehydrogenase inhibitor	DPYD	Launched
ginsenoside-rg3	angiogenesis inhibitor, apoptosis stimulant	KCNH2	Launched
gliclazide	ATP channel blocker, insulin secretagogue	ABCC8, VEGFA	Launched
glyburide	ATP channel blocker, insulin secretagogue, sulfonylurea	ABCA1, ABCB11, ABCC8, ABCC9, CFTR, CPT1A, KCNJ1, KCNJ11, KCNJ5, KCNJ8, SLCO2B1	Launched
glycerol-monolaurate	beta lactamase inhibitor		Launched
glycopyrrolate	acetylcholine receptor antagonist	CHRM1, CHRM2, CHRM3, CHRM4, CHRM5	Launched
GR-235	estrogen receptor agonist, FXR antagonist, progesterone receptor agonist	NR1H4	Launched
granisetron	serotonin receptor antagonist	HTR3A	Launched
grapiprant	prostaglandin inhibitor	PTGER4	Launched
grazoprevir	HCV inhibitor		Launched
griseofulvin	tubulin polymerization inhibitor	KRT12	Launched
guanadrel	adrenergic inhibitor	SLC6A2	Launched
guanethidine	adrenergic inhibitor	SLC6A2	Launched
guanidine	HSP inhibitor	ALDH2, DLG4, GAMT, RNASE1	Launched
halofuginone	collagenase inhibitor	COL1A1, MMP2	Launched
haloperidol	dopamine receptor antagonist	DRD1, DRD2, DRD3, DRD4, DRD5, GRIN2B, HRH1, HTR1A, HTR1D, HTR2A, HTR2B, HTR7, KCNH1	Launched
halothane	glutamate receptor antagonist	ATP2C1, ATP5D, GABRA1, GABRA2, GABRA3, GABRA4, GABRA5, GABRA6, GABRB1, GABRB2, GABRB3, GABRD, GABRE, GABRG1, GABRG2, GABRG3, GABRP, GABRQ, GLRA1, GLRB, GNG2, GRIN2A, GRIN3A, GRIN3B, KCNJ3, KCNJ6, KCNK10, KCNK12, KCNK13, KCNK15, KCNK18, KCNK2, KCNK3, KCNK9, KCNMA1, KCNN4, MT-ND1, NPSR1, RHO	Launched
hesperetin	ACAT inhibitor	DGAT1, MTTP, SOAT1, SOAT2	Launched
hetacillin	bacterial cell wall synthesis inhibitor		Launched
hexylcaine	sodium channel blocker	SCN10A, SCN5A	Launched
homatropine	acetylcholine receptor antagonist	CES1, CHRM1	Launched
homatropine-methylbromide	acetylcholine receptor antagonist	CHRM1, CHRM2, CHRM3, CHRM4, CHRM5	Launched
homoharringtonine	protein synthesis inhibitor	RPL3	Launched
hycanthone	RNA synthesis inhibitor		Launched
hydroflumethiazide	sodium/potassium/chloride transporter inhibitor	ATP1A1, CA1, CA12, CA2, CA4, CA9, KCNMA1, SLC12A1, SLC12A3	Launched
hydroquinone	melanin inhibitor	TYR	Launched
hydroxyurea	ribonucleotide reductase inhibitor	RRM1, RRM2, RRM2B	Launched
hyoscyamine	acetylcholine receptor antagonist	CHRM1, CHRM2, CHRM3, CHRM4	Launched
ibandronate	bone resorption inhibitor	FDPS	Launched
ibrutinib	Bruton's tyrosine kinase (BTK) inhibitor	BLK, BMX, BTK	Launched
ibudilast	leukotriene receptor antagonist, phosphodiesterase inhibitor	IL1B, IL6, PDE3A, PDE4A, PDE4B, PDE4C, PDE4D, PDE5A	Launched
ibuprofen	cyclooxygenase inhibitor	PTGS1, PTGS2	Launched
ibuprofen-lysine	cyclooxygenase inhibitor	PTGS1, PTGS2	Launched
ibuprofen-piconol	cyclooxygenase inhibitor	PTGS1, PTGS2	Launched
ibuproxam	cyclooxygenase inhibitor, prostaglandin inhibitor	ALOX5	Launched
ibutilide	potassium channel blocker	CACNA1C, CACNA2D1, CACNB1, CACNG1, KCNH2, KCNH6, KCNH7, KCNJ11, KCNK1, KCNK6	Launched
icatibant-acetate	bradykinin receptor antagonist	ANPEP, BDKRB2	Launched
icosapent	platelet aggregation inhibitor	ACSL3, ACSL4, FADS1, FFAR1, PPARD, PPARG, PTGS1, PTGS2, SLC8A1, TRPV1	Launched
icotinib	EGFR inhibitor	EGFR	Launched
idarubicin	topoisomerase inhibitor	TOP2A	Launched
idelalisib	PI3K inhibitor	PIK3CA, PIK3CB, PIK3CD, PIK3CG	Launched
idoxuridine	DNA directed DNA polymerase inhibitor		Launched
ifenprodil	adrenergic receptor antagonist, glutamate receptor antagonist	GRIN1, GRIN2B	Launched
iguratimod	cyclooxygenase inhibitor, NFkB pathway inhibitor	PTGS2	Launched
iloperidone	dopamine receptor antagonist, serotonin receptor antagonist	ADRA1A, ADRA2C, DRD1, DRD2, DRD3, DRD4, HRH1, HTR1A, HTR2A, HTR6, HTR7	Launched
iloprost	platelet aggregation inhibitor, prostanoid receptor agonist	PDE4A, PDE4B, PDE4C, PDE4D, PLAT, PTGDR, PTGER1, PTGER2, PTGER3, PTGER4, PTGFR, PTGIR, TBXA2R	Launched
imatinib	Bcr-Abl kinase inhibitor, KIT inhibitor, PDGFR tyrosine kinase receptor inhibitor	ABL1, CSF1R, DDR1, KIT, NTRK1, PDGFRA, PDGFRB, RET	Launched
imidacloprid	acetylcholine receptor antagonist	CHRFAM7A	Launched
imidafenacin	acetylcholine receptor antagonist	CHRM1, CHRM3	Launched
imidapril	angiotensin converting enzyme inhibitor	ACE	Launched
imipenem	bacterial cell wall synthesis inhibitor		Launched
imipramine	norepinephrine reputake inhibitor, serotonin reuptake inhibitor	ADRA1A, ADRA1B, ADRA1D, CHRM1, CHRM2, CHRM3, CHRM4, CHRM5, DRD1, DRD2, DRD5, HRH1, HTR1A, HTR2A, HTR2C, HTR6, HTR7, KCND2, KCND3, KCNH1, KCNH2, SLC6A2, SLC6A3, SLC6A4	Launched
indinavir	HIV protease inhibitor	CYP3A4, CYP3A5, CYP3A7	Launched
indobufen	cyclooxygenase inhibitor, platelet aggregation inhibitor	PTGS1, PTGS2	Launched
indomethacin	cyclooxygenase inhibitor	GLO1, PLA2G2A, PPARA, PPARG, PTGDR2, PTGR2, PTGS1, PTGS2, SLC46A1	Launched
indoramin	adrenergic receptor antagonist	ADRA1A, ADRA1B, ADRA1D, ADRA2B, ADRA2C	Launched
ipragliflozin-l-proline	sodium/glucose cotransporter inhibitor	SLC5A2	Launched
ipratropium	acetylcholine receptor antagonist	CHRM1, CHRM2, CHRM3, CHRM4, CHRM5	Launched
ipriflavone	bone resorption inhibitor		Launched
irbesartan	angiotensin receptor antagonist	AGTR1, JUN, SLC10A1	Launched
irinotecan	topoisomerase inhibitor	TOP1, TOP1MT	Launched
irsogladine	phosphodiesterase inhibitor	PDE4A	Launched
isepamicin	protein synthesis inhibitor		Launched
isocarboxazid	monoamine oxidase inhibitor	MAOA, MAOB	Launched
isoconazole	fungal lanosterol demethylase inhibitor	CYP17A1	Launched
isoflurophate	cholinesterase inhibitor	ACHE, BCHE	Launched
isoniazid	FABI inhibitor	CYP1A2, CYP2C19, CYP2C8, CYP2E1, CYP3A4	Launched
isopropamide-iodide	acetylcholine receptor antagonist	CHRM3, CHRM4	Launched
isradipine	calcium channel blocker	CACNA1C, CACNA1D, CACNA1F, CACNA1H, CACNA1S, CACNA2D1, CACNA2D2, CACNB2	Launched
istradefylline	adenosine receptor antagonist	ADORA1, ADORA2A, ADORA2B, ADORA3	Launched
itopride	dopamine receptor antagonist	CHRM3, DRD2	Launched
itraconazole	cytochrome P450 inhibitor	CYP51A1	Launched
ivabradine	HCN channel antagonist, potassium channel blocker, sodium channel blocker	HCN1, HCN3, HCN4	Launched
ivosidenib	isocitrate dehydrogenase inhibitor	IDH1	Launched
ixazomib	proteasome inhibitor		Launched
ixazomib-citrate	proteasome inhibitor		Launched
josamycin	bacterial 50S ribosomal subunit inhibitor		Launched
kanamycin	bacterial 30S ribosomal subunit inhibitor		Launched
ketanserin	serotonin receptor antagonist	ADRA1A, ADRA1B, ADRA1D, DRD1, DRD5, HTR1A, HTR1B, HTR1D, HTR2A, HTR2B, HTR2C, HTR5A, HTR7, SLC18A1, SLC18A2	Launched
ketoconazole	sterol demethylase inhibitor	AR, CYP19A1, CYP21A2, KCNA10	Launched
ketoprofen	cyclooxygenase inhibitor	CXCR1, PTGS1, PTGS2, SLC5A8	Launched
ketorolac	cyclooxygenase inhibitor	PTGS1, PTGS2	Launched
ketotifen	histamine receptor agonist, leukotriene receptor antagonist, phosphodiesterase inhibitor	HRH1, PDE4A, PDE4B, PDE4C, PDE4D, PDE7A, PDE7B, PDE8A, PDE8B, PGD	Launched
L-Theanine	glutamate receptor antagonist		Launched
labetalol	adrenergic receptor antagonist	ADRA1A, ADRA1B, ADRA1D, ADRB1, ADRB2	Launched
lacidipine	calcium channel blocker	CACNA1C	Launched
lacosamide	collapsin response mediator protein inhibitor, collapsin response mediator protein stimulant, sodium channel blocker	SCN10A, SCN11A, SCN1A, SCN2A, SCN3A, SCN4A, SCN5A, SCN7A, SCN8A, SCN9A	Launched
lafutidine	histamine receptor antagonist	HRH2	Launched
lamivudine	nucleoside reverse transcriptase inhibitor		Launched
lamotrigine	serotonin receptor antagonist, sodium channel blocker	SCN10A, SCN11A, SCN1A, SCN2A, SCN3A, SCN4A, SCN5A, SCN7A, SCN8A, SCN9A	Launched
landiolol	adrenergic receptor antagonist	ADRB1	Launched
lanoconazole	sterol demethylase inhibitor		Launched
lansoprazole	ATPase inhibitor	ATP4A, ATP4B	Launched
lapatinib	EGFR inhibitor	EGFR, ERBB2	Launched
laropiprant	prostanoid receptor antagonist	PTGDR, PTGDR2, PTGER1, PTGER2, PTGER3, PTGFR, PTGIR, TBXA2R	Launched
LCZ696	angiotensin receptor antagonist		Launched
ledipasvir	HCV inhibitor		Launched
leflunomide	dihydroorotate dehydrogenase inhibitor, PDGFR tyrosine kinase receptor inhibitor	AHR, DHODH, PTK2B	Launched
lenvatinib	FGFR inhibitor, KIT inhibitor, PDGFR tyrosine kinase receptor inhibitor, VEGFR inhibitor	FLT4, KDR	Launched
lercanidipine	calcium channel blocker	CACNA2D1, CACNG1	Launched
letrozole	aromatase inhibitor	CYP19A1	Launched
levallorphan	opioid antagonist	CHRNA2, OPRM1	Launched
levetiracetam	calcium channel blocker	CACNA1B, SCN1A, SV2A	Launched
levo-phencynonate	acetylcholine receptor antagonist	CHRM1	Launched
levobetaxolol	adrenergic receptor antagonist	ADRB1, ADRB2	Launched
levobunolol	adrenergic receptor antagonist	ADRB1, ADRB2, ADRB3	Launched
levocabastine	histamine receptor antagonist	HRH1, NTSR2	Launched
levocarnitine-propionate	carnitine palmitoyltransferase inhibitor	CRAT	Launched
levocetirizine	histamine receptor antagonist	HRH1	Launched
levofloxacin	bacterial DNA gyrase inhibitor	TOP2A	Launched
levomepromazine	dopamine receptor antagonist	ADRA1A, ADRA1B, ADRA1D, ADRA2A, ADRA2B, ADRA2C, CHRM1, CHRM2, CHRM3, CHRM4, CHRM5, DRD1, DRD2, DRD3, DRD4, DRD5, HRH1, HTR2A, HTR2C	Launched
levonorgestrel	estrogen receptor agonist, glucocorticoid receptor antagonist, progesterone receptor agonist, progesterone receptor antagonist	AR, ESR1, PGR, SRD5A1	Launched
levosulpiride	dopamine receptor antagonist	CA1, CA12, CA7, DRD2, DRD3	Launched
lidoflazine	calcium channel blocker	SCN1A, SCN3A, SLC29A1	Launched
linagliptin	dipeptidyl peptidase inhibitor	DPP4	Launched
lincomycin	bacterial 30S ribosomal subunit inhibitor		Launched
linezolid	bacterial 50S ribosomal subunit inhibitor	MAOA, MAOB	Launched
liranaftate	fungal squalene epoxidase inhibitor		Launched
lisinopril	angiotensin converting enzyme inhibitor	ACE, ACE2	Launched
lobeline	acetylcholine receptor antagonist	CHRNA10, CHRNA9, SLC18A2	Launched
lodoxamide	histamine receptor antagonist		Launched
lofepramine	norepinephrine reuptake inhibitor, serotoninâ€“norepinephrine reuptake inhibitor (SNRI)	HTR1A, SLC6A2, SLC6A4	Launched
lomefloxacin	bacterial DNA gyrase inhibitor	TOP2A	Launched
lomerizine	calcium channel blocker	CACNA1B, SCN5A	Launched
lomitapide	microsomal trigylceride transfer protein inhibitor	MTTP	Launched
lomustine	DNA synthesis inhibitor	STMN4	Launched
lonidamine	glucokinase inhibitor	GCK	Launched
lopinavir	HIV protease inhibitor		Launched
loracarbef	bacterial cell wall synthesis inhibitor		Launched
loratadine	histamine receptor antagonist	HRH1	Launched
lornoxicam	cyclooxygenase inhibitor	PTGS1, PTGS2	Launched
losartan	angiotensin receptor antagonist	AGTR1	Launched
loteprednol	glucocorticoid receptor agonist, phospholipase inhibitor	NR3C1	Launched
lovastatin	HMGCR inhibitor	HDAC2, HMGCR, ITGAL, NR1I2	Launched
loxapine	dopamine receptor antagonist, serotonin receptor antagonist	ADRA1A, ADRA1B, ADRA2A, ADRA2B, ADRA2C, ADRB1, CHRM1, CHRM2, CHRM3, CHRM4, CHRM5, DRD1, DRD2, DRD3, DRD4, DRD5, HRH1, HRH2, HRH4, HTR1A, HTR1B, HTR1D, HTR1E, HTR2A, HTR2C, HTR3A, HTR5A, HTR6, HTR7, SLC6A2, SLC6A3, SLC6A4	Launched
loxoprofen	cyclooxygenase inhibitor, prostanoid receptor antagonist	PTGS2	Launched
lufenuron	chitin inhibitor		Launched
luliconazole	sterol demethylase inhibitor		Launched
lurasidone	dopamine receptor antagonist, serotonin receptor antagonist	ADRA2A, ADRA2C, DRD2, HTR1A, HTR2A, HTR7	Launched
lymecycline	bacterial 50S ribosomal subunit inhibitor		Launched
mabuprofen	cyclooxygenase inhibitor		Launched
macitentan	endothelin receptor antagonist	EDNRA, EDNRB	Launched
mafenide	carbonic anhydrase inhibitor	CA12, CA14, CA2, CA4, CA6, CA9	Launched
malathion	cholinesterase inhibitor	ACHE, BCHE	Launched
maltobionic-acid	matrix metalloprotease inhibitor		Launched
manidipine	calcium channel blocker	CACNA1C, CACNA1D	Launched
maprotiline	norepinephrine reputake inhibitor, tricyclic antidepressant	ADRA1A, ADRA1B, ADRA1D, ADRA2A, ADRA2B, ADRA2C, CHRM1, CHRM2, CHRM3, CHRM4, CHRM5, DRD2, HRH1, HTR2A, HTR2C, HTR7, SLC6A2	Launched
maraviroc	CC chemokine receptor antagonist	CCR5	Launched
marbofloxacin	bacterial DNA gyrase inhibitor		Launched
maropitant	neurokinin receptor antagonist	TACR1	Launched
masitinib	KIT inhibitor, PDGFR tyrosine kinase receptor inhibitor, src inhibitor	FGFR3, KIT, PDGFRA, PDGFRB	Launched
masoprocol	lipoxygenase inhibitor	ALOX5	Launched
mazindol	dopamine reuptake inhibitor, selective serotonin reuptake inhibitor (SSRI)	SLC6A2, SLC6A3, SLC6A4	Launched
mebendazole	tubulin polymerization inhibitor	TUBA1A, TUBB, TUBB4B	Launched
mebeverine	acetylcholine receptor antagonist	CHRM1	Launched
mecamylamine	acetylcholine receptor antagonist	CHRNA1, CHRNA2, CHRNA3, CHRNA4, CHRNA6, CHRNA7	Launched
mechlorethamine	DNA inhibitor		Launched
meclocycline-sulfosalicylate	bacterial 50S ribosomal subunit inhibitor		Launched
meclofenamic-acid	cyclooxygenase inhibitor, prostanoid receptor antagonist	ALOX5, CNR1, KCNQ2, KCNQ3, PTGS1, PTGS2	Launched
medronic-acid	bone resorption inhibitor		Launched
mefenamic-acid	cyclooxygenase inhibitor	KCNQ1, PTGS1, PTGS2, TRPM3	Launched
mefloquine	adenosine receptor antagonist, hemoglobin antagonist	ADORA2A, HBA1	Launched
meglutol	HMGCR inhibitor	HMGCR	Launched
melatonin	melatonin receptor agonist, nitric oxide synthase inhibitor	ASMT, CALM1, CALR, EPX, ESR1, HTR2B, MPO, MTNR1A, MTNR1B, NQO2, RORB	Launched
meldonium	gamma butyrobetaine hydroxylase inhibitor	BBOX1	Launched
meloxicam	cyclooxygenase inhibitor	PTGS1, PTGS2	Launched
melperone	dopamine receptor antagonist, serotonin receptor antagonist	DRD2, HTR2A	Launched
melphalan	DNA alkylating agent, DNA inhibitor		Launched
memantine	glutamate receptor antagonist	CHRFAM7A, DRD2, GRIN1, GRIN2A, GRIN2B, GRIN3A, HTR3A	Launched
menadione	mitochondrial DNA polymerase inhibitor, phosphatase inhibitor	AOX1, BGLAP, F10, F2, F7, F9, GGCX, NQO1, NQO2, PROC, PROS1, PROZ, VKORC1, VKORC1L1	Launched
menatetrenone	bone resorption inhibitor		Launched
mepacrine	cytokine production inhibitor, NFkB pathway inhibitor, TP53 activator	PLA2G1B, PLA2G4A, PLA2G6, PLCL1	Launched
mepenzolate	acetylcholine receptor antagonist	CHRM1, CHRM3	Launched
mepivacaine	potassium channel blocker, sodium channel blocker	SCN10A	Launched
mepyramine	histamine receptor antagonist	HRH1	Launched
mercaptopurine	immunosuppressant, protein synthesis inhibitor, purine antagonist	HPRT1, IMPDH1, IMPDH2, PPAT	Launched
meropenem	bacterial cell wall synthesis inhibitor		Launched
mesalazine	cyclooxygenase inhibitor, lipoxygenase inhibitor, prostanoid receptor antagonist	ALOX5, CHUK, IKBKB, MPO, PPARG, PTGS1, PTGS2	Launched
mesoridazine	dopamine receptor antagonist	DRD2, HTR2A	Launched
mestinon	cholinesterase inhibitor	ACHE, BCHE	Launched
metergoline	dopamine receptor agonist, serotonin receptor antagonist	HTR1A, HTR1B, HTR1D, HTR1E, HTR1F, HTR2A, HTR2B, HTR2C, HTR5A, HTR6, HTR7	Launched
methacycline	protein synthesis inhibitor		Launched
methantheline	acetylcholine receptor antagonist	CHRM1, HRH2	Launched
methazolamide	carbonic anhydrase inhibitor	CA1, CA12, CA14, CA2, CA4, CA7	Launched
methenamine	bacterial DNA inhibitor		Launched
methicillin	bacterial cell wall synthesis inhibitor		Launched
methotrexate	dihydrofolate reductase inhibitor	DHFR	Launched
methoxsalen	DNA synthesis inhibitor	CYP1A1, CYP1A2, CYP2A13, CYP2A6, CYP3A4	Launched
methoxyflurane	membrane permeability inhibitor	ATP2C1, ATP5D, GABRA1, GABRA2, GABRA3, GABRA4, GABRA5, GABRA6, GABRB1, GABRB2, GABRB3, GABRD, GABRE, GABRG1, GABRG2, GABRG3, GABRP, GABRQ, GLRA1, GLRB, GRIA1, KCNA1, MT-ND1	Launched
methscopolamine	acetylcholine receptor antagonist	CHRM1, CHRM2, CHRM3	Launched
methyclothiazide	chloride reabsorption inhibitor	CA1, CA2, CA4, SLC12A1, SLC12A3	Launched
methylene-blue	guanylyl cyclase inhibitor, nitric oxide production inhibitor	ACHE	Launched
methylergometrine	dopamine receptor antagonist, serotonin receptor antagonist	DRD1, HTR1E, HTR1F, HTR2A, HTR2B, HTR2C	Launched
methylnaltrexone	opioid receptor antagonist	OPRD1, OPRK1, OPRM1	Launched
methylphenidate	dopamine-norepinephrine reuptake inhibitor	SLC6A2, SLC6A3, SLC6A4	Launched
methysergide	serotonin receptor antagonist	HTR1A, HTR1B, HTR1D, HTR1E, HTR1F, HTR2A, HTR2B, HTR2C, HTR5A, HTR6, HTR7	Launched
metirosine	tyrosine hydroxylase inhibitor	TH	Launched
metixene	acetylcholine receptor antagonist	CHRM1, CHRM2, CHRM3, CHRM4, CHRM5	Launched
metoclopramide	dopamine receptor antagonist, serotonin receptor antagonist	CHRM1, DRD2, HTR3A, HTR3B, HTR4	Launched
metocurine	acetylcholine receptor antagonist	CHRM2, CHRNA2	Launched
metolazone	carbonic anhydrase inhibitor	SLC12A3	Launched
metoprolol	adrenergic receptor antagonist	ADRB1, ADRB2	Launched
metoxibutropate	cyclooxygenase inhibitor	PTGS1, PTGS2	Launched
metronidazole	DNA inhibitor	CYP2C9, CYP3A4	Launched
metyrapone	cytochrome P450 inhibitor	CYP11B1	Launched
mexiletine	sodium channel blocker	AHR, SCN4A, SCN5A	Launched
mezlocillin	bacterial cell wall synthesis inhibitor		Launched
mianserin	serotonin receptor antagonist	ADRA1A, ADRA1B, ADRA1D, ADRA2A, ADRA2B, ADRA2C, DRD1, DRD2, DRD3, DRD5, HRH1, HRH2, HRH4, HTR1A, HTR1F, HTR2A, HTR2B, HTR2C, HTR6, HTR7, OPRK1, SLC6A2, SLC6A3, SLC6A4	Launched
micafungin	fungal 1,3-beta-D-glucan synthase inhibitor		Launched
miconazole	bacterial cell wall synthesis inhibitor	KCNH2, KCNH6, KCNH7, KCNMA1, KCNMB1, KCNMB2, KCNMB3, KCNMB4, KCNN1, KCNN2, KCNN3, KCNN4, NOS2, NOS3, TRPM2, TRPV5	Launched
micronomicin	protein synthesis inhibitor		Launched
midecamycin	protein synthesis inhibitor		Launched
midostaurin	FLT3 inhibitor, KIT inhibitor, PKC inhibitor	FLT3, PRKCG	Launched
mifepristone	glucocorticoid receptor antagonist, progesterone receptor antagonist	AR, NR1I2, NR3C1, PGR	Launched
miglitol	glucosidase inhibitor	GAA, GANAB, GANC, MGAM	Launched
miglustat	Glycosyl transferase inhibitor	UGCG	Launched
milnacipran	serotoninâ€“norepinephrine reuptake inhibitor (SNRI)	GRIN1, GRIN2A, GRIN2B, GRIN2C, GRIN2D, GRIN3A, GRIN3B, SLC6A2, SLC6A4	Launched
milrinone	phosphodiesterase inhibitor	PDE2A, PDE3A, PDE3B, PDE5A	Launched
miltefosine	membrane integrity inhibitor	PLA2G1B	Launched
minocycline	bacterial 30S ribosomal subunit inhibitor	ALOX5, CASP1, CASP3, CYCS, IL1B, MMP9, VEGFA	Launched
minodronic-acid	bone resorption inhibitor	FDPS, GGPS1	Launched
miriplatin	DNA synthesis inhibitor		Launched
mirodenafil	phosphodiesterase inhibitor	PDE5A	Launched
mirtazapine	adrenergic receptor antagonist, serotonin receptor antagonist	ADRA1A, ADRA1B, ADRA1D, ADRA2A, ADRA2B, ADRA2C, ADRB1, ADRB2, DRD1, DRD2, DRD3, DRD5, HRH1, HRH3, HTR2A, HTR2B, HTR2C, HTR3A, HTR7, OPRK1, SLC6A2, SLC6A3, SLC6A4	Launched
mitomycin-c	DNA alkylating agent, DNA synthesis inhibitor		Launched
mitoxantrone	topoisomerase inhibitor	TOP2A	Launched
mivacurium	acetylcholine receptor antagonist	BCHE, CHRM2, CHRM3, CHRNA2	Launched
mizolastine	histamine receptor antagonist	HRH1	Launched
mizoribine	immunosuppressant, inosine monophosphate dehydrogenase inhibitor	IMPDH1	Launched
moclobemide	monoamine oxidase inhibitor	MAOA, MAOB	Launched
moexipril	angiotensin converting enzyme inhibitor	ACE, ACE2	Launched
mofezolac	cyclooxygenase inhibitor	PTGS1	Launched
molindone	dopamine receptor antagonist	CHRM1, DRD2, HRH1, HTR1A, HTR2A	Launched
monobenzone	melanin inhibitor	TYR	Launched
montelukast	leukotriene receptor antagonist	ALOX5, CYSLTR1	Launched
moprolol	adrenergic receptor antagonist		Launched
moracizine	sodium channel blocker	SCN5A	Launched
moxalactam	bacterial cell wall synthesis inhibitor		Launched
moxaverine	phosphodiesterase inhibitor		Launched
moxidectin	chloride channel antagonist		Launched
moxifloxacin	bacterial DNA gyrase inhibitor	TOP2A	Launched
mozavaptan	vasopressin receptor antagonist	AVPR1A, AVPR1B, AVPR2	Launched
mupirocin	isoleucyl-tRNA synthetase inhibitor		Launched
mycophenolate-mofetil	dehydrogenase inhibitor, inositol monophosphatase inhibitor	IMPDH1, IMPDH2	Launched
mycophenolic-acid	dehydrogenase inhibitor, inositol monophosphatase inhibitor	IMPDH1, IMPDH2	Launched
nabumetone	cyclooxygenase inhibitor	PTGS1, PTGS2	Launched
nadifloxacin	bacterial DNA gyrase inhibitor		Launched
nadolol	adrenergic receptor antagonist	ADRB1, ADRB2, ADRB3	Launched
nafamostat	serine protease inhibitor	ASIC1, ASIC2, ASIC3, C1R, PRSS1, TPSAB1, TRPM7	Launched
nafcillin	bacterial cell wall synthesis inhibitor	CYP1A2, CYP3A4, SLC22A6	Launched
naftidrofuryl	adrenergic receptor antagonist		Launched
naftifine	fungal squalene epoxidase inhibitor	SQLE	Launched
naftopidil	adrenergic receptor antagonist	ADRA1A	Launched
nalbuphine	opioid receptor agonist, opioid receptor antagonist	OPRD1, OPRK1, OPRM1	Launched
nalidixic-acid	bacterial DNA gyrase inhibitor		Launched
nalmefene	opioid receptor antagonist	OPRD1, OPRK1, OPRM1	Launched
naloxegol	opioid receptor antagonist	OPRM1	Launched
naloxone	opioid receptor antagonist	CREB1, ESR1, OPRD1, OPRK1, OPRM1, TLR4	Launched
naltrexone	opioid receptor antagonist	OPRD1, OPRK1, OPRM1, SIGMAR1	Launched
naproxen	cyclooxygenase inhibitor	PTGS1, PTGS2	Launched
natamycin	fungal ergosterol inhibitor		Launched
nebivolol	adrenergic receptor antagonist	ADRB1, ADRB2	Launched
nedaplatin	DNA inhibitor		Launched
nedocromil	histamine receptor antagonist	CYSLTR1, CYSLTR2, FPR1, HSP90AA1, PTGDR	Launched
nefopam	cyclooxygenase inhibitor		Launched
nelarabine	DNA synthesis inhibitor, T cell inhibitor	POLA1	Launched
nelfinavir	HIV protease inhibitor	CYP1A2, CYP2B6, CYP2C19, CYP2C9, CYP2D6, CYP3A4, CYP3A7	Launched
nemonapride	dopamine receptor antagonist	DRD2, DRD3, DRD4	Launched
neomycin	bacterial 30S ribosomal subunit inhibitor	CXCR4	Launched
neomycin-sulfate	bacterial 30S ribosomal subunit inhibitor		Launched
neostigmine	acetylcholinesterase inhibitor	ACHE	Launched
nepafenac	cyclooxygenase inhibitor	PTGS1, PTGS2	Launched
neridronic-acid	bone resorption inhibitor	FDPS	Launched
netilmicin	protein synthesis inhibitor		Launched
netupitant	tachykinin antagonist	TACR1	Launched
nevirapine	non-nucleoside reverse transcriptase inhibitor	CYP1A2, CYP2A6, CYP2B6, CYP2C9, CYP2D6, CYP3A4, CYP3A5	Launched
nicardipine	calcium channel blocker	ADORA3, ADRA1A, ADRA1B, ADRA1D, CACNA1C, CACNA1D, CACNA2D1, CACNB2, CALM1, CHRM1, CHRM2, CHRM3, CHRM4, CHRM5, PDE1A, PDE1B	Launched
nicergoline	adrenergic receptor antagonist	ADRA1A	Launched
niclosamide	DNA replication inhibitor, STAT inhibitor	STAT3	Launched
nifedipine	calcium channel blocker	CACNA1C, CACNA1D, CACNA1F, CACNA1H, CACNA1S, CACNA2D1, CACNB2, CALM1, GLRA1, GLRA3, GLRB, KCNA1, KCNA5, NR1I2, TRPM3	Launched
nifekalant	potassium channel blocker		Launched
nifenalol	adrenergic receptor antagonist	ADRB1, ADRB2	Launched
niflumic-acid	cyclooxygenase inhibitor	ANO1, CLCN1, CLCNKA, CLCNKB, KCNQ1, PLA2G1B, PLA2G4A, PTGS1, PTGS2, UGT1A9	Launched
nifuroxazide	bacterial DNA inhibitor		Launched
nifursol	bacterial DNA inhibitor		Launched
nifurtimox	DNA inhibitor		Launched
nilotinib	Abl kinase inhibitor, Bcr-Abl kinase inhibitor	ABL1, KIT	Launched
nilutamide	androgen receptor antagonist	AR	Launched
nilvadipine	calcium channel blocker	CACNA1C, CACNA1D, CACNA1S, CACNA2D1, CACNA2D3, CACNB2	Launched
nimesulide	cyclooxygenase inhibitor	LTF, PLA2G2E, PTGS1, PTGS2	Launched
nimodipine	calcium channel blocker	AHR, CACNA1C, CACNA1D, CACNA1F, CACNA1S, CACNB1, CACNB2, CACNB3, CACNB4, CFTR, NR3C2	Launched
nimorazole	bacterial DNA inhibitor		Launched
nintedanib	FGFR inhibitor, PDGFR tyrosine kinase receptor inhibitor, VEGFR inhibitor	FGFR1, FGFR2, FGFR3, FGFR4, FLT1, FLT4, KDR, PDGFRA, PDGFRB	Launched
niraparib	PARP inhibitor	PARP1	Launched
niridazole	phosphofructokinase inhibitor		Launched
nisoldipine	calcium channel blocker	CACNA1C, CACNA1D, CACNA1F, CACNA1S, CACNA2D1, CACNB2	Launched
nitazoxanide	pyruvate ferredoxin oxidoreductase inhibitor		Launched
nitisinone	hydroxyphenylpyruvate dioxygenase inhibitor	HPD	Launched
nitrendipine	calcium channel blocker	CACNA1C, CACNA1D, CACNA1H, CACNA1S, CACNA2D1, CACNA2D2, CACNB2, CACNG1, KCNN4	Launched
nitrofurantoin	DNA inhibitor		Launched
nitrofurazone	bacterial DNA inhibitor		Launched
nitroxoline	cathepsin inhibitor	METAP2	Launched
nizatidine	histamine receptor antagonist	HRH2	Launched
nizofenone	ion channel antagonist		Launched
nonoxynol-9	membrane integrity inhibitor		Launched
norfloxacin	bacterial DNA gyrase inhibitor	TOP2A	Launched
noscapine	bradykinin receptor antagonist, tubulin polymerization inhibitor	SIGMAR1	Launched
novobiocin	bacterial DNA gyrase inhibitor		Launched
nystatin	fungal ergosterol inhibitor		Launched
octenidine	membrane integrity inhibitor		Launched
ofloxacin	bacterial DNA gyrase inhibitor	TOP2A	Launched
olanzapine	dopamine receptor antagonist, serotonin receptor antagonist	ADRA1A, ADRA1B, ADRA2A, ADRA2B, ADRA2C, ADRB1, ADRB2, ADRB3, CHRM1, CHRM2, CHRM3, CHRM4, CHRM5, DRD1, DRD2, DRD3, DRD4, DRD5, GABRA1, GABRA2, GABRA3, GABRA4, GABRA5, GABRA6, GABRB1, GABRB2, GABRB3, GABRD, GABRE, GABRG1, GABRG2, GABRG3, GABRP, GABRQ, HRH1, HRH2, HRH4, HTR1A, HTR1B, HTR1D, HTR1E, HTR1F, HTR2A, HTR2B, HTR2C, HTR3A, HTR5A, HTR6, HTR7	Launched
olaparib	PARP inhibitor	PARP1, PARP2	Launched
olmesartan	angiotensin receptor antagonist	AGTR1	Launched
olmesartan-medoxomil	angiotensin receptor antagonist	AGTR1	Launched
olmutinib	EGFR inhibitor, Bruton's tyrosine kinase (BTK) inhibitor	BTK, EGFR	Launched
olopatadine	histamine receptor antagonist	HRH1, S100A1, S100A12, S100A13, S100A2, S100B	Launched
olprinone	phosphodiesterase inhibitor	PDE3A	Launched
olsalazine	cyclooxygenase inhibitor	IFNG, TPMT	Launched
omarigliptin	dipeptidyl peptidase inhibitor	DPP4	Launched
ombitasvir	HCV inhibitor		Launched
omega-3-acid-esters	cholesterol inhibitor		Launched
omeprazole	ATPase inhibitor	ATP4A, CLCN2	Launched
omeprazole-magnesium	proton pump inhibitor	ATP4A, ATP4B	Launched
ondansetron	serotonin receptor antagonist	HTR1A, HTR1B, HTR3A, HTR3B, HTR4, OPRM1	Launched
orbifloxacin	bacterial DNA gyrase inhibitor		Launched
oritavancin	bacterial cell wall synthesis inhibitor		Launched
orlistat	lipase inhibitor	CNR1, DAGLA, DAGLB, FASN, LIPF, PNLIP	Launched
orphenadrine	acetylcholine receptor antagonist	GRIN1, GRIN2D, GRIN3A, GRIN3B, HRH1, SCN10A, SLC6A2	Launched
oseltamivir-carboxylate	neuraminidase inhibitor		Launched
oseltamivir-phosphate	neuraminidase inhibitor	CES1, NEU1, NEU2	Launched
osimertinib	EGFR inhibitor	EGFR	Launched
otilonium	acetylcholine receptor antagonist	CACNA1C	Launched
ouabain	ATPase inhibitor	ATP1A1	Launched
oxacillin	bacterial cell wall synthesis inhibitor		Launched
oxaliplatin	DNA inhibitor		Launched
oxaprozin	cyclooxygenase inhibitor	PTGS1, PTGS2	Launched
oxatomide	histamine receptor antagonist	HRH1	Launched
oxcarbazepine	sodium channel blocker	SCN10A, SCN11A, SCN1A, SCN2A, SCN3A, SCN4A, SCN5A, SCN7A, SCN8A, SCN9A	Launched
oxibendazole	tubulin polymerization inhibitor	TUBB, TUBB4B	Launched
oxiconazole	bacterial cell wall synthesis inhibitor		Launched
oxprenolol	adrenergic receptor antagonist	ADRB1, ADRB2	Launched
oxtriphylline	adenosine receptor antagonist	ADORA1, ADORA2A, ADORA2B, ADORA3, HDAC2, PDE3A, PDE4A, PDE4B, PDE5A	Launched
oxybenzone	lipase inhibitor	LIPE	Launched
oxybutynin	acetylcholine receptor antagonist	CHRM1, CHRM2, CHRM3	Launched
oxyphencyclimine	cholinergic receptor antagonist	CHRM1, CHRM2, CHRM3	Launched
oxyphenonium	cholinergic receptor antagonist	CHRM1	Launched
oxytetracycline	bacterial 30S ribosomal subunit inhibitor		Launched
ozagrel	thromboxane synthase inhibitor	TBXAS1	Launched
paclitaxel	tubulin polymerization inhibitor	BCL2, MAP2, MAP4, MAPT, NR1I2, TLR4, TUBB, TUBB1	Launched
palbociclib	CDK inhibitor	CDK4, CDK6	Launched
paliperidone	dopamine receptor antagonist, serotonin receptor antagonist	ADRA1A, ADRA1B, ADRA2A, ADRA2B, ADRA2C, CYP2D6, CYP3A4, CYP3A5, DRD1, DRD2, DRD3, DRD4, HRH1, HTR1A, HTR1D, HTR2A, HTR2C	Launched
palonosetron	serotonin receptor antagonist	HTR3A	Launched
pamidronate	bone resorption inhibitor	FDPS	Launched
pancuronium	acetylcholine receptor antagonist	CHRM2, CHRM3, CHRNA1, CHRNA2	Launched
panobinostat	HDAC inhibitor	HDAC1, HDAC2, HDAC3, HDAC4, HDAC6, HDAC7, HDAC8, HDAC9	Launched
pantoprazole	ATPase inhibitor	ATP4A	Launched
papaverine	phosphodiesterase inhibitor	PDE10A, PDE4B, PDE5A	Launched
paracetamol	cyclooxygenase inhibitor	FAAH, PTGS1, PTGS2, TRPV1	Launched
parecoxib	cyclooxygenase inhibitor	LTF	Launched
pargyline	monoamine oxidase inhibitor	MAOA, MAOB	Launched
paritaprevir	HCV inhibitor		Launched
paromomycin	bacterial 30S ribosomal subunit inhibitor		Launched
paroxetine	selective serotonin reuptake inhibitor (SSRI)	CHRM1, CHRM2, CHRM3, CHRM4, CHRM5, HTR2A, SLC6A2, SLC6A4	Launched
paroxypropione	gonadotropin inhibitor		Launched
pasiniazid	cyclooxygenase inhibitor		Launched
pazopanib	KIT inhibitor, PDGFR tyrosine kinase receptor inhibitor, VEGFR inhibitor	CSF1R, FGF1, FGFR1, FGFR3, FLT1, FLT4, ITK, KDR, KIT, PDGFRA, PDGFRB, SH2B3	Launched
pazufloxacin	topoisomerase inhibitor		Launched
pefloxacin	bacterial DNA gyrase inhibitor	TOP2A	Launched
pemetrexed	dihydrofolate reductase inhibitor, thymidylate synthase inhibitor	ATIC, DHFR, GART, TYMS	Launched
pemirolast	mediator release inhibitor	HRH1	Launched
pempidine	ganglionic blocker		Launched
penbutolol	adrenergic receptor antagonist	ADRB1, ADRB2, HTR1A, HTR1B	Launched
penciclovir	DNA directed DNA polymerase inhibitor		Launched
penfluridol	T-type calcium channel blocker	CACNA1G	Launched
penicillin-v-potassium	bacterial cell wall synthesis inhibitor		Launched
pentolinium	cholinergic receptor antagonist	CHRNA10, CHRNA3, CHRNA4, CHRNB4	Launched
pentostatin	adenosine deaminase inhibitor, ribonucleotide reductase inhibitor	ADA	Launched
pentoxifylline	phosphodiesterase inhibitor	ADORA1, ADORA2A, ADORA2B, ADRA2B, NT5E, PDE10A, PDE1A, PDE1B, PDE1C, PDE2A, PDE3A, PDE3B, PDE4A, PDE4B, PDE4C, PDE4D, PDE5A, PDE6A, PDE6B, PDE6C, PDE6D, PDE6G, PDE6H, PDE7A, PDE7B, PDE8A, PDE8B, PDE9A, TNF	Launched
peramivir	neuraminidase inhibitor		Launched
perampanel	glutamate receptor antagonist	GRIA1, GRIA2, GRIA3, GRIA4	Launched
perhexiline	carnitine palmitoyltransferase inhibitor	CPT1A, CPT2	Launched
perindopril	angiotensin converting enzyme inhibitor	ACE	Launched
perospirone	dopamine receptor antagonist, serotonin receptor antagonist	DRD2, DRD3, DRD4	Launched
perphenazine	dopamine receptor antagonist	CALM1, DRD1, DRD2, HRH1, HTR2A, HTR2C, HTR6, HTR7	Launched
phenacemide	sodium channel blocker	SCN10A, SCN11A, SCN1A, SCN2A, SCN3A, SCN4A, SCN5A, SCN7A, SCN8A, SCN9A	Launched
phenazone	cyclooxygenase inhibitor	PTGS1, PTGS2	Launched
phenelzine	monoamine oxidase inhibitor	ABAT, AOC3, GAD2, GPT, GPT2, MAOA, MAOB, SLC6A2, SLC6A3, SLC6A4	Launched
phenethicillin	bacterial cell wall synthesis inhibitor		Launched
phenindamine	histamine receptor antagonist	HRH1	Launched
phenindione	vitamin K antagonist	VKORC1	Launched
pheniramine	histamine receptor antagonist	HRH1	Launched
phenoxybenzamine	adrenergic receptor antagonist	ADRA1A, ADRA1B, ADRA1D, ADRA2A, ADRA2B, ADRA2C, ADRB2, CALM1	Launched
phenprocoumon	vitamin K antagonist	VKORC1	Launched
phentermine	dopamine uptake inhibitor, serotonin reuptake inhibitor	MAOA, MAOB, SLC6A2, SLC6A3, SLC6A4	Launched
phentolamine	adrenergic receptor antagonist	ADRA1A, ADRA1B, ADRA1D, ADRA2A, ADRA2B, ADRA2C	Launched
phenylbutyrate	HDAC inhibitor	HDAC1	Launched
phenylpiracetam	noradrenaline uptake inhibitor		Launched
phloretin	sodium/glucose cotransporter inhibitor	AQP9, CLCN3, SLC23A1	Launched
phthalylsulfathiazole	dihydropteroate synthetase inhibitor		Launched
physostigmine	cholinesterase inhibitor	ACHE, BCHE	Launched
picotamide	thromboxane receptor antagonist, thromboxane synthase inhibitor	TBXA2R	Launched
piketoprofen	cyclooxygenase inhibitor		Launched
pilsicainide	sodium channel blocker	SCN5A	Launched
pimecrolimus	calcineurin inhibitor	FKBP1A, MTOR	Launched
pimobendan	calcium sensitizer, phosphodiesterase inhibitor	PDE3A	Launched
pimozide	dopamine receptor antagonist	CACNA1I, CALM1, DRD1, DRD2, DRD3, DRD4, DRD5, HRH1, HTR1A, HTR2A, KCNA10, KCNH2	Launched
pinaverium	T-type calcium channel blocker	CACNA1C	Launched
pindolol	adrenergic receptor antagonist	ADRB1, ADRB2, HTR1A, HTR1B, HTR2A, HTR2B	Launched
pipamperone	dopamine receptor antagonist	DRD2, HRH1, HTR1A, HTR1B, HTR1D, HTR2A	Launched
pipecuronium	neuromuscular blocker	CHRM2, CHRM3, CHRNA2	Launched
pipemidic-acid	topoisomerase inhibitor		Launched
pipenzolate	cholinergic receptor antagonist	CHRM1	Launched
piperacetazine	dopamine receptor antagonist		Launched
piperacillin	bacterial cell wall synthesis inhibitor		Launched
piperidolate	acetylcholine receptor antagonist	CHRM1	Launched
piperonyl-butoxide	cytochrome P450 inhibitor		Launched
pipotiazine-palmitate	dopamine receptor antagonist, serotonin receptor antagonist	DRD1, DRD2, HTR1A, HTR2A	Launched
pirarubicin	topoisomerase inhibitor	TOP2A	Launched
pirenoxine	AGE inhibitor		Launched
pirenzepine	acetylcholine receptor antagonist	CHRM1, CHRM2, CHRM3, CHRM4, CHRM5	Launched
pirfenidone	TGF beta receptor inhibitor	FURIN, TNF	Launched
pirlindole	monoamine oxidase inhibitor	MAOA	Launched
piroxicam	cyclooxygenase inhibitor	PTGS1, PTGS2	Launched
pitavastatin	HMGCR inhibitor	HMGCR	Launched
pivagabine	corticosteroid releasing factor receptor antagonist	CRHR1, CRHR2	Launched
pivampicillin	bacterial cell wall synthesis inhibitor		Launched
pivmecillinam	bacterial cell wall synthesis inhibitor		Launched
pixantrone	topoisomerase inhibitor	TOP2A	Launched
pizotifen	serotonin receptor antagonist	HTR1A, HTR2A, HTR2C	Launched
plerixafor	CC chemokine receptor antagonist	ACKR3, CCR4, CXCR4	Launched
plicamycin	alcohol dehydrogenase inhibitor		Launched
podophyllotoxin	microtubule inhibitor, tubulin polymerization inhibitor	IGF1R, TOP2A, TUBA4A, TUBB	Launched
polythiazide	sodium/chloride cotransporter inhibitor	SLC12A3	Launched
pomalidomide	angiogenesis inhibitor, tumor necrosis factor production inhibitor	CRBN, PTGS2, TNF	Launched
ponatinib	Bcr-Abl kinase inhibitor, FLT3 inhibitor, PDGFR tyrosine kinase receptor inhibitor	ABL1, BCR, FGFR1, FGFR2, FGFR3, FGFR4, FLT3, KDR, KIT, LCK, LYN, PDGFRA, RET, SRC, TEK	Launched
posaconazole	sterol demethylase inhibitor	CYP3A4	Launched
potassium-canrenoate	mineralocorticoid receptor antagonist	NR3C2	Launched
pralatrexate	dihydrofolate reductase inhibitor	DHFR, TYMS	Launched
pralidoxime	acetylcholinesterase inhibitor	ACHE, BCHE	Launched
pralidoxime-chloride	acetylcholinesterase inhibitor	ACHE, BCHE	Launched
pranlukast	leukotriene receptor antagonist	CYSLTR1, CYSLTR2, IL5, MUC2, NFKB1, RNASE3, TNF	Launched
pranoprofen	cyclooxygenase inhibitor		Launched
prasugrel	purinergic receptor antagonist	P2RY12	Launched
pravastatin	HMGCR inhibitor	HMGCR, SLCO1B1	Launched
prazosin	adrenergic receptor antagonist	ADRA1A, ADRA1B, ADRA1D, ADRA2A, ADRA2B, ADRA2C, KCNH2, KCNH6, KCNH7	Launched
primaquine	antimalarial agent, DNA inhibitor	KRT7, NQO2	Launched
primidone	GABA receptor antagonist	CHRNA4, CHRNA7, GABRA1, GABRA2, GABRA3, GABRA4, GABRA5, GABRA6, GABRB1, GABRB2, GABRB3, GABRD, GABRE, GABRG1, GABRG2, GABRG3, GABRP, GABRQ, GRIA2, GRIK2, SCN10A, SCN11A, SCN1A, SCN2A, SCN3A, SCN4A, SCN5A, SCN7A, SCN8A, SCN9A	Launched
probenecid	uricosuric blocker	PANX1, SLC22A11, SLC22A6, SLC22A8, SLCO1C1	Launched
probucol	atherogenesis inhibitor	ABCA1, ABCB11, CES1	Launched
procainamide	sodium channel blocker	DNMT1, SCN5A	Launched
procaine	HMGCR inhibitor	CHRNA2, GRIN3A, HTR3A, KCNMA1, KCNMB1, KCNMB2, KCNMB3, KCNMB4, KCNN1, KCNN2, KCNN3, KCNN4, MAOA, MAOB, RYR1, RYR2, SCN10A, SLC6A3	Launched
procarbazine	monoamine oxidase inhibitor		Launched
prochlorperazine	dopamine receptor antagonist	DRD1, DRD2, DRD3, DRD4	Launched
procyclidine	acetylcholine receptor antagonist	CHRM1, CHRM2, CHRM3, CHRM4	Launched
profenamine	butyrylcholinesterase inhibitor, cholinergic receptor antagonist	CHRM1, CHRM2, GRIN3A	Launched
proglumetacin	cyclooxygenase inhibitor	PTGS1, PTGS2	Launched
proguanil	dihydrofolate reductase inhibitor	DHFR	Launched
promazine	dopamine receptor antagonist	ADRA1A, ADRA1B, ADRA1D, CHRM1, CHRM2, CHRM3, CHRM4, CHRM5, DRD1, DRD2, DRD3, DRD4, HRH1, HTR2A, HTR2C	Launched
promethazine	histamine receptor antagonist	ADRA1A, CALM1, CHRM1, CHRM2, CHRM3, CHRM4, CHRM5, DRD2, HRH1, HTR2A	Launched
propacetamol	cyclooxygenase inhibitor	PTGS2	Launched
propantheline	acetylcholine receptor antagonist	CHRM1, CHRM2, CHRM3, CHRM4	Launched
propentofylline	adenosine reuptake inhibitor, phosphodiesterase inhibitor	PDE1A	Launched
propiverine	acetylcholine receptor antagonist	CHRM1	Launched
propranolol	adrenergic receptor antagonist		Launched
propylthiouracil	thyroid peroxidase inhibitor	DIO1, TPO	Launched
proquazone	cyclooxygenase inhibitor	PTGS1, PTGS2	Launched
proxodolol	adrenergic receptor antagonist		Launched
proxymetacaine	sodium channel blocker	SCN10A, SCN5A	Launched
prulifloxacin	bacterial DNA gyrase inhibitor		Launched
pyrantel-pamoate	neuromuscular blocker		Launched
pyrazinamide	fatty acid synthase inhibitor	FASN	Launched
pyrimethamine	dihydrofolate reductase inhibitor	DHFR, SLC47A1	Launched
pyrithione-zinc	ATP synthase inhibitor	KCNQ1, KCNQ2, KCNQ4, KCNQ5	Launched
pyrvinium	androgen receptor antagonist		Launched
pyrvinium-pamoate	androgen receptor antagonist	AR	Launched
quercetin	polar auxin transport inhibitor	ATP5A1, ATP5B, ATP5C1, HCK, HIBCH, PIK3CG, PIM1, STK17B, UGT3A1	Launched
quetiapine	dopamine receptor antagonist, serotonin receptor antagonist	ADRA1A, ADRA1B, ADRA1D, ADRA2A, ADRA2B, ADRA2C, CHRM1, CHRM2, CHRM3, CHRM4, CHRM5, DRD1, DRD2, DRD3, DRD4, DRD5, HRH1, HTR1A, HTR1B, HTR1D, HTR1E, HTR1F, HTR2A, HTR2C, HTR3A, HTR6, HTR7, SLC6A2	Launched
quinapril	angiotensin converting enzyme inhibitor	ACE	Launched
quinaprilat	angiotensin converting enzyme inhibitor	ACE	Launched
quinidine	sodium channel blocker	KCNA5, KCNA7, KCNH1, KCNH2, KCNH5, KCNK1, KCNK6, SCN5A, SLC29A4	Launched
quinine	hemozoin biocrystallization inhibitor	GP9, KCNB2, KCNN4, SLC29A4	Launched
rabeprazole	ATPase inhibitor, gastrin inhibitor	ATP4A	Launched
racecadotril	enkephalinase inhibitor	MME	Launched
raclopride	dopamine receptor antagonist	DRD2, DRD3, HTR1A	Launched
raloxifene	estrogen receptor antagonist, selective estrogen receptor modulator (SERM)	ESR1, ESR2	Launched
raltegravir	HIV integrase inhibitor		Launched
raltitrexed	thymidylate synthase inhibitor	FPGS, TYMS	Launched
ramatroban	prostanoid receptor antagonist	PTGDR2, TBXA2R	Launched
ramifenazone	cyclooxygenase inhibitor		Launched
ramipril	angiotensin converting enzyme inhibitor	ACE	Launched
ramosetron	serotonin receptor antagonist	HTR3A	Launched
ranitidine	histamine receptor antagonist	HRH2	Launched
ranolazine	sodium channel blocker	SCN10A, SCN4A, SCN5A, SCN9A	Launched
rasagiline	monoamine oxidase inhibitor	BCL2, MAOB	Launched
reboxetine	adrenergic receptor antagonist	SLC6A2	Launched
regorafenib	FGFR inhibitor, KIT inhibitor, PDGFR tyrosine kinase receptor inhibitor, RAF inhibitor, RET tyrosine kinase inhibitor, VEGFR inhibitor	ABL1, BRAF, DDR2, EPHA2, FGFR1, FGFR2, FLT1, FLT4, FRK, KDR, KIT, MAPK11, NTRK1, PDGFRA, PDGFRB, RAF1, RET, TEK	Launched
reserpine	vesicular monoamine transporter inhibitor	SLC18A1, SLC18A2	Launched
resorcinol	phosphodiesterase inhibitor	CA12, CA14, CA2, PTGS1	Launched
resveratrol	cytochrome P450 inhibitor, SIRT activator	CSNK2A1, NQO2, PTGS1, PTGS2	Launched
retapamulin	protein synthesis inhibitor		Launched
revaprazan	potassium-competitive acid antagonist	ATP4A	Launched
ribociclib	CDK inhibitor	CDK4, CDK6	Launched
ribostamycin	bacterial 30S ribosomal subunit inhibitor		Launched
ribostamycin-sulfate	bacterial 30S ribosomal subunit inhibitor	P4HB	Launched
rifabutin	protein synthesis inhibitor	HSP90AA1, HSP90B1	Launched
rifampin	RNA polymerase inhibitor	NR1I2, SLCO1A2, SLCO1B1, SLCO1B3	Launched
rifamycin	DNA directed RNA polymerase inhibitor	SLCO1A2, SLCO1B1, SLCO1B3, SLCO2B1	Launched
rifapentine	RNA polymerase inhibitor	CYP2C8, CYP2C9, CYP3A4	Launched
rifaximin	RNA synthesis inhibitor	NR1I2	Launched
rilpivirine	non-nucleoside reverse transcriptase inhibitor	NR1I2, SCN10A	Launched
riluzole	glutamate inhibitor	KCNK10, KCNK2, KCNK4, KCNN4, SCN10A, SCN11A, SCN1A, SCN2A, SCN3A, SCN4A, SCN5A, SCN7A, SCN8A, SCN9A, SLC7A11	Launched
rimantadine	antiviral, RNA synthesis inhibitor		Launched
ripasudil	rho associated kinase inhibitor	ROCK1, ROCK2	Launched
risedronate	osteoclast inhibitor	FDPS	Launched
risperidone	dopamine receptor antagonist, serotonin receptor antagonist	ADRA1A, ADRA1B, ADRA1D, ADRA2A, ADRA2B, ADRA2C, DRD1, DRD2, DRD3, DRD4, HRH1, HTR1A, HTR1B, HTR1D, HTR1E, HTR1F, HTR2A, HTR2C, HTR6, HTR7	Launched
ritonavir	HIV protease inhibitor	CYP1A2, CYP2B6, CYP2C19, CYP2C8, CYP2C9, CYP2D6, CYP2E1, CYP3A4, CYP3A5, CYP3A7	Launched
rivaroxaban	coagulation factor inhibitor	F10	Launched
rivastigmine	acetylcholinesterase inhibitor	ACHE, BCHE	Launched
rocuronium	acetylcholine receptor antagonist	CHRM2, CHRNA2, HTR3A	Launched
roflumilast	phosphodiesterase inhibitor	PDE4A, PDE4B, PDE4C, PDE4D	Launched
rolitetracycline	bacterial 30S ribosomal subunit inhibitor		Launched
romidepsin	HDAC inhibitor	HDAC1, HDAC2, HDAC3, HDAC4, HDAC5, HDAC6, HDAC7, HDAC8, HDAC9	Launched
ropivacaine	sodium channel blocker	SCN10A	Launched
rosmarinic-acid	GABA transaminase inhibitor	MCL1, TYR	Launched
rosoxacin	topoisomerase inhibitor		Launched
rosuvastatin	HMGCR inhibitor	HMGCR	Launched
roxatidine-acetate	histamine receptor antagonist	HRH2	Launched
roxithromycin	bacterial 50S ribosomal subunit inhibitor	ABCB1, MLNR	Launched
rufinamide	voltage-gated sodium channel blocker	GRM5, SCN10A, SCN11A, SCN1A, SCN2A, SCN3A, SCN4A, SCN5A, SCN7A, SCN8A, SCN9A	Launched
rufloxacin	bacterial DNA gyrase inhibitor		Launched
rupatadine	histamine receptor antagonist, platelet activating factor receptor antagonist	HRH1, PTAFR	Launched
ruxolitinib	JAK inhibitor	JAK1, JAK2, JAK3, TYK2	Launched
saccharin	DNA polymerase inhibitor	CA1, CA12, CA2, CA9	Launched
sacubitril	neprilysin inhibitor	MME	Launched
safinamide	dopamine uptake inhibitor, glutamate inhibitor, monoamine oxidase inhibitor	MAOB	Launched
salicylic-acid	cyclooxygenase inhibitor	AKR1C1, PTGS1, PTGS2	Launched
saquinavir	HIV protease inhibitor	CYP3A4	Launched
sarafloxacin	bacterial DNA gyrase inhibitor		Launched
sarpogrelate	serotonin receptor antagonist	HTR2A, HTR2B, HTR2C	Launched
sasapyrine	NFkB pathway inhibitor	PTGS1, PTGS2	Launched
saxagliptin	dipeptidyl peptidase inhibitor	DPP4	Launched
scopolamine	acetylcholine receptor antagonist		Launched
secnidazole	acetylcholinesterase inhibitor, microtubule inhibitor		Launched
selegiline	monoamine oxidase inhibitor	MAOA, MAOB	Launched
seratrodast	prostanoid receptor antagonist	TBXA2R	Launched
sertaconazole	sterol demethylase inhibitor		Launched
sertraline	selective serotonin reuptake inhibitor (SSRI)	SLC6A3, SLC6A4	Launched
setiptiline	adrenergic receptor antagonist	HRH1, HTR2A, HTR2C	Launched
sevelamer	phosphate antagonist		Launched
sevoflurane	membrane integrity inhibitor	ATP2C1, ATP5D, GABRA1, GABRA2, GABRA3, GABRA4, GABRA5, GABRA6, GABRB1, GABRB2, GABRB3, GABRD, GABRE, GABRG1, GABRG2, GABRG3, GABRP, GABRQ, GLRA1, GLRB, GRIA1, KCNA1, KCNK10, KCNK18, KCNK2, KCNK3, KCNK9, MT-ND1	Launched
sildenafil	phosphodiesterase inhibitor	PDE5A, PDE6G, PDE6H, SLCO1B1, SLCO1B3	Launched
silibinin	cytochrome P450 inhibitor	ALOX5	Launched
silodosin	adrenergic receptor antagonist	ADRA1A, ADRA1B, ADRA1D	Launched
silver-sulfadiazine	PABA antagonist		Launched
simeprevir	HCV inhibitor	CYP1A2, CYP3A4	Launched
simvastatin	HMGCR inhibitor	HMGCR, ITGB2	Launched
sirolimus	mTOR inhibitor	FGF2, FKBP1A, MTOR	Launched
sisomicin	protein synthesis inhibitor		Launched
sisomicin-sulfate	bacterial 30S ribosomal subunit inhibitor		Launched
sitafloxacin	bacterial DNA gyrase inhibitor		Launched
sitagliptin	dipeptidyl peptidase inhibitor	DPP4	Launched
sivelestat	elastase inhibitor	CELA1, ELANE	Launched
SN-38	topoisomerase inhibitor	TOP1	Launched
sodium-salicylate	prostanoid receptor antagonist	ASIC3, PTGS1, PTGS2	Launched
sodium-stibogluconate	tyrosine phosphatase inhibitor	PTPN6, TOP1	Launched
sofosbuvir	RNA polymerase inhibitor		Launched
solifenacin-succinate	acetylcholine receptor antagonist	CHRM1, CHRM2, CHRM3, CHRM4, CHRM5	Launched
sonidegib	smoothened receptor antagonist	SMO	Launched
sorafenib	FLT3 inhibitor, KIT inhibitor, PDGFR tyrosine kinase receptor inhibitor, RAF inhibitor, RET tyrosine kinase inhibitor, VEGFR inhibitor	BRAF, DDR2, FGFR1, FLT1, FLT3, FLT4, KDR, KIT, PDGFRB, RAF1, RET	Launched
sotalol	adrenergic receptor antagonist	ADRB1, ADRB2, KCNH2	Launched
spaglumic-acid	glutamate receptor antagonist	GRM3	Launched
spectinomycin	bacterial 30S ribosomal subunit inhibitor		Launched
spiperone	dopamine receptor antagonist	ADRA1A, ADRA1B, ADRA1D, DRD1, DRD2, DRD3, DRD4, DRD5, HTR1A, HTR1D, HTR2A, HTR2B, HTR2C, HTR6, HTR7	Launched
spiramycin	bacterial 50S ribosomal subunit inhibitor		Launched
spironolactone	mineralocorticoid receptor antagonist	AR, CACNA1A, CACNA1B, CACNA1C, CACNA1D, CACNA1F, CACNA1G, CACNA1H, CACNA1I, CACNA1S, CACNA2D1, CACNA2D2, CACNA2D3, CACNB1, CACNB2, CACNB3, CACNB4, CACNG1, CYP11B2, NR3C1, NR3C2, PGR, SHBG	Launched
stavudine	DNA directed DNA polymerase inhibitor, nucleoside reverse transcriptase inhibitor		Launched
stiripentol	GABA uptake inhibitor	GABRA3	Launched
streptomycin	bacterial 30S ribosomal subunit inhibitor		Launched
strontium-ranelate	bone formation stimulant, bone resorption inhibitor	CASR	Launched
sulbactam	beta lactamase inhibitor		Launched
sulbactam-pivoxil	beta lactamase inhibitor		Launched
sulbutiamine	acetylcholine receptor antagonist		Launched
sulconazole	sterol demethylase inhibitor		Launched
sulfacetamide	PABA antagonist		Launched
sulfadoxine	dihydropteroate synthase inhibitor		Launched
sulfameter	dihydrofolate reductase inhibitor	DHFR	Launched
sulfamethazine	PABA antagonist		Launched
sulfamethoxazole	PABA antagonist		Launched
sulfametopyrazine	PABA antagonist		Launched
sulfamoxole	PABA antagonist		Launched
sulfanilamide	carbonic anhydrase inhibitor	CYP2C19, CYP2C9, CYP2D6, CYP2E1, CYP3A4	Launched
sulfaphenazole	dihydropteroate synthetase inhibitor	DHPS	Launched
sulfapyridine	PABA antagonist		Launched
sulfaquinoxaline	vitamin K antagonist		Launched
sulfasalazine	cyclooxygenase inhibitor	ACAT1, ALOX5, CHUK, IKBKB, PLA2G1B, PPARG, PTGS1, PTGS2, SLC46A1, SLC7A11, TBXAS1	Launched
sulfathiazole	dihydropteroate synthase inhibitor		Launched
sulfinpyrazone	uricosuric blocker	ABCC1, ABCC2, FPR1, SLC22A12	Launched
sulfisoxazole-acetyl	folic acid antagonist		Launched
sulindac	cyclooxygenase inhibitor	AKR1B1, MAPK3, PPARD, PTGDR2, PTGS1, PTGS2	Launched
sulmetozine	gastrin inhibitor	GAST	Launched
sulphadimethoxine	dihydropteroate synthetase inhibitor		Launched
sulpiride	dopamine receptor antagonist		Launched
sunitinib	FLT3 inhibitor, KIT inhibitor, PDGFR tyrosine kinase receptor inhibitor, RET tyrosine kinase inhibitor, VEGFR inhibitor	CSF1R, FGFR1, FLT1, FLT3, FLT4, KDR, KIT, PDGFRA, PDGFRB, RET	Launched
suplatast	histamine release inhibitor, immunoglobulin inhibitor		Launched
suramin	DNA synthesis inhibitor	F2, FSHR, P2RY1, P2RY11, P2RY13, P2RY2, PLA2G2A, RYR1, RYR2, SIRT5	Launched
suvorexant	orexin receptor antagonist	HCRTR1, HCRTR2	Launched
suxibuzone	cyclooxygenase inhibitor		Launched
tacrine	acetylcholinesterase inhibitor	ACHE, BCHE	Launched
tacrolimus	calcineurin inhibitor	FKBP1A	Launched
tadalafil	phosphodiesterase inhibitor	PDE11A, PDE5A	Launched
tafamidis-meglumine	transthyretin amyloid inhibitor	TTR	Launched
talinolol	adrenergic receptor antagonist	ADRB1	Launched
talniflumate	cyclooxygenase inhibitor	CLCA1	Launched
tamoxifen	estrogen receptor antagonist, selective estrogen receptor modulator (SERM)	EBP, ESR1, ESR2, GPER1, PRKCA, PRKCB, PRKCD, PRKCE, PRKCG, PRKCI, PRKCQ, PRKCZ	Launched
tamsulosin	adrenergic receptor antagonist	ADRA1A, ADRA1B, ADRA1D	Launched
tannic-acid	PARG inhibitor	ANO1	Launched
tavaborole	leucyl-tRNA synthetase inhibitor		Launched
tazobactam	beta lactamase inhibitor		Launched
tebipenem	bacterial cell wall synthesis inhibitor	CNR1	Launched
tedizolid	bacterial 50S ribosomal subunit inhibitor		Launched
tedizolid-phosphate	protein synthesis inhibitor		Launched
teicoplanin	bacterial cell wall synthesis inhibitor		Launched
teicoplanin-A2-1	bacterial cell wall synthesis inhibitor		Launched
teicoplanin-a2-3	bacterial cell wall synthesis inhibitor		Launched
telaprevir	HCV inhibitor	CTSA, PGR	Launched
telbivudine	DNA polymerase inhibitor	TK2	Launched
telithromycin	bacterial 30S ribosomal subunit inhibitor, bacterial 50S ribosomal subunit inhibitor	CYP1A2, CYP2D6, CYP3A4, CYP3A5, CYP3A7	Launched
telmisartan	angiotensin receptor antagonist	AGTR1, PPARG	Launched
telotristat	tryptophan hydroxylase inhibitor	TPH1	Launched
telotristat-ethyl	tryptophan hydroxylase inhibitor	TPH1	Launched
temefos	cholinesterase inhibitor		Launched
temocapril	angiotensin converting enzyme inhibitor	ACE	Launched
temsirolimus	mTOR inhibitor	MTOR	Launched
teneligliptin	dipeptidyl peptidase inhibitor	DPP4	Launched
teniposide	topoisomerase inhibitor	TOP2A, TOP2B	Launched
tenofovir	HIV integrase inhibitor, nucleoside reverse transcriptase inhibitor		Launched
tenofovir-disoproxil	nucleoside reverse transcriptase inhibitor	CYP1A2	Launched
tenoxicam	cyclooxygenase inhibitor	PTGS1, PTGS2	Launched
tepoxalin	cyclooxygenase inhibitor, lipoxygenase inhibitor	ALOX5	Launched
terazosin	adrenergic receptor antagonist	ADRA1A, ADRA1B, ADRA1D, KCNH2, KCNH6, KCNH7	Launched
terbinafine	fungal squalene epoxidase inhibitor	SQLE	Launched
terconazole	sterol demethylase inhibitor		Launched
terguride	dopamine receptor agonist, serotonin receptor antagonist	ADRA1A, ADRA2A, ADRA2B, ADRA2C, DRD2, DRD3, DRD4, HTR1A, HTR1B, HTR1D, HTR2A, HTR2B, HTR2C	Launched
teriflunomide	dihydroorotate dehydrogenase inhibitor	DHODH	Launched
testolactone	aromatase inhibitor	CYP19A1	Launched
tetrabenazine	vesicular monoamine transporter inhibitor	DRD2, SLC18A1, SLC18A2	Launched
tetracaine	membrane integrity inhibitor	SCN10A, SCN11A, SCN1A, SCN2A, SCN3A, SCN4A, SCN5A, SCN7A, SCN8A, SCN9A	Launched
tetracycline	bacterial 30S ribosomal subunit inhibitor	PRNP	Launched
thalidomide	tumor necrosis factor production inhibitor	CRBN, FGFR2, NFKB1, ORM1, ORM2, PTGS2, TNF	Launched
theobromine	phosphodiesterase inhibitor	ADORA1, ADORA2A, PDE4B	Launched
theophylline	adenosine receptor antagonist		Launched
thiamphenicol	bacterial 50S ribosomal subunit inhibitor		Launched
thiamylal	glutamate receptor antagonist	GABRA1, KCNJ11, KCNJ8	Launched
thiethylperazine	dopamine receptor antagonist	DRD1, DRD2, DRD4	Launched
thiocolchicoside	GABA receptor antagonist	GABRA1, GABRB2, GABRG2, GLRA1, GLRB	Launched
thioguanine	purine antagonist	IMPDH1, IMPDH2	Launched
thiopental	GABA receptor antagonist	CHRNA4, CHRNA7, FAAH, GABRA1, GABRA2, GABRA3, GABRA4, GABRA5, GABRA6, GRIA2, GRIK2	Launched
thioproperazine	dopamine receptor antagonist	ADRA1A, ADRA1B, DRD1, DRD2, HTR1A, HTR2A	Launched
thiostrepton	FOXM1 inhibitor, protein synthesis inhibitor	FOXM1	Launched
thiotepa	cytochrome P450 inhibitor	CYP2B6, CYP3A4	Launched
thiothixene	dopamine receptor antagonist	DRD1, DRD2, HRH1, HTR2A	Launched
thonzonium	ATPase inhibitor		Launched
tiabendazole	angiogenesis inhibitor		Launched
tiagabine	GABA uptake inhibitor	SLC6A1	Launched
tiapride	dopamine receptor antagonist	DRD2, DRD3	Launched
tiaprofenic-acid	cyclooxygenase inhibitor	PTGS1, PTGS2	Launched
ticagrelor	purinergic receptor antagonist	P2RY12	Launched
ticarcillin	lactamase inhibitor		Launched
ticlopidine	purinergic receptor antagonist	P2RY12	Launched
tigecycline	bacterial 30S ribosomal subunit inhibitor		Launched
tiletamine	glutamate receptor antagonist		Launched
tilmicosin	bacterial 50S ribosomal subunit inhibitor		Launched
tiludronate	bone resorption inhibitor, osteoclast inhibitor	ATP6V1A, MMP2, PTPN1	Launched
timolol	adrenergic receptor antagonist	ADRB1, ADRB2	Launched
tioconazole	sterol demethylase inhibitor	CYP51A1	Launched
tiotropium	acetylcholine receptor antagonist	CHRM1, CHRM2, CHRM3	Launched
tipiracil	thymidine phosphorylase inhibitor	TYMP	Launched
tipranavir	HIV protease inhibitor		Launched
tiquizium	acetylcholine receptor antagonist		Launched
tirofiban	platelet aggregation inhibitor, structural glycoprotein antagonist	ITGA2B, ITGB3	Launched
tobramycin	bacterial 30S ribosomal subunit inhibitor		Launched
tocainide	sodium channel blocker	SCN5A	Launched
toceranib	protein tyrosine kinase inhibitor	FLT1, FLT3, KDR, PDGFRA, PDGFRB	Launched
tofacitinib	JAK inhibitor	JAK1, JAK2, JAK3, TYK2	Launched
tofisopam	phosphodiesterase inhibitor, cytochrome P450 inhibitor	CYP3A4, PDE10A, PDE2A, PDE3A, PDE4A	Launched
tofogliflozin	sodium/glucose cotransporter inhibitor	GCK	Launched
tolazamide	ATP channel blocker	ABCC8, KCNJ1, KCNJ10, KCNJ11	Launched
tolazoline	adrenergic receptor antagonist	ADRA1A, ADRA2A, ADRA2B, ADRA2C, HRH1, HRH2	Launched
tolbutamide	ATP channel blocker	ABCC8, KCNJ1, KCNJ11, KCNJ8	Launched
tolfenamic-acid	cyclooxygenase inhibitor, prostanoid receptor antagonist		Launched
tolmetin	cyclooxygenase inhibitor	PTGS1, PTGS2	Launched
tolnaftate	fungal squalene epoxidase inhibitor		Launched
tolonidine	adrenergic receptor antagonist	ADRA2A	Launched
toloxatone	monoamine oxidase inhibitor	MAOA, MAOB	Launched
tolperisone	voltage-gated sodium channel blocker	CYP2C19, CYP2D6	Launched
tolterodine	acetylcholine receptor antagonist	CHRM1, CHRM2, CHRM3, CHRM4, CHRM5	Launched
tolvaptan	vasopressin receptor antagonist	AVPR1A, AVPR2	Launched
topiramate	carbonic anhydrase inhibitor, glutamate receptor antagonist, kainate receptor antagonist	CA1, CA12, CA2, CA4, CA7, GABRA1, GABRA2, GABRA3, GABRA4, GABRA5, GABRA6, GABRB1, GABRB2, GABRB3, GABRD, GABRE, GABRG1, GABRG2, GABRG3, GABRP, GABRQ, GRIA1, GRIA2, GRIA3, GRIA4, GRIK1, GRIK2, GRIK3, GRIK4, GRIK5, SCN10A, SCN11A, SCN1A, SCN2A, SCN3A, SCN4A, SCN5A, SCN7A, SCN8A, SCN9A	Launched
topiroxostat	xanthine oxidase inhibitor	XDH	Launched
topotecan	topoisomerase inhibitor	TOP1, TOP1MT	Launched
torasemide	electrolyte reabsorption inhibitor, thromboxane receptor antagonist	SLC12A1	Launched
toremifene	estrogen receptor antagonist, selective estrogen receptor modulator (SERM)	ESR1	Launched
tosufloxacin	bacterial DNA gyrase inhibitor		Launched
tramadol	norepinephrine reputake inhibitor, opioid receptor agonist, serotonin reuptake inhibitor	CHRFAM7A, CHRM3, GRIN3A, HTR2C, OPRD1, OPRK1, OPRM1, SLC6A2, SLC6A4	Launched
trametinib	MEK inhibitor	MAP2K1, MAP2K2	Launched
trandolapril	angiotensin converting enzyme inhibitor	ACE	Launched
tranexamic-acid	antifibrinolytic, plasminogen activator inhibitor	PLG	Launched
tranilast	angiogenesis inhibitor	HPGDS, HRH1	Launched
tranylcypromine	monoamine oxidase inhibitor	KDM1A, MAOA, MAOB	Launched
trapidil	PDGFR tyrosine kinase receptor inhibitor	PDGFRA	Launched
trazodone	adrenergic receptor antagonist, serotonin receptor antagonist, serotonin reuptake inhibitor	ADRA1A, ADRA2A, HRH1, HTR1A, HTR2A, HTR2B, HTR2C, SLC6A4	Launched
trelagliptin	dipeptidyl peptidase inhibitor	DPP4	Launched
treosulfan	DNA synthesis inhibitor		Launched
trepibutone	cholinergic receptor antagonist	CHRM1, CHRM2, CHRM3, CHRM4	Launched
triamterene	sodium channel blocker	SCNN1A, SCNN1B, SCNN1D, SCNN1G	Launched
trichlormethiazide	chloride channel blocker	ATP1A1, CA1, CA2, CA4, SLC12A1, SLC12A3	Launched
triclabendazole	microtubule inhibitor	DNMT1	Launched
tridihexethyl	acetylcholine receptor antagonist	CHRM1, CHRM2, CHRM3	Launched
trifluoperazine	dopamine receptor antagonist	ADRA1A, CALM1, CALY, DRD2, DRD4, HRH1, HTR2A, HTR2C, S100A4, TNNC1	Launched
triflupromazine	dopamine receptor antagonist	CHRM1, CHRM2, DRD1, DRD2, HTR2B	Launched
trifluridine	DNA directed DNA polymerase inhibitor, thymidylate synthase inhibitor	TYMS	Launched
triflusal	cyclooxygenase inhibitor, platelet aggregation inhibitor, thromboxane synthase inhibitor	NFKB1, NOS2, PDE10A, PTGS1	Launched
trihexyphenidyl	acetylcholine receptor antagonist	CHRM1, CHRM2, CHRM3, CHRM4, CHRM5	Launched
trilostane	3beta-hydroxy-delta5-steroid dehydrogenase inhibitor	ESR1, ESR2, HSD3B1, HSD3B2	Launched
trimeprazine	histamine receptor ligand, histamine receptor antagonist	HRH1	Launched
trimetazidine	3-ketoacyl CoA thiolase inhibitor	ACAA2	Launched
trimethobenzamide	histamine receptor antagonist	DRD2	Launched
trimethoprim	dihydrofolate reductase inhibitor	DHFR, TYMS	Launched
trimethoquinol	adrenergic receptor antagonist	ADRB2, ADRB3	Launched
trimipramine	norepinephrine reputake inhibitor, tricyclic antidepressant	ADRA1A, ADRA1B, ADRA2A, ADRA2B, ADRB1, ADRB2, ADRB3, CHRM1, CHRM2, CHRM3, CHRM4, CHRM5, DRD1, DRD2, DRD5, HRH1, HTR1A, HTR1D, HTR2A, HTR2C, HTR3A, SLC6A2, SLC6A3, SLC6A4	Launched
trioxsalen	DNA synthesis inhibitor		Launched
tripelennamine	histamine receptor antagonist	HRH1	Launched
triprolidine	histamine receptor antagonist	HRH1	Launched
troleandomycin	protein synthesis inhibitor		Launched
tromaril	prostanoid receptor antagonist		Launched
tropesin	cyclooxygenase inhibitor	PTGS1, PTGS2	Launched
tropicamide	acetylcholine receptor antagonist	CHRM1, CHRM2, CHRM3, CHRM4	Launched
tropisetron	serotonin receptor antagonist	GLRA1, GLRA2, GLRB, HTR3A, HTR4	Launched
trospium	acetylcholine receptor antagonist	CHRM1	Launched
tubocurarine	acetylcholine receptor antagonist	ACHE, CHRNA2, HTR3A, HTR3B, KCNN1, KCNN2, KCNN3, ZACN	Launched
tylosin	protein synthesis inhibitor		Launched
tyloxapol	NFkB pathway inhibitor	LPL, NFKB2	Launched
ubenimex	leukotriene synthesis inhibitor	LTA4H, RNPEP	Launched
ufenamate	cyclooxygenase inhibitor	PTGS1, PTGS2	Launched
ulipristal	progesterone receptor antagonist	PGR	Launched
umeclidinium	acetylcholine receptor antagonist	CHRM1, CHRM2, CHRM3	Launched
uracil-mustard	DNA synthesis inhibitor		Launched
urapidil	adrenergic receptor antagonist	HTR1A	Launched
valaciclovir	DNA polymerase inhibitor		Launched
valethamate	acetylcholine receptor antagonist	CHRM1, CHRM4, CHRM5	Launched
valganciclovir	DNA synthesis inhibitor		Launched
valnemulin	bacterial 50S ribosomal subunit inhibitor		Launched
valproic-acid	HDAC inhibitor	ABAT, ACADSB, ALDH5A1, HDAC1, HDAC2, HDAC9, OGDH, SCN10A, SCN11A, SCN1A, SCN1B, SCN2A, SCN2B, SCN3A, SCN3B, SCN4A, SCN4B, SCN5A, SCN7A, SCN8A, SCN9A	Launched
valpromide	epoxide hydolase inhibitor		Launched
valrubicin	DNA inhibitor, topoisomerase inhibitor	TOP2A	Launched
valsartan	angiotensin receptor antagonist	AGTR1	Launched
vancomycin	bacterial cell wall synthesis inhibitor		Launched
vandetanib	EGFR inhibitor, RET tyrosine kinase inhibitor, VEGFR inhibitor	EGFR, EPHA1, EPHA10, EPHA2, EPHA3, EPHA4, EPHA5, EPHA6, EPHA7, EPHA8, EPHB1, EPHB2, EPHB3, EPHB4, EPHB6, ERBB2, ERBB3, ERBB4, FLT1, FLT4, KDR, PTK6, RET, SRC, TEK, VEGFA	Launched
vardenafil	phosphodiesterase inhibitor	PDE5A, PDE6G, PDE6H	Launched
vecuronium	acetylcholine receptor antagonist	CHRNA2	Launched
vemurafenib	RAF inhibitor	BRAF, RAF1	Launched
venetoclax	BCL inhibitor	BCL2	Launched
venlafaxine	adrenergic inhibitor, norepinephrine reuptake inhibitor, serotoninâ€“norepinephrine reuptake inhibitor (SNRI)	SLC6A2, SLC6A3, SLC6A4	Launched
verapamil	calcium channel blocker	CACNA1A, CACNA1B, CACNA1C, CACNA1D, CACNA1F, CACNA1G, CACNA1I, CACNA1S, CACNB1, CACNB2, CACNB3, CACNB4, CYP3A4, KCNA10, KCNA7, KCNH2, KCNJ11, NALCN, SCN5A, SLC29A4, SLC6A4	Launched
vernakalant	potassium channel blocker	KCNA5	Launched
vesnarinone	phosphodiesterase inhibitor	KCNH2, PDE3A	Launched
vigabatrin	GABA aminotransferase inhibitor	ABAT, GABBR1, SLC32A1	Launched
vilazodone	serotonin reuptake inhibitor	DRD2, DRD3, HRH1, HTR1A, HTR4, SLC6A4	Launched
vildagliptin	dipeptidyl peptidase inhibitor	DPP4	Launched
viloxazine	norepinephrine reuptake inhibitor	SLC6A2	Launched
vinblastine	microtubule inhibitor, tubulin polymerization inhibitor	JUN, TUBA1A, TUBB, TUBD1, TUBE1, TUBG1	Launched
vinburnine	adrenergic receptor antagonist	CHRM1, CHRM2, CHRM3, CHRM4	Launched
vincristine	tubulin polymerization inhibitor	TUBA4A, TUBB	Launched
vindesine	tubulin polymerization inhibitor	TUBB, TUBB1	Launched
vinflunine	microtubule inhibitor		Launched
vinorelbine	tubulin polymerization inhibitor	TUBA1A, TUBA1B, TUBA1C, TUBA3C, TUBA3D, TUBA3E, TUBA4A, TUBB, TUBB1, TUBB2A, TUBB2B, TUBB3, TUBB4A, TUBB4B, TUBB6, TUBB8	Launched
vinpocetine	phosphodiesterase inhibitor, sodium channel blocker	PDE1A, PDE1C	Launched
viomycin	protein synthesis inhibitor		Launched
vismodegib	hedgehog pathway inhibitor, smoothened receptor antagonist	SMO	Launched
voglibose	glucosidase inhibitor	MGAM	Launched
vonoprazan	potassium-competitive acid antagonist	ATP4A	Launched
vorapaxar	thrombin receptor antagonist	F2R	Launched
voriconazole	cytochrome P450 inhibitor	CYP2C19, CYP2C9, CYP3A4, CYP3A5, PTGS1	Launched
vorinostat	HDAC inhibitor	HDAC1, HDAC10, HDAC11, HDAC2, HDAC3, HDAC5, HDAC6, HDAC8, HDAC9	Launched
vortioxetine	serotonin receptor agonist, serotonin receptor antagonist	HTR1A, HTR1B, HTR2A, HTR2C, HTR3A, HTR5A, HTR6, HTR7, SLC6A4	Launched
warfarin	vitamin K antagonist	VKORC1	Launched
xipamide	carbonic anhydrase inhibitor	SLC12A3	Launched
yohimbine	adrenergic receptor antagonist	ADRA2A, ADRA2B, ADRA2C, DRD2, DRD3, HTR1A, HTR1B, HTR1D, HTR1E, HTR1F, HTR2A, HTR2B, HTR2C, HTR5A, HTR7, KCNJ1, KCNJ10, KCNJ11, KCNJ12, KCNJ14, KCNJ15, KCNJ8	Launched
zafirlukast	leukotriene receptor antagonist	CYSLTR1, CYSLTR2	Launched
zalcitabine	nucleoside reverse transcriptase inhibitor		Launched
zaltoprofen	cyclooxygenase inhibitor		Launched
zanamivir	neuraminidase inhibitor	NEU2	Launched
zidovudine	nucleoside reverse transcriptase inhibitor	TERT	Launched
zileuton	leukotriene synthesis inhibitor, lipoxygenase inhibitor	ALOX5	Launched
ziprasidone	dopamine receptor antagonist, serotonin receptor antagonist	ADRA1A, ADRA1B, ADRA2A, ADRA2B, ADRA2C, CHRM1, CHRM2, CHRM3, CHRM4, CHRM5, DRD1, DRD2, DRD3, DRD4, DRD5, HRH1, HTR1A, HTR1B, HTR1D, HTR1E, HTR2A, HTR2C, HTR3A, HTR6, HTR7, SLC6A4	Launched
zofenopril-calcium	angiotensin converting enzyme inhibitor	ACE	Launched
zoledronic-acid	bone resorption inhibitor	FDPS, GGPS1	Launched
zonisamide	sodium channel blocker, T-type calcium channel blocker	CA1, CA10, CA11, CA12, CA13, CA14, CA2, CA3, CA4, CA5A, CA5B, CA6, CA7, CA8, CA9, CACNA1G, CACNA1H, CACNA1I, MAOA, MAOB, SCN10A, SCN11A, SCN1A, SCN1B, SCN2A, SCN2B, SCN3A, SCN3B, SCN4A, SCN4B, SCN5A, SCN7A, SCN8A, SCN9A	Launched
zotarolimus	mTOR inhibitor	FKBP1A	Launched
zotepine	dopamine receptor antagonist, serotonin receptor antagonist	ADRA2B, DRD2, DRD3, DRD4, HRH1, HTR1A, HTR1B, HTR1D, HTR1E, HTR2A, HTR2C, HTR6, HTR7, SLC6A2, SLC6A4	Launched
zuclopenthixol	dopamine receptor antagonist	ADRA1A, ADRA2A, DRD1, DRD2, DRD5, HRH1, HTR2A	Launched
17-alpha-methyltestosterone	aromatase inhibitor	AR	Launched
5-fluorouracil	thymidylate synthase inhibitor	DPYD, TYMS	Launched
ABT-239	histamine receptor antagonist	HRH1, HRH2, HRH3	Phase 1
ABT-491	platelet activating factor receptor antagonist	PTAFR	Phase 1
acalisib	PI3K inhibitor	PIK3CB, PIK3CD	Phase 1
ACPC	glutamate receptor antagonist		Phase 1
ACT-462206	orexin receptor antagonist	HCRTR1, HCRTR2	Phase 1
ACTB-1003	FGFR inhibitor, VEGFR inhibitor	KDR, TEK	Phase 1
alafosfalin	bacterial cell wall synthesis inhibitor		Phase 1
ALS-8176	RNA polymerase inhibitor		Phase 1
altiratinib	VEGFR inhibitor, MET inhibitor	KDR, MET, TEK	Phase 1
ALX-5407	Glycine transporter 1 inhibitor	SLC6A9	Phase 1
AMG-208	tyrosine kinase inhibitor	MET	Phase 1
AMG-517	TRPV antagonist	TRPV1	Phase 1
AMG-548	MAP kinase inhibitor	MAPK11, MAPK12, MAPK13, MAPK14	Phase 1
AMG-925	CDK inhibitor, FLT3 inhibitor	CDK4, CDK6, FLT3	Phase 1
AMG900	Aurora kinase inhibitor	AURKA, AURKB, AURKC	Phase 1
amiflamine	monoamine oxidase inhibitor	MAOA, SLC6A2	Phase 1
ammonium-perfluorocaprylate	Pim kinase inhibitor	PIM1	Phase 1
antagonist-g	neuropeptide receptor antagonist	MAPK8	Phase 1
AN2718	leucyl-tRNA synthetase inhibitor		Phase 1
aphidicolin	RNA synthesis inhibitor		Phase 1
apocynin	NADPH oxidase inhibitor	NOX4	Phase 1
AR-12	phosphoinositide dependent kinase inhibitor	PDPK1	Phase 1
AR-42	HDAC inhibitor	HDAC1	Phase 1
arachidonic-acid	cytochrome P450 inhibitor	CLCN2, KCNJ4, KCNK10, KCNK18, KCNK2, PRKCZ, PTGS1, TRPC6, TRPM2	Phase 1
ARQ-092	AKT inhibitor	AKT2	Phase 1
ARQ-621	kinesin-like spindle protein inhibitor	KIF11	Phase 1
ASP-2535	glycine transporter inhibitor	SLC6A9	Phase 1
ASP3026	ALK tyrosine kinase receptor inhibitor	ALK	Phase 1
AST-1306	EGFR inhibitor	EGFR, ERBB2	Phase 1
asymmetrical-dimethylarginine	nitric oxide synthase inhibitor	NOS2, NOS3	Phase 1
AT13148	protein kinase inhibitor	AKT1, AKT2, AKT3, ROCK1, ROCK2, SGK3	Phase 1
AV-412	protein tyrosine kinase inhibitor	EGFR, ERBB2	Phase 1
AZD1080	glycogen synthase kinase inhibitor	GSK3A, GSK3B	Phase 1
AZD1208	Pim kinase inhibitor	PIM1, PIM2, PIM3	Phase 1
AZD1480	JAK inhibitor	JAK1, JAK2, JAK3	Phase 1
AZD2461	PARP inhibitor		Phase 1
AZD3759	EGFR inhibitor	EGFR	Phase 1
AZD3839	beta-secretase inhibitor	BACE1	Phase 1
AZD3965	monocarboxylate transporter inhibitor	SLC16A1	Phase 1
AZD4282	glutamate receptor antagonist	AGXT, AGXT2, ALAS1, ALAS2, BAAT, GARS, GATM, GCAT, GCSH, GLDC, GLRA1, GLRA2, GLRA3, GLRB, GLYAT, GLYATL1, GLYATL2, GNMT, GPR18, GPRC6A, GRIN1, GRIN2A, GRIN2B, GRIN2C, GRIN2D, GRIN3B, GSS, PIPOX, SHMT1, SHMT2, SLC32A1, SLC36A1, SLC6A5, SLC6A9	Phase 1
AZD5438	CDK inhibitor	KCNH2	Phase 1
AZD6482	PI3K inhibitor	PIK3CA, PIK3CB, PIK3CD, PIK3CG	Phase 1
AZD7545	pyruvate dehydrogenase kinase inhibitor	PDK1	Phase 1
AZD7687	diacylglycerol O acyltransferase inhibitor	DGAT1	Phase 1
AZD7762	CHK inhibitor	CHEK1, CHEK2	Phase 1
AZD8055	mTOR inhibitor	MTOR	Phase 1
AZD8186	PI3K inhibitor	PIK3CB, PIK3CD	Phase 1
AZD8330	MEK inhibitor		Phase 1
AZD8835	PI3K inhibitor	PIK3CA, PIK3CD	Phase 1
BAY-87-2243	hypoxia inducible factor inhibitor	HIF1A	Phase 1
BCX-1470	serine protease inhibitor, complement inhibitor	CFD	Phase 1
begacestat	gamma secretase inhibitor	PSEN1	Phase 1
benurestat	urease inhibitor		Phase 1
benzotript	CCK receptor antagonist	CCKAR, CCKBR	Phase 1
BI-224436	HIV integrase inhibitor		Phase 1
BI-847325	MEK inhibitor, Aurora kinase inhibitor	AURKA, AURKB, AURKC, MAP2K1, MAP2K2	Phase 1
BIBX-1382	EGFR inhibitor	EGFR, ERBB2	Phase 1
BMS-299897	gamma secretase inhibitor		Phase 1
BMS-387032	CDK inhibitor, cell cycle inhibitor, MCL1 inhibitor	CDK2, CDK7, CDK9	Phase 1
BMS-599626	EGFR inhibitor, protein tyrosine kinase inhibitor	EGFR, ERBB2, ERBB4	Phase 1
BMS-806	HIV attachment inhibitor		Phase 1
BMS-817378	c-Met inhibitor, VEGFR inhibitor	KDR, MET	Phase 1
BMS-983970	notch signaling inhibitor		Phase 1
BQ-788	endothelin receptor antagonist	EDNRB	Phase 1
briciclib	cyclin D inhibitor	CCND1	Phase 1
BRL-26314	cholesterol inhibitor	LPL	Phase 1
BTS-72664	GABA receptor antagonist	GABBR1	Phase 1
bupicomide	adrenergic receptor antagonist	ADRB1	Phase 1
buthionine-sulfoximine	glutathione transferase inhibitor	GCLM	Phase 1
butylated-hydroxytoluene	carbonic anhydrase inhibitor	CA2	Phase 1
BW-A4C	lipoxygenase inhibitor	ALOX5	Phase 1
carboxylosartan	angiotensin antagonist	AGTR1	Phase 1
carebastine	histamine receptor antagonist	HRH1	Phase 1
CB-10-277	DNA synthesis inhibitor		Phase 1
CB-5083	valosin-containing protein inhibitor	VCP	Phase 1
CBS-1114	lipoxygenase inhibitor	ALOX5	Phase 1
CC-115	mTOR inhibitor, DNA protein kinase inhibitor	MTOR	Phase 1
CC-401	JNK inhibitor	MAPK8	Phase 1
centazolone	monoamine oxidase inhibitor		Phase 1
CEP-37440	ALK tyrosine kinase receptor inhibitor	ALK	Phase 1
cevipabulin	microtubule stimulant, tubulin polymerization inhibitor	TUBB	Phase 1
CGM097	MDM inhibitor	MDM2	Phase 1
CGP-37849	glutamate receptor antagonist	GRIN2A, GRIN2B, GRIN2C, GRIN2D	Phase 1
CH-5183284	fibroblast growth factor inhibitor	FGFR1, FGFR2, FGFR3	Phase 1
chlorophyllin-copper	cytochrome P450 inhibitor		Phase 1
chrysin	breast cancer resistance protein inhibitor	AKR1B1, CDK6, CYP19A1, CYP1B1	Phase 1
CH5132799	PI3K inhibitor	MTOR, PIK3CA, PIK3CB, PIK3CD, PIK3CG	Phase 1
CI-923	acetylcholine receptor antagonist		Phase 1
CI-966	GAT inhibitor	SLC6A1	Phase 1
CI-976	ACAT inhibitor	ACAT1, CES1	Phase 1
cinchonidine	P glycoprotein inhibitor		Phase 1
CKD-712	NFkB pathway inhibitor	JAK2, STAT1	Phase 1
clomesone	DNA inhibitor		Phase 1
CNQX	glutamate receptor antagonist	GRIA1, GRIA2, GRIA3, GRIA4	Phase 1
CP-376395	corticosteroid releasing factor receptor antagonist	CRHR1	Phase 1
CP-532623	cholesteryl ester transfer protein inhibitor	CETP	Phase 1
CPI-0610	bromodomain inhibitor	BRD4	Phase 1
CTS21166	beta-secretase inhibitor	BACE1	Phase 1
CUDC-101	EGFR inhibitor	EGFR, ERBB2	Phase 1
CUDC-427	apoptosis inhibitor	XIAP	Phase 1
CUR-61414	smoothened receptor antagonist	DHH, IHH, SMO	Phase 1
curcumol	JAK inhibitor	JAK1, JAK2, JAK3	Phase 1
CVT-10216	aldehyde dehydrogenase inhibitor	ALDH2	Phase 1
CX-5461	RNA polymerase inhibitor		Phase 1
CYC116	Aurora kinase inhibitor	AURKA, AURKB, KDR	Phase 1
dacinostat	HDAC inhibitor	HDAC1, HDAC2, HDAC3, HDAC4, HDAC5, HDAC6, HDAC7, HDAC8, HDAC9	Phase 1
DBPR108	dipeptidyl peptidase inhibitor	DPP4	Phase 1
DCC-2618	PDGFR tyrosine kinase receptor inhibitor, KIT inhibitor	KIT, PDGFRA	Phase 1
delta-Tocotrienol	HMGCR inhibitor	HMGCR	Phase 1
desoxypeganine	acetylcholinesterase inhibitor, monoamine oxidase inhibitor	ACHE	Phase 1
diadenosine-tetraphosphate	adenosine kinase inhibitor	P2RY13, P2RY2	Phase 1
dideoxyadenosine	nucleoside reverse transcriptase inhibitor		Phase 1
dizocilpine-(-)	glutamate receptor antagonist		Phase 1
DPC-681	HIV protease inhibitor		Phase 1
DPCPX	adenosine receptor antagonist	ADORA1, ADORA2A, ADORA2B, ADORA3	Phase 1
DU-728	structural glycoprotein antagonist	ITGA2B, ITGB3	Phase 1
DUP-697	cyclooxygenase inhibitor	PTGS2	Phase 1
E-4031	potassium channel blocker	KCNH1, KCNH2	Phase 1
elacridar	P glycoprotein inhibitor	ABCB1	Phase 1
elactocin	exportin antagonist	XPO1	Phase 1
EMD-1214063	hepatocyte growth factor receptor inhibitor	MET	Phase 1
EMD-53998	phosphodiesterase inhibitor	TNNC1	Phase 1
eperezolid	bacterial 30S ribosomal subunit inhibitor		Phase 1
EPZ-5676	histone lysine methyltransferase inhibitor	DOT1L	Phase 1
ETC-159	porcupine inhibitor, beta catenin inhibitor	PORCN	Phase 1
EW-7197	TGF beta receptor inhibitor	ACVR1B, TGFBR1	Phase 1
farnesyl-thiosalicylic-acid-amide	Ras GTPase inhibitor	HRAS	Phase 1
FCE-22250	DNA directed DNA polymerase inhibitor		Phase 1
FPL-12495	glutamate receptor antagonist		Phase 1
FPL-55712	leukotriene receptor antagonist		Phase 1
FR-139317	endothelin receptor antagonist	EDNRA	Phase 1
furegrelate	thromboxane synthase inhibitor	TBXAS1	Phase 1
GDC-0152	XIAP inhibitor	BIRC2, BIRC3, BIRC7, XIAP	Phase 1
GDC-0349	Pim kinase inhibitor	PIK3CA	Phase 1
GDC-0623	MEK inhibitor		Phase 1
GDC-0834	Bruton's tyrosine kinase (BTK) inhibitor	BTK	Phase 1
GDC-0994	MAP kinase inhibitor	MAPK1, MAPK3	Phase 1
gemcitabine-elaidate	DNA synthesis inhibitor, apoptosis inhibitor	CMPK1, RRM1, TYMS	Phase 1
genz-644282	topoisomerase inhibitor	TOP1	Phase 1
GS-6201	adenosine receptor antagonist	ADORA1, ADORA2A, ADORA2B, ADORA3	Phase 1
GSK1059615	PI3K inhibitor	PIK3CG	Phase 1
GSK1070916	Aurora kinase inhibitor	AURKA, AURKB, AURKC, CYP2D6, CYP3A4	Phase 1
GSK2126458	mTOR inhibitor, PI3K inhibitor	MTOR, PIK3CA, PIK3CB, PIK3CD, PIK3CG	Phase 1
GSK2256294A	epoxide hydolase inhibitor	EPHX2	Phase 1
GSK2816126	histone lysine methyltransferase inhibitor	EZH2	Phase 1
GSK2838232	HIV gag inhibitor		Phase 1
GSK2879552	histone lysine demethylase inhibitor	KDM1A	Phase 1
GSK461364	PLK inhibitor	PLK1	Phase 1
GSK690693	AKT inhibitor	AKT1, AKT2, AKT3, PAK4, PAK6, PAK7, PRKCQ, PRKG1, PRKX	Phase 1
GSK923295	centromere associated protein inhibitor	CENPE	Phase 1
GW-311616	leukocyte elastase inhibitor, elastase inhibitor	ELANE	Phase 1
GW-803430	melanin inhibitor	KCNH2, MCHR1	Phase 1
HC-030031	TRPA1 channel blocker	TRPA1	Phase 1
HKI-357	EGFR inhibitor	EGFR	Phase 1
HMN-214	PLK inhibitor	PLK1	Phase 1
hyodeoxycholic-acid	atherosclerosis formation inhibitor		Phase 1
hypoestoxide	IKK inhibitor	IKBKB, IL1B, TNF	Phase 1
ICI-162846	histamine receptor antagonist	HRH2	Phase 1
ICI-185,282	thromboxane receptor antagonist		Phase 1
ICI-89406	adrenergic receptor antagonist	ADRB1, ADRB2	Phase 1
IKK-2-inhibitor-V	IKK inhibitor, NFkB pathway inhibitor	IKBKB	Phase 1
imiloxan	adrenergic receptor antagonist	ADRA2A, ADRA2B	Phase 1
integrin-antagonist-1	integrin antagonist	ITGAV, ITGB6	Phase 1
isamoltane	adrenergic receptor antagonist	HTR1A, HTR1B	Phase 1
ITI214	phosphodiesterase inhibitor	PDE1A	Phase 1
JDTic	opioid receptor antagonist	OPRK1	Phase 1
JNJ-38877605	tyrosine kinase inhibitor	MET	Phase 1
kifunensine	mannosidase inhibitor	MAN1B1, MAN2A1	Phase 1
KW-2449	Abl kinase inhibitor, Aurora kinase inhibitor, FLT3 inhibitor	ABL1, AURKA, AURKB, FLT3	Phase 1
L-368899	oxytocin receptor antagonist	AVPR1A, AVPR2, OXTR	Phase 1
L-655240	thromboxane receptor antagonist	PTGES	Phase 1
L-778123	farnesyltransferase inhibitor	FNTA, FNTB, PGGT1B	Phase 1
latrunculin-b	actin polymerization inhibitor	ACTA1, MKL1, SPIRE2	Phase 1
LB-100	protein phosphatase inhibitor		Phase 1
lorglumide	CCK receptor antagonist	CCKAR, CCKBR	Phase 1
lupanine	sodium channel blocker	INS	Phase 1
LY215490	glutamate receptor antagonist	GRIA1, GRIA2, GRIA3, GRIA4, GRIK1	Phase 1
LY2334737	antitumor agent, ribonucleotide reductase inhibitor		Phase 1
LY2584702	ribosomal protein inhibitor	RPS6KB1	Phase 1
LY2811376	beta-secretase inhibitor	BACE1	Phase 1
LY2874455	FGFR antagonist	FGFR1, FGFR2, FGFR3, FGFR4, KDR	Phase 1
LY3000328	cathepsin inhibitor	CTSS	Phase 1
LY3009120	RAF inhibitor	BRAF, RAF1	Phase 1
MD-920	NFkB pathway inhibitor	AADACL2	Phase 1
MDL-73005EF	serotonin receptor antagonist	HTR1A	Phase 1
melphalan-n-oxide	hypoxia inducible factor inhibitor	HIF1A	Phase 1
metatinib	Bcr-Abl kinase inhibitor	ABL1, BCR	Phase 1
MK-5108	Aurora kinase inhibitor	AURKA, AURKB, AURKC	Phase 1
MK-8033	c-Met inhibitor	MET	Phase 1
MKT-077	HSP inhibitor		Phase 1
MLN-8054	Aurora kinase inhibitor	AURKA	Phase 1
MLN2480	RAF inhibitor		Phase 1
mofegiline	monoamine oxidase inhibitor	MAOA, MAOB	Phase 1
MR-948	thromboxane synthase inhibitor	TBXAS1	Phase 1
MSX-122	CC chemokine receptor antagonist	CXCR4	Phase 1
mubritinib	protein tyrosine kinase inhibitor	EGFR, ERBB2	Phase 1
MUT056399	FABI inhibitor		Phase 1
naringenin	aromatase inhibitor, TRPV antagonist	CYP19A1, CYP1B1, ESR2, GLO1, HSD17B1	Phase 1
NG-nitro-arginine	nitric oxide synthase inhibitor	NOS1, NOS2, NOS3	Phase 1
NGD-94-1	dopamine receptor antagonist	DRD4	Phase 1
nisin	bacterial cell wall synthesis inhibitor		Phase 1
nisoxetine	norepinephrine reuptake inhibitor	SLC6A2, SLC6A3, SLC6A4	Phase 1
NKP-1339	HSP inhibitor		Phase 1
NLG919	indoleamine 2,3-dioxygenase inhibitor	IDO1	Phase 1
NMS-1286937	PLK inhibitor	FLT3, PLK1, PLK2, PLK3	Phase 1
norfluoxetine	selective serotonin reuptake inhibitor (SSRI)	HTR2B	Phase 1
NVP-HSP990	HSP inhibitor	HSP90AA1, HSP90AB1	Phase 1
ochromycinone	STAT inhibitor	STAT3	Phase 1
oleandrin	Na/K-ATPase inhibitor		Phase 1
omeprazole-sulfide	ATPase inhibitor		Phase 1
ONO-4059	Bruton's tyrosine kinase (BTK) inhibitor	BTK	Phase 1
ONO-4817	matrix metalloprotease inhibitor	MMP8	Phase 1
OPC-21268	vasopressin receptor antagonist	AVPR1A, AVPR2, OXTR	Phase 1
org-9768	adrenergic receptor antagonist	ADRA2A	Phase 1
OSI-027	mTOR inhibitor	MTOR	Phase 1
OSI-930	KIT inhibitor, VEGFR inhibitor	KDR, KIT	Phase 1
OTS167	maternal embryonic leucine zipper kinase inhibitor	MELK	Phase 1
oxfenicine	carnitine palmitoyltransferase inhibitor	CPT1A, CPT1B	Phase 1
palomid-529	AKT inhibitor, mTOR inhibitor	MTOR	Phase 1
paraxanthine	adenosine receptor antagonist		Phase 1
parthenolide	NFkB pathway inhibitor		Phase 1
PCA-4248	platelet activating factor receptor antagonist	PTAFR	Phase 1
PD-123319	angiotensin antagonist	AGTR2	Phase 1
PD-153035	EGFR inhibitor	EGFR, KDR	Phase 1
pexmetinib	TIE tyrosine kinase inhibitor, MAP kinase inhibitor	MAPK14, TEK	Phase 1
PF-03758309	p21 activated kinase inhibitor	PAK4	Phase 1
PF-03814735	Aurora kinase inhibitor	AURKA, AURKB	Phase 1
PF-04217903	c-Met inhibitor	MET	Phase 1
PF-04418948	prostaglandin inhibitor	PTGER2	Phase 1
PF-04620110	diacylglycerol O acyltransferase inhibitor	DGAT1	Phase 1
PF-477736	CHK inhibitor	CHEK1, CHEK2	Phase 1
PF-562271	focal adhesion kinase inhibitor	PTK2, PTK2B	Phase 1
PF-915275	11-beta hydroxysteroid dehydrogenase inhibitor	HSD11B1	Phase 1
PFK-015	phosphofructokinase inhibitor	PFKFB3	Phase 1
PFK-158	phosphofructokinase inhibitor	PFKFB3	Phase 1
PHA-793887	CDK inhibitor	CDK1, CDK2, CDK4, CDK5, CDK7, CDK9	Phase 1
piperine	monoamine oxidase inhibitor	MAOA, MAOB, TRPV1	Phase 1
pirquinozol	histamine release inhibitor		Phase 1
PK-11195	benzodiazepine receptor antagonist	TSPO	Phase 1
PKI-166	EGFR inhibitor	EGFR	Phase 1
PKI-179	mTOR inhibitor, PI3K inhibitor	MTOR	Phase 1
proacipimox	cholesterol inhibitor		Phase 1
PRT062070	JAK inhibitor, syk inhibitor	SYK	Phase 1
PSI-6130	RNA polymerase inhibitor		Phase 1
PT-2385	hypoxia inducible factor inhibitor	EPAS1	Phase 1
PU-H71	HSP inhibitor	HSP90AA1	Phase 1
PX-478	hypoxia inducible factor inhibitor		Phase 1
pyroxamide	HDAC inhibitor	HDAC1	Phase 1
Q-203	ATP synthase inhibitor		Phase 1
R-1479	HCV inhibitor		Phase 1
R-1485	serotonin receptor antagonist	HTR6	Phase 1
R-428	AXL kinase inhibitor	AXL	Phase 1
ravoxertinib	ERK1 and ERK2 phosphorylation inhibitor	MAPK1, MAPK3	Phase 1
rebastinib	Bcr-Abl kinase inhibitor, TIE tyrosine kinase inhibitor, VEGFR inhibitor	ABL1, BCR, FGR, FLT3, HCK, LYN, SRC	Phase 1
RGB-286638	CDK inhibitor	CDK1, CDK2, CDK3, CDK4, CDK5, CDK6, CDK7, CDK9, FLT3, GSK3B, JAK2, MAP3K7, MAPK9	Phase 1
RG1530	FGFR inhibitor, PDGFR tyrosine kinase receptor inhibitor, VEGFR inhibitor	FGFR1, FGFR2	Phase 1
RG2833	HDAC inhibitor	HDAC1, HDAC3	Phase 1
RG7112	MDM inhibitor	MDM2	Phase 1
rimcazole	sigma receptor antagonist	SIGMAR1	Phase 1
Ro-4987655	MEK inhibitor	MAP2K1	Phase 1
Ro-5126766	RAF inhibitor, MEK inhibitor	BRAF, MAP2K1, MAP2K2, RAF1	Phase 1
RS-127445	serotonin receptor antagonist	HTR2A, HTR2B, HTR2C	Phase 1
rucinol	tyrosinase inhibitor	TYR	Phase 1
RWJ-67657	MAP kinase inhibitor	MAPK14, PTGS2	Phase 1
R306465	HDAC inhibitor		Phase 1
R406	SYK inhibitor	RET, SYK	Phase 1
R547	CDK inhibitor	CDK1, CDK2, CDK4, CDK7	Phase 1
safingol	PKC inhibitor	TRPM3	Phase 1
sangivamycin	DNA inhibitor		Phase 1
SAR405838	MDM inhibitor	MDM2	Phase 1
SB-2343	mTOR inhibitor, PI3K inhibitor	MTOR, PIK3CA, PIK3CB, PIK3CD, PIK3CG	Phase 1
SB-242235	p38 MAPK inhibitor	HSPB1, MAPK14	Phase 1
SB-271046	serotonin receptor antagonist	HTR6	Phase 1
SB-683698	integrin antagonist	ITGA4, ITGAV, ITGB1, ITGB7	Phase 1
SCH-28080	ATPase inhibitor	ATP4A	Phase 1
SDZ-NKT-343	tachykinin antagonist	TACR1	Phase 1
10735454	D-Amino Acid Oxidase Inhibitor	DAO	Phase 1
serdemetan	MDM inhibitor	MDM2	Phase 1
SGI-1776	Pim kinase inhibitor	FLT3, PIM1, PIM2, PIM3	Phase 1
SGX523	hepatocyte growth factor receptor inhibitor	MET	Phase 1
siguazodan	phosphodiesterase inhibitor	PDE3A	Phase 1
SNS-314	Aurora kinase inhibitor	AURKA, AURKB, AURKC	Phase 1
SNX-2112	HSP inhibitor		Phase 1
solcitinib	JAK inhibitor	JAK1	Phase 1
SR-33805	calcium channel blocker		Phase 1
substance-p	neurokinin receptor antagonist	TACR1, TACR2, TACR3	Phase 1
sulmazole	adenosine receptor antagonist		Phase 1
TAK-220	CC chemokine receptor antagonist	CCR5	Phase 1
TAK-285	EGFR inhibitor	ERBB2	Phase 1
TAK-593	VEGFR inhibitor	PDGFRA	Phase 1
TAK-733	MEK inhibitor	MAP2K1	Phase 1
TAK-901	Aurora kinase inhibitor	AURKB	Phase 1
TAK-960	PLK inhibitor	PLK1	Phase 1
taltobulin	tubulin polymerization inhibitor		Phase 1
TAS-103	topoisomerase inhibitor	TOP1	Phase 1
teroxirone	DNA inhibitor		Phase 1
TG-02	CDK inhibitor, FLT3 inhibitor, JAK inhibitor	CDK1, CDK2, CDK7, CDK9, FLT3, JAK2	Phase 1
thiorphan	membrane metalloendopeptidase inhibitor	MME	Phase 1
tiplaxtinin	plasminogen activator inhibitor	SERPINE1	Phase 1
toyocamycin	serine/threonine kinase inhibitor	ERN1	Phase 1
trequinsin	phosphodiesterase inhibitor	PDE5A	Phase 1
tributyrin	HDAC inhibitor		Phase 1
trovirdine	non-nucleoside reverse transcriptase inhibitor		Phase 1
UK-383367	Procollagen C-Endopeptidase Inhibitors	BMP1	Phase 1
UNBS-5162	CC chemokine receptor antagonist		Phase 1
URB597	FAAH inhibitor	FAAH, FAAH2, TRPA1	Phase 1
ursolic-acid	ATPase inhibitor, NFkB pathway inhibitor, STAT inhibitor	HSD11B1, PLA2G1B, PTPN1, PYGM	Phase 1
V-51	adrenergic receptor antagonist		Phase 1
VCH-916	HCV inhibitor		Phase 1
VGX-1027	tumor necrosis factor receptor antagonist	TLR4	Phase 1
vipadenant	adenosine receptor antagonist	ADORA1, ADORA2A, ADORA2B, ADORA3	Phase 1
VLX600	ubiquitin C-terminal hydrolase inhibitor	USP14	Phase 1
VP-20629	beta amyloid antagonist	PLA2G2E, SLC36A1	Phase 1
VS-4718	focal adhesion kinase inhibitor		Phase 1
VTP-27999	renin inhibitor	REN	Phase 1
WAY-100635	serotonin receptor antagonist	HTR1A	Phase 1
WP1066	STAT inhibitor	STAT3	Phase 1
Wy-16922	histamine release inhibitor		Phase 1
XL019	JAK inhibitor	JAK1, JAK2, JAK3	Phase 1
XL228	Abl kinase inhibitor, insulin growth factor receptor inhibitor, src inhibitor	IGF1R, SRC	Phase 1
XL888	HSP inhibitor		Phase 1
YM-750	ACAT inhibitor	SOAT1	Phase 1
YM-976	phosphodiesterase inhibitor	PDE4A	Phase 1
ZK-93426	benzodiazepine receptor antagonist	GABRA1, GABRA2, GABRA3, GABRA5	Phase 1
2-(3-mercaptopropyl)pentanedioic acid	glutamate carboxypeptidase inhibitor	FOLH1	Phase 1
4SC-202	HDAC inhibitor	HDAC1	Phase 1
5-FP	thymidylate synthase inhibitor	TYMS	Phase 1
5-hydroxymethyl-tolterodine	acetylcholine receptor antagonist	CHRM3	Phase 1
ABC-294640	sphingosine kinase inhibitor	SPHK2	Phase 1/Phase 2
ABT-737	BCL inhibitor	BCL2, BCL2L1, BCL2L2	Phase 1/Phase 2
ACY-1215	HDAC inhibitor	HDAC1, HDAC2, HDAC3, HDAC6, HDAC8	Phase 1/Phase 2
AEE788	EGFR inhibitor, VEGFR inhibitor	EGFR, ERBB2, ERBB4, FGFR2, FGFR3, KDR	Phase 1/Phase 2
AMD11070	CC chemokine receptor antagonist	CXCR4	Phase 1/Phase 2
AMG-232	MDM inhibitor	MDM2	Phase 1/Phase 2
APC-100	anti-inflammatory agent, androgen receptor antagonist	AR	Phase 1/Phase 2
AZD6738	ATR kinase inhibitor	ATR	Phase 1/Phase 2
betulinic-acid	apoptosis stimulant, NFkB pathway inhibitor	GPBAR1	Phase 1/Phase 2
BGT226	PI3K inhibitor	MTOR, PIK3CA, PIK3CB, PIK3CG	Phase 1/Phase 2
BMS-777607	AXL kinase inhibitor, c-Met inhibitor, FLT3 inhibitor, hepatocyte growth factor receptor inhibitor, macrophage migration inhibiting factor inhibitor, tyrosine kinase inhibitor	AXL, MERTK, MET, MST1R, TYRO3	Phase 1/Phase 2
BMS-863233	CDC inhibitor	CDC7, PIM1	Phase 1/Phase 2
BVD-523	MAP kinase inhibitor		Phase 1/Phase 2
CB-839	glutaminase inhibitor	GLS	Phase 1/Phase 2
CC-223	mTOR inhibitor	MTOR	Phase 1/Phase 2
CEP-32496	RAF inhibitor	BRAF, RAF1	Phase 1/Phase 2
cordycepin	DNA inhibitor		Phase 1/Phase 2
CX-4945	casein kinase inhibitor	CSNK2A1, CSNK2A2, DAPK3, HIPK3	Phase 1/Phase 2
delanzomib	proteasome inhibitor	CMA1, CTSG, CYP3A4, ELANE	Phase 1/Phase 2
E7449	PARP inhibitor	PARP1, PARP2, TNKS, TNKS2	Phase 1/Phase 2
GMX1778	NAMPT inhibitor	NAMPT	Phase 1/Phase 2
indibulin	tubulin polymerization inhibitor		Phase 1/Phase 2
KW-2478	HSP inhibitor		Phase 1/Phase 2
LX7101	LIM kinase inhibitor, rho associated kinase inhibitor	LIMK2, ROCK1, ROCK2	Phase 1/Phase 2
LY2886721	beta-secretase inhibitor	BACE1	Phase 1/Phase 2
minerval	FAAH inhibitor		Phase 1/Phase 2
MK-0752	gamma secretase inhibitor		Phase 1/Phase 2
MK-2461	FGFR inhibitor, VEGFR inhibitor	FGFR1, FGFR2, FGFR3, FLT1, FLT3, FLT4, KDR, MERTK, MET, MST1R, NTRK1, NTRK2, PDGFRB	Phase 1/Phase 2
MLN1117	PI3K inhibitor	PIK3CA	Phase 1/Phase 2
NS-018	JAK inhibitor	JAK1, JAK2, JAK3, TYK2	Phase 1/Phase 2
N6022	alcohol dehydrogenase inhibitor	ADH5	Phase 1/Phase 2
oprozomib	proteasome inhibitor		Phase 1/Phase 2
ORE1001	angiotensin converting enzyme inhibitor	ACE2	Phase 1/Phase 2
ORY-1001	histone lysine demethylase inhibitor	KDM1A	Phase 1/Phase 2
OTX015	bromodomain inhibitor	BRD2, BRD3, BRD4	Phase 1/Phase 2
PCI-24781	HDAC inhibitor	HDAC1, HDAC2, HDAC3, HDAC6	Phase 1/Phase 2
PLX8394	serine/threonine kinase inhibitor	BRAF	Phase 1/Phase 2
RX-3117	DNA synthesis inhibitor, CDK inhibitor	CDK2, DNMT1	Phase 1/Phase 2
SAR-245409	PI3K inhibitor	MTOR, PIK3CG	Phase 1/Phase 2
SB-743921	kinesin-like spindle protein inhibitor	KIF11	Phase 1/Phase 2
SNX-5422	HSP inhibitor	HSP90AA1	Phase 1/Phase 2
terameprocol	lipoxygenase inhibitor	BIRC5, CDK1	Phase 1/Phase 2
TG100-115	PI3K inhibitor	PIK3CA, PIK3CB, PIK3CD, PIK3CG	Phase 1/Phase 2
triciribine	AKT inhibitor	AKT1, AKT2, AKT3	Phase 1/Phase 2
ZSTK-474	PI3K inhibitor	PIK3CB, PIK3CD, PIK3CG	Phase 1/Phase 2
2-hydroxyflutamide	androgen receptor antagonist	AR	Phase 1/Phase 2
ABT-639	calcium channel blocker	CACNA1G, CACNA1H, CACNA1I	Phase 2
ABT-751	tubulin polymerization inhibitor	TUBB	Phase 2
acetyl-11-keto-beta-boswellic-acid	lipoxygenase inhibitor	HSD11B1, HSD11B2	Phase 2
acivicin	gamma glutamyltransferase Inhibitors	CTPS1	Phase 2
AD-5467	aldose reductase inhibitor	AKR1B1	Phase 2
adaptavir	CC chemokine receptor antagonist	CCR5	Phase 2
adatanserin	serotonin receptor agonist, serotonin receptor antagonist	HTR1A, HTR2A	Phase 2
adoprazine	dopamine receptor antagonist, serotonin receptor agonist	DRD2, HTR1A	Phase 2
afimoxifene	estrogen receptor antagonist	ESR1, ESR2, ESRRG, PLD1, PRKCD, PRKCE, PRKCQ, PRKCZ	Phase 2
AFN-1252	FABI inhibitor		Phase 2
AGM-1470	cell cycle inhibitor	METAP2	Phase 2
alaproclate	serotonin receptor antagonist	SLC6A4	Phase 2
allicin	cytokine production inhibitor	TRPA1, TRPV1	Phase 2
altanserin	serotonin receptor antagonist	HTR2A	Phase 2
alvespimycin	HSP inhibitor	HSP90AA1	Phase 2
alvocidib	CDK inhibitor	CDK1, CDK2, CDK4, CDK5, CDK6, CDK7, CDK8, CDK9, EGFR, PYGM	Phase 2
AM-24	lipoxygenase inhibitor	ALOX5	Phase 2
amflutizole	xanthine oxidase inhibitor	XDH	Phase 2
AMG-319	PI3K inhibitor	PIK3CD	Phase 2
AMG-337	MET inhibitor	MET	Phase 2
AMG-487	CC chemokine receptor antagonist		Phase 2
AMG-487-(+/-)	CC chemokine receptor antagonist	CXCR3	Phase 2
AMG319	PI3K inhibitor	PIK3CD	Phase 2
aminothiadiazole	inosine monophosphate dehydrogenase inhibitor	ADORA3, IMPDH1	Phase 2
amuvatinib	FLT3 inhibitor, KIT inhibitor, PDGFR tyrosine kinase receptor inhibitor, RAD51 inhibitor, RET tyrosine kinase inhibitor	KIT, MET	Phase 2
andrographolide	tumor necrosis factor production inhibitor	NFKB1	Phase 2
anguidine	protein synthesis inhibitor	SLC5A1	Phase 2
API-001	sigma receptor antagonist	SIGMAR1	Phase 2
apratastat	matrix metalloprotease inhibitor, tumor necrosis factor production inhibitor	ADAM17, MMP1, MMP13, MMP9	Phase 2
AP26113	ALK tyrosine kinase receptor inhibitor	ALK, EGFR	Phase 2
ARRY-334543	EGFR inhibitor	ERBB2	Phase 2
AS-703026	MEK inhibitor	MAP2K1, MAP2K2	Phase 2
AT-7519	CDK inhibitor	CDK1, CDK2, CDK4, CDK5, CDK6, CDK9	Phase 2
AT-9283	Aurora kinase inhibitor, JAK inhibitor	AURKA, AURKB, JAK2, JAK3, RPS6KA6, STK17A	Phase 2
ATB-346	cyclooxygenase inhibitor	PTGER2	Phase 2
atenolol-(-)	adrenergic receptor antagonist		Phase 2
atiprimod	JAK inhibitor, STAT inhibitor	JAK2, STAT3	Phase 2
atizoram	phosphodiesterase inhibitor	PDE4A, PDE4B, PDE4C, PDE4D	Phase 2
ATN-161	integrin antagonist	ITGA5, ITGAV, ITGB1, ITGB3	Phase 2
AT13387	HSP antagonist	HSP90AA1	Phase 2
AV-608	tachykinin antagonist	TACR1	Phase 2
avagacestat	gamma secretase inhibitor	PSEN1	Phase 2
AVL-292	Bruton's tyrosine kinase (BTK) inhibitor	BTK, YES1	Phase 2
AVN-944	inosine monophosphate dehydrogenase inhibitor	IMPDH1, IMPDH2	Phase 2
AZD1981	CRTH receptor antagonist	PTGDR2	Phase 2
AZD2014	mTOR inhibitor	MTOR	Phase 2
AZD5069	CC chemokine receptor antagonist	CXCR2	Phase 2
AZD5363	AKT inhibitor	AKT1, AKT2, AKT3	Phase 2
AZD6765	glutamate receptor antagonist	GRIN1	Phase 2
AZD8931	EGFR inhibitor	EGFR, ERBB2, ERBB3	Phase 2
AZD9668	elastase inhibitor	ELANE	Phase 2
azodicarbonamide	DNA synthesis inhibitor		Phase 2
bafetinib	Bcr-Abl kinase inhibitor, LYN tyrosine kinase inhibitor	ABL1, BCR, LYN	Phase 2
bakuchiol	DNA polymerase inhibitor	HIF1A	Phase 2
balapiravir	RNA polymerase inhibitor		Phase 2
balicatib	cathepsin inhibitor	CTSK	Phase 2
basimglurant	glutamate receptor antagonist	GRM5	Phase 2
bavisant	histamine receptor antagonist	HRH3	Phase 2
BE-2254	adrenergic receptor antagonist	ADRA1A	Phase 2
benzamil	sodium channel blocker	ASIC1, PKD2L1, SCNN1A, SCNN1B, SCNN1D, SCNN1G, SLC8A1	Phase 2
beta-lapachone	topoisomerase inhibitor	TOP1	Phase 2
bevirimat-dimeglumine	HIV capsid assembly inhibitor		Phase 2
BI-2536	PLK inhibitor	BRD4, PLK1, PLK2, PLK3	Phase 2
BIBN4096	calcitonin antagonist	CALCA, CALCRL, RAMP1	Phase 2
BIIB021	HSP inhibitor	HSP90AA1	Phase 2
bindarit	NFkB pathway inhibitor	CCL2, CCL7, CCL8	Phase 2
BIO-1211	integrin antagonist	ITGA4, ITGB1	Phase 2
bipenamol	dipeptidyl peptidase inhibitor	CTSC	Phase 2
birinapant	XIAP inhibitor	BIRC2, XIAP	Phase 2
bis(maltolato)oxovanadium(IV)	tyrosine phosphatase inhibitor	PTPN1	Phase 2
bleomycetin	EGFR expression inhibitor		Phase 2
BMS-182874	endothelin receptor antagonist	EDNRA	Phase 2
BMS-587101	integrin antagonist	ITGAL, ITGB2	Phase 2
BMS-690514	EGFR inhibitor, VEGFR inhibitor	EGFR, ERBB2, FLT3, KDR	Phase 2
BMS-707035	HIV integrase inhibitor		Phase 2
BMS-754807	IGF-1 inhibitor	AKT1, IGF1R	Phase 2
BMS-833923	smoothened receptor antagonist	SMO	Phase 2
BMS-927711	calcitonin antagonist	CALCA	Phase 2
BMS-986020	lysophosphatidic acid receptor antagonist	LPAR1	Phase 2
BMY-14802	sigma receptor antagonist	HTR1A	Phase 2
BNC105	tubulin polymerization inhibitor		Phase 2
BQ-123	endothelin receptor antagonist	EDNRA	Phase 2
brequinar	dihydroorotate dehydrogenase inhibitor	DHODH	Phase 2
bruceantin	protein synthesis inhibitor		Phase 2
bryostatin-1	protein kinase C inhibitor	PRKCE	Phase 2
butaclamol	dopamine receptor antagonist	DRD1, DRD2, DRD3, DRD4, DRD5, HTR1A, HTR2A	Phase 2
butofilolol	adrenergic receptor antagonist		Phase 2
caracemide	ribonucleotide reductase inhibitor	RRM1	Phase 2
caricotamide	NADPH quinone oxidoreductase inhibitor	NQO2	Phase 2
castanospermine	glucosidase inhibitor	GAA, GBA	Phase 2
CC-930	JNK inhibitor		Phase 2
cepharanthine	NFkB pathway inhibitor		Phase 2
cetaben	cholesterol inhibitor, ACAT inhibitor	PPARA	Phase 2
CG-400549	FABI inhibitor		Phase 2
cinalukast	leukotriene receptor antagonist	CYSLTR1	Phase 2
clofilium	potassium channel blocker	KCNA5, KCNH1	Phase 2
clorgiline	monoamine oxidase inhibitor	MAOA	Phase 2
combretastatin-A-4	tubulin polymerization inhibitor		Phase 2
corosolic-acid	PKC inhibitor, protein tyrosine kinase inhibitor	HSD11B1, PTPN1	Phase 2
CP-724714	EGFR inhibitor, protein tyrosine kinase inhibitor	ERBB2	Phase 2
CP-99994	tachykinin antagonist	TACR1	Phase 2
CPI-1189	tumor necrosis factor release inhibitor	TNF	Phase 2
CPI-613	pyruvate dehydrogenase inhibitor	PDHA1	Phase 2
CPP	glutamate receptor antagonist	GRIN1, GRIN2A, GRIN2B, GRIN2C, GRIN2D	Phase 2
crenolanib	PDGFR tyrosine kinase receptor inhibitor	CSF1R, FLT3, KIT, PDGFRA, PDGFRB	Phase 2
CS-917	fructose biphosphate inhibitor	FBP1	Phase 2
CT-7758	integrin antagonist	ITGA4	Phase 2
CTS-1027	metalloproteinase inhibitor	MMP1, MMP13, MMP2, MMP3, MMP9	Phase 2
CUDC-907	PI3K inhibitor	HDAC2, PIK3R1	Phase 2
cyanopindolol	adrenergic receptor antagonist	ADRB1, HTR1A, HTR1D	Phase 2
CYT-997	tubulin polymerization inhibitor	TUBB	Phase 2
cytochalasin-b	microtubule inhibitor	ACTB	Phase 2
danirixin	CC chemokine receptor antagonist	CXCR2	Phase 2
danoprevir	HCV inhibitor		Phase 2
danusertib	Aurora kinase inhibitor, growth factor receptor inhibitor	AURKA, AURKB, AURKC, FGFR1, NTRK1, RET, SLK	Phase 2
darglitazone	PPAR receptor antagonist	PPARG	Phase 2
dazmegrel	thromboxane synthase inhibitor	TBXAS1	Phase 2
dazoxiben	thromboxane synthase inhibitor	TBXAS1	Phase 2
defactinib	focal adhesion kinase inhibitor	PTK2	Phase 2
delphinidin	membrane permeability inhibitor	GLO1	Phase 2
dexniguldipine	calmodulin antagonist	ADORA3	Phase 2
diazooxonorleucine	glutamate receptor antagonist		Phase 2
DMP-777	elastase inhibitor	MPO	Phase 2
docebenone	lipoxygenase inhibitor	ALOX5	Phase 2
dolastatin-10	tubulin polymerization inhibitor	TUBB	Phase 2
doramapimod	p38 MAPK inhibitor	MAPK11, MAPK12, MAPK13, MAPK14	Phase 2
edelfosine	phospholipase inhibitor		Phase 2
efaroxan	adrenergic receptor antagonist	ADORA2A	Phase 2
EGF816	EGFR inhibitor	EGFR	Phase 2
elemene	VEGFR inhibitor		Phase 2
elinogrel	purinergic receptor antagonist	P2RY12	Phase 2
ellagic-acid	glutathione transferase inhibitor, non-nucleoside reverse transcriptase inhibitor	CA1, CA12, CA14, CA2, CA3, CA4, CA5A, CA5B, CA6, CA7, CA9, CSNK2A1, GSK3B, PRKACA, PRKCA, PRKCB, SQLE, SYK	Phase 2
emetine	protein synthesis inhibitor	RPS2	Phase 2
endoxifen	estrogen receptor antagonist	ESR1	Phase 2
ENMD-2076	Aurora kinase inhibitor, FLT3 inhibitor, VEGFR inhibitor	AURKA, FLT3, KDR, PDGFRA, PTK2, SRC	Phase 2
entrectinib	ALK tyrosine kinase receptor inhibitor, proto-oncogene tyrosine protein kinase inhibitor	ALK, NTRK1, NTRK2, NTRK3, ROS1	Phase 2
epicatechin-gallate-(-)	bacterial DNA gyrase inhibitor	BACE1, FASN	Phase 2
epothilone-d	microtubule stabilizing agent, tubulin polymerization inhibitor	TUBA1A, TUBA1B, TUBA1C, TUBA3C, TUBA4A, TUBA8, TUBB, TUBB1, TUBB3, TUBB4A, TUBB4B	Phase 2
erdafitinib	FGFR inhibitor	FGFR1, FGFR2, FGFR3, FGFR4	Phase 2
etazolate	phosphodiesterase inhibitor	GABRB3, PDE4A	Phase 2
ethyl-pyruvate	tumor necrosis factor production inhibitor	HMGB1, TNF	Phase 2
etomoxir	carnitine palmitoyltransferase inhibitor	CPT1A	Phase 2
evatanepag	prostaglandin inhibitor	PTGER2, PTGER4	Phase 2
EX-527	SIRT inhibitor	SIRT1	Phase 2
exherin	cadherin antagonist	CDH2	Phase 2
ezatiostat	glutathione transferase inhibitor	GSTP1	Phase 2
fagomine	glucosidase inhibitor	GLB1	Phase 2
fananserin	dopamine receptor antagonist, serotonin receptor antagonist	HTR2A	Phase 2
fdcyd	DNA methyltransferase inhibitor		Phase 2
fenobam	glutamate receptor antagonist	GRM5	Phase 2
FG-2216	hypoxia inducible factor prolyl hydroxylase inhibitor	EGLN1, EGLN2, HIF1A	Phase 2
fiacitabine	DNA synthesis inhibitor		Phase 2
filgotinib	JAK inhibitor	JAK1, JAK2, JAK3, TYK2	Phase 2
firategrast	integrin antagonist	ITGA4	Phase 2
FK-3311	cyclooxygenase inhibitor	PTGS2	Phase 2
FK-866	niacinamide phosphoribosyltransferase inhibitor	NAMPT	Phase 2
FK-888	tachykinin antagonist	TACR1, TACR2	Phase 2
foretinib	VEGFR inhibitor	FLT1, FLT4, KDR, MET	Phase 2
forodesine	purinergic receptor antagonist	PNP	Phase 2
FPL-62064	cyclooxygenase inhibitor, lipoxygenase inhibitor		Phase 2
F351	TGF beta receptor inhibitor	TGFB1	Phase 2
gamma-linolenic-acid	cyclooxygenase inhibitor, prostanoid receptor agonist	PTGS1, PTGS2	Phase 2
GDC-0068	AKT inhibitor	AKT1, AKT2, AKT3, PRKG1	Phase 2
GDC-0941	PI3K inhibitor	PIK3CA, PIK3CB, PIK3CD, PIK3CG	Phase 2
GDC-0980	mTOR inhibitor, PI3K inhibitor	FGR, MAP3K9, MTOR, PIK3CA, PIK3CB, PIK3CD, PIK3CG, SYK	Phase 2
givinostat	HDAC inhibitor	HDAC1, HDAC2, HDAC3, HDAC4, HDAC5, HDAC6, HDAC7, HDAC8, HDAC9	Phase 2
GKT137831	NADPH oxidase inhibitor	NOX1, NOX4	Phase 2
glasdegib	hedgehog pathway inhibitor	SMO	Phase 2
glutathione-monoisopropyl-ester	lipid peroxidase inhibitor		Phase 2
golvatinib	VEGFR inhibitor	KDR, MET	Phase 2
gossypol	BCL inhibitor, MCL1 inhibitor	BCL2	Phase 2
GS-9973	syk inhibitor	SYK	Phase 2
GSK163090	serotonin receptor antagonist	HTR1A, HTR1B, HTR1D	Phase 2
GSK2110183	AKT inhibitor	AKT1, AKT2, AKT3	Phase 2
GSK2190915	lipoxygenase inhibitor	ALOX5AP	Phase 2
GSK2330672	bile acid transporter inhibitor	SLC10A2	Phase 2
GSK256066	phosphodiesterase inhibitor	PDE4A	Phase 2
GSK2636771	PI3K inhibitor	PIK3CB	Phase 2
guanidinoethyldisulfide-bicarbonate	nitric oxide synthase inhibitor	NOS2	Phase 2
guanidinopropionic-acid	creatine kinase inhibitor	CKM	Phase 2
HA-1004	calcium channel blocker		Phase 2
halopemide	phospholipase inhibitor	PLD1, PLD2	Phase 2
hexamethylenebisacetamide	AKT inhibitor, differentiation inducer, NFKB pathway inhibitor	AKT1	Phase 2
huperzine-a	acetylcholinesterase inhibitor	ACHE	Phase 2
hymecromone	monoamine oxidase inhibitor	MAOA, MAOB	Phase 2
hypericin	tyrosine kinase inhibitor		Phase 2
I-BET-762	bromodomain inhibitor	BRD2, BRD3, BRD4	Phase 2
icaritin	PPAR receptor antagonist	PDE5A	Phase 2
ICI-118,551	adrenergic receptor antagonist	ADRB2, ADRB3	Phase 2
ICI-192605	thromboxane receptor antagonist	TBXA2R	Phase 2
imeglimin	gluconeogenesis inhibitor		Phase 2
imexon	apoptosis stimulant, ribonucleotide reductase inhibitor	RRM1, RRM2	Phase 2
INC-280	c-Met inhibitor	MET	Phase 2
INCB-003284	CC chemokine receptor antagonist		Phase 2
INCB-024360	indoleamine 2,3-dioxygenase inhibitor	IDO1	Phase 2
INCB-3284	CC chemokine receptor antagonist	CCR2	Phase 2
indisulam	CDK inhibitor	CA1, CA12, CA14, CA2, CA6, CA7, CA9	Phase 2
indoximod	indoleamine 2,3-dioxygenase inhibitor	IDO1	Phase 2
INS316	purinergic receptor antagonist		Phase 2
iododexetimide	acetylcholine receptor antagonist		Phase 2
IOWH032	CFTR channel antagonist	CFTR	Phase 2
irosustat	steroid sulfatase inhibitor	CA2, STS	Phase 2
isbufylline	phosphodiesterase inhibitor		Phase 2
isodibut	aldehyde reductase inhibitor		Phase 2
isofloxythepin	dopamine receptor antagonist		Phase 2
isovaleramide	alcohol dehydrogenase inhibitor		Phase 2
ispinesib	kinesin inhibitor	KIF11	Phase 2
istaroxime	ATPase inhibitor	ATP1A1	Phase 2
itacitinib	JAK inhibitor	JAK1	Phase 2
JNJ-26481585	HDAC inhibitor	HDAC1, HDAC10, HDAC11, HDAC2, HDAC3, HDAC4, HDAC5, HDAC6, HDAC7, HDAC8, HDAC9, MDM2	Phase 2
JNJ-37822681	dopamine receptor antagonist	DRD2	Phase 2
JNJ-42165279	FAAH inhibitor	FAAH	Phase 2
JTC-801	opioid receptor antagonist	OPRL1	Phase 2
JTE-607	cytokine production inhibitor	IL10, IL1B, IL6, TNF	Phase 2
k-strophanthidin	ATPase inhibitor	ATP1A1	Phase 2
kakonein	GABA receptor antagonist, serotonin receptor antagonist		Phase 2
KBG	neprilysin inhibitor	MME	Phase 2
KD-023	ACAT inhibitor	ACACA, ACACB	Phase 2
KD025	rho associated kinase inhibitor	ROCK2	Phase 2
KX2-391	src inhibitor, tubulin polymerization inhibitor	SRC	Phase 2
L-365260	CCK receptor antagonist	CCKAR, CCKBR, KCNQ1	Phase 2
lappaconite	sodium channel blocker		Phase 2
LCL-161	XIAP inhibitor	BIRC2, XIAP	Phase 2
lersivirine	non-nucleoside reverse transcriptase inhibitor		Phase 2
levomequitazine	histamine receptor antagonist	HRH1	Phase 2
LGK-974	porcupine inhibitor	PORCN	Phase 2
lirimilast	phosphodiesterase inhibitor		Phase 2
lisofylline	interleukin receptor antagonist, STAT inhibitor		Phase 2
litronesib	kinesin-like spindle protein inhibitor	KIF11	Phase 2
lomeguatrib	O6-alkylguanine-DNA alkyltransferase inhibitor	MGMT	Phase 2
lometrexol	glycinamide ribonucleotide formyltransferase inhibitor	GART, MTHFD1	Phase 2
lorlatinib	ALK tyrosine kinase receptor inhibitor	ALK	Phase 2
LOXO-101	tropomyosin receptor kinase inhibitor	NTRK1, NTRK2, NTRK3	Phase 2
Lu-AA-47070	adenosine receptor antagonist	ADORA2A	Phase 2
lucitanib	FGFR inhibitor, VEGFR inhibitor	FGFR1, FLT1, KDR, KIT, PDGFRA, PDGFRB, RET	Phase 2
luteolin	glucosidase inhibitor	TOP1	Phase 2
LX1031	tryptophan hydroxylase inhibitor	TPH1	Phase 2
LY2090314	glycogen synthase kinase inhibitor	GSK3B	Phase 2
LY2228820	p38 MAPK inhibitor	MAPK14	Phase 2
LY223982	leukotriene receptor antagonist	LTB4R	Phase 2
LY2603618	CHK inhibitor	CHEK1	Phase 2
LY2606368	CHK inhibitor	CHEK1	Phase 2
LY2784544	JAK inhibitor	JAK2, JAK3	Phase 2
LY2801653	MET inhibitor	MET	Phase 2
LY3023414	PI3K inhibitor, mTOR inhibitor	MTOR	Phase 2
M-14157	ATP-sensitive potassium channel antagonist	KCNQ1	Phase 2
mavoglurant	glutamate receptor antagonist	GRM5	Phase 2
MDL-11939	serotonin receptor antagonist	HTR2A, HTR2B, HTR2C	Phase 2
MDMS	DNA inhibitor		Phase 2
medica-16	ATP citrase lyase inhibitor	FFAR1	Phase 2
meglitinide	potassium channel blocker	CCR2	Phase 2
mepazine	MALT1 inhibitor (JH)	MALT1	Phase 2
merbarone	topoisomerase inhibitor	TOP2A	Phase 2
mericitabine	HCV inhibitor		Phase 2
merimepodib	inosine monophosphate dehydrogenase inhibitor	IMPDH1	Phase 2
metazosin	adrenergic receptor antagonist	ADRA1A	Phase 2
methanesulfonyl-fluoride	acetylcholinesterase inhibitor	ACHE	Phase 2
methiopril	angiotensin converting enzyme inhibitor	ACE	Phase 2
methoxyamine	DNA repair enzyme inhibitor	APEX1	Phase 2
mifobate	PPAR receptor antagonist	PPARG	Phase 2
MK-0812	CC chemokine receptor antagonist	CCR2	Phase 2
MK-0893	glucagon receptor antagonist	GCGR	Phase 2
MK-1775	WEE1 kinase inhibitor	WEE1	Phase 2
MK-2206	AKT inhibitor	AKT1, AKT2, AKT3	Phase 2
MK-2295	TRPV antagonist	TRPV1	Phase 2
MK-3207	calcitonin antagonist	CALCA	Phase 2
MK-3697	orexin receptor antagonist	HCRTR2	Phase 2
MK-571	leukotriene receptor antagonist	ABCC2, CYSLTR1	Phase 2
MK-6096	orexin receptor antagonist	HCRTR1, HCRTR2	Phase 2
MK-8245	stearoyl-CoA desaturase inhibitor	SCD	Phase 2
MLN0128	mTOR inhibitor	MTOR, PIK3CA, PIK3CD, PIK3CG	Phase 2
mocetinostat	HDAC inhibitor	HDAC1, HDAC11, HDAC2, HDAC3	Phase 2
moguisteine	ATP-sensitive potassium channel inhibitor		Phase 2
molidustat	hypoxia inducible factor inhibitor	EGLN2	Phase 2
nastorazepide	CCK receptor antagonist	CCKBR	Phase 2
navarixin	CC chemokine receptor antagonist	CXCR1, CXCR2	Phase 2
navitoclax	BCL inhibitor	BCL2, BCL2L1, BCL2L2	Phase 2
NE-100	sigma receptor antagonist	SIGMAR1	Phase 2
nemorubicin	topoisomerase inhibitor	TOP1, TOP2A	Phase 2
nepicastat	dopamine beta hydroxylase inhibitor	DBH	Phase 2
nesbuvir	RNA polymerase inhibitor		Phase 2
nibentan	potassium channel blocker		Phase 2
nitecapone	catechol O methyltransferase inhibitor	COMT	Phase 2
NM107	RNA polymerase inhibitor		Phase 2
NO-ASA	cyclooxygenase inhibitor	PTGS2	Phase 2
NPC-15199	ICAM1 antagonist	PPARG	Phase 2
NSC-4644	ACAT inhibitor, sterol regulatory element binding protein (SREBP) inhibitor	PYGM	Phase 2
NVP-AUY922	HSP inhibitor	HSP90AA1, HSP90AB1	Phase 2
NVP-BEZ235	mTOR inhibitor, PI3K inhibitor	ATR, MTOR, PIK3CA, PIK3CD, PIK3CG	Phase 2
NVP-BGJ398	FGFR inhibitor	FGFR1, FGFR2, FGFR3, FGFR4, KDR	Phase 2
NVP-DPP728	dipeptidyl peptidase inhibitor	DPP4	Phase 2
OCO-1112	cholesterol inhibitor		Phase 2
OC000459	CRTH receptor antagonist	PTGDR2	Phase 2
oglemilast	phosphodiesterase inhibitor		Phase 2
ONC201	AKT inhibitor, MAP kinase inhibitor	TNFSF10	Phase 2
oxiperomide	dopamine receptor antagonist		Phase 2
palosuran	urotensin receptor antagonist	UTS2R	Phase 2
PD-0325901	MEK inhibitor	MAP2K1	Phase 2
PD-184352	MEK inhibitor	MAP2K1, MAP3K1, MAP3K2	Phase 2
pelanserin	serotonin receptor antagonist	HTR2A	Phase 2
pelitinib	EGFR inhibitor	EGFR	Phase 2
perillyl-alcohol	apoptosis stimulant, farnesyltransferase inhibitor	FNTA	Phase 2
perindoprilat	angiotensin converting enzyme inhibitor	ACE	Phase 2
perzinfotel	glutamate receptor antagonist	GRIN1, GRIN2A, GRIN2B	Phase 2
pevonedistat	nedd activating enzyme inhibitor	NAE1, UBA3	Phase 2
PF-02545920	phosphodiesterase inhibitor	PDE10A	Phase 2
PF-03049423	phosphodiesterase inhibitor	PDE5A	Phase 2
PF-03084014	gamma secretase inhibitor		Phase 2
PF-04136309	CC chemokine receptor antagonist		Phase 2
PF-04447943	phosphodiesterase inhibitor	PDE9A	Phase 2
PF-04457845	FAAH inhibitor	FAAH	Phase 2
PF-04691502	mTOR inhibitor, PI3K inhibitor	MTOR, PIK3CA	Phase 2
PF-05212384	mTOR inhibitor, PI3K inhibitor	MTOR, PIK3CA	Phase 2
PF-06463922	ALK tyrosine kinase receptor inhibitor	ALK, FES, ROS1	Phase 2
PF-3274167	oxytocin receptor antagonist	AVPR1A, OXTR	Phase 2
PGL5001	JNK inhibitor	MAPK10, MAPK8, MAPK9	Phase 2
PH-797804	p38 MAPK inhibitor	MAPK11, MAPK14	Phase 2
PHA-848125	CDK inhibitor, growth factor receptor inhibitor	CDK2, CDK4, CDK7, NTRK1	Phase 2
phenylacetylglutamine	DNA methylase inhibitor, protein synthesis inhibitor		Phase 2
pibenzimol	DNA inhibitor		Phase 2
piboserod	serotonin receptor antagonist	HTR2B, HTR4	Phase 2
picartamide	H+/K+-ATPase inhibitor	ATP4A	Phase 2
piclamilast	phosphodiesterase inhibitor	PDE4A, PDE4B, PDE4C, PDE4D	Phase 2
picrotin	GABA receptor antagonist	GABRA1, GABRR1, GLRA1, GLRA2, GLRA3, GLRB	Phase 2
pilaralisib	PI3K inhibitor		Phase 2
pinitol	gamma secretase inhibitor		Phase 2
pinocembrin	cytochrome P450 inhibitor	CYP1B1	Phase 2
piperazinedione	DNA synthesis inhibitor		Phase 2
piricapiron	dopamine receptor antagonist, serotonin receptor antagonist	HTR2A	Phase 2
piromidic-acid	bacterial DNA gyrase inhibitor		Phase 2
piroximone	phosphodiesterase inhibitor	PDE3A	Phase 2
pivanex	HDAC inhibitor	HDAC1, HDAC2, HDAC3, HDAC8	Phase 2
PI3K-IN-2	PI3K inhibitor		Phase 2
polydatin	ICAM1 expression inhibitor	ICAM1	Phase 2
pozanicline	acetylcholine receptor antagonist	CHRNA4, CHRNB2	Phase 2
poziotinib	EGFR inhibitor	EGFR, ERBB2, ERBB4	Phase 2
pranidipine	calcium channel blocker	CACNA1C	Phase 2
presatovir	RSV fusion inhibitor		Phase 2
pritelivir	helicase primase inhibitor		Phase 2
prolylleucylglycinamide	melanocyte-stimulating hormone release inhibitor		Phase 2
PRT062607	syk inhibitor	FGR, MAP3K9, SYK	Phase 2
pruvanserin	serotonin receptor antagonist	HTR2A, HTR2C	Phase 2
PRX-08066	serotonin receptor antagonist	HTR2B	Phase 2
puerarin	serotonin receptor antagonist		Phase 2
putrescine	tissue transglutaminase inhibitor	AMD1, KCNJ4, ODC1	Phase 2
PX-12	thioredoxin inhibitor	TXN, TXNRD1	Phase 2
pyrazoloacridine	topoisomerase inhibitor	TOP1, TOP2A	Phase 2
P276-00	CDK inhibitor	CDK1, CDK4, CDK9	Phase 2
quazinone	phosphodiesterase inhibitor	PDE3A, PDE3B	Phase 2
quiflapon	leukotriene synthesis inhibitor	ALOX5, ALOX5AP	Phase 2
radafaxine	dopamine-norepinephrine reuptake inhibitor	SLC6A3	Phase 2
radezolid	bacterial 30S ribosomal subunit inhibitor, bacterial 50S ribosomal subunit inhibitor		Phase 2
RAF265	RAF inhibitor, VEGFR inhibitor	BRAF	Phase 2
ravuconazole	sterol demethylase inhibitor		Phase 2
Rec-15/2615	adrenergic receptor antagonist	ADRA1A	Phase 2
refametinib	MEK inhibitor	MAP2K1, MAP2K2	Phase 2
relcovaptan	vasopressin receptor antagonist	AVPR1A, AVPR1B, AVPR2, OXTR	Phase 2
resibufogenin	Na/K-ATPase inhibitor		Phase 2
resminostat	HDAC inhibitor	HDAC1, HDAC3, HDAC6, HDAC8	Phase 2
REV-5901	leukotriene receptor antagonist, lipoxygenase inhibitor	ALOX5	Phase 2
RG4733	gamma secretase inhibitor	PSEN1	Phase 2
riodipine	calcium channel blocker		Phase 2
robalzotan	serotonin receptor antagonist	HTR1A	Phase 2
rosamicin	protein synthesis inhibitor		Phase 2
roscovitine	CDK inhibitor	CDK2, CDK9	Phase 2
rostafuroxine	ATPase inhibitor	ATP1A1	Phase 2
RRx-001	glucose 6-phosphate dehydrogenase inhibitor	G6PD	Phase 2
RSV604	RSV replication inhibitor		Phase 2
RTA-408	nitric oxide production inhibitor	NFE2L2	Phase 2
RU-28318	cytochrome P450 inhibitor	NR3C2	Phase 2
RU-58841	androgen receptor antagonist	AR	Phase 2
S-111	PARP inhibitor	PARP1	Phase 2
salirasib	mTOR inhibitor	TRPA1	Phase 2
salvianolic-acid-B	metalloproteinase inhibitor, EGFR inhibitor	MMP9	Phase 2
sarcosine	Glycine transporter 1 inhibitor	SLC6A9	Phase 2
SAR407899	rho associated kinase inhibitor	ROCK1	Phase 2
savolitinib	c-Met inhibitor	MET	Phase 2
SB-705498	TRPV antagonist	TRPV1	Phase 2
SB-939	HDAC inhibitor	HDAC1, HDAC10, HDAC3, HDAC4, HDAC5, HDAC9	Phase 2
SC-12267	dihydroorotate dehydrogenase inhibitor	IL17A	Phase 2
SCH-900776	CHK inhibitor	CDK2, CHEK1	Phase 2
semapimod	cytokine production inhibitor, p38 MAPK inhibitor	MAPK14	Phase 2
sipatrigine	voltage-gated sodium channel blocker	CACNA1D, SCN10A, SCN1A, SCN3A, SCN4A, SCN5A, SCN9A	Phase 2
siramesine	sigma receptor antagonist	ADRA1A, ADRA1B, ADRA1D	Phase 2
SLV-319-(+/-)	cannabinoid receptor antagonist	CNR1, DRD2, HTR1A	Phase 2
SLV-320	adenosine receptor antagonist	ADORA1, ADORA2A, ADORA2B, ADORA3	Phase 2
sodium-butyrate	HDAC inhibitor	BCHE, FFAR2, FFAR3, HDAC1, HDAC2, HDAC3, HDAC8	Phase 2
sotrastaurin	PKC inhibitor	PRKCA, PRKCB, PRKCD, PRKCE, PRKCH, PRKCQ	Phase 2
SR-140333	neurokinin receptor antagonist	TACR1	Phase 2
SR-2640	leukotriene receptor antagonist	CYSLTR1	Phase 2
SR-27897	CCK receptor antagonist	CCKAR	Phase 2
STA-5326	interleukin synthesis inhibitor	IL12A	Phase 2
stobadine	adrenergic receptor antagonist	ADRA1A	Phase 2
succinylsulfathiazole	dihydrofolate reductase inhibitor	DHFR	Phase 2
sulforaphane	anticancer agent, aryl hydrocarbon receptor antagonist	NFE2L2	Phase 2
sutezolid	protein synthesis inhibitor		Phase 2
SU014813	PDGFR tyrosine kinase receptor inhibitor, VEGFR inhibitor	KDR	Phase 2
swainsonine	alpha mannosidase inhibitor	MAN2A1	Phase 2
T-5224	AP inhibitor	JUN	Phase 2
TAK-063	phosphodiesterase inhibitor	PDE10A	Phase 2
TAK-715	p38 MAPK inhibitor	MAPK14	Phase 2
taladegib	smoothened receptor antagonist	DHH, IHH, SMO	Phase 2
talampanel	glutamate receptor antagonist	GRIA1, GRIA2, GRIA3, GRIA4	Phase 2
talarozole	cytochrome P450 inhibitor	CYP26A1	Phase 2
talmapimod	p38 MAPK inhibitor	MAPK11, MAPK14	Phase 2
talnetant	tachykinin antagonist	TACR2, TACR3	Phase 2
talopram	adrenergic inhibitor	SLC6A2	Phase 2
tandutinib	FLT3 inhibitor, KIT inhibitor, PDGFR tyrosine kinase receptor inhibitor	CSF1R, FLT3, KIT, PDGFD, PDGFRB	Phase 2
tanshinone-i	AP inhibitor	IFNG	Phase 2
tarafenacin	acetylcholine receptor antagonist	CHRM3	Phase 2
taxifolin	opioid receptor antagonist	ADIPOR2	Phase 2
tazemetostat	histone lysine methyltransferase inhibitor	EZH2	Phase 2
telatinib	KIT inhibitor, PDGFR tyrosine kinase receptor inhibitor, VEGFR inhibitor	KDR	Phase 2
tenatoprazole	ATPase inhibitor	IDO1	Phase 2
tetradecylthioacetic-acid	lipid peroxidase inhibitor		Phase 2
tetrahydrouridine	cytidine deaminase inhibitor	CDA	Phase 2
TG-100801	src inhibitor, VEGFR inhibitor	FGFR1, FLT1, KDR, SRC	Phase 2
thaliblastine	DNA inhibitor		Phase 2
TIC10	AKT inhibitor, TRAIL modulator	AKT1, MAPK1	Phase 2
tideglusib	glycogen synthase kinase inhibitor	GSK3B	Phase 2
timofibrate	cholesterol inhibitor, lipase clearing factor inhibitor	LPL	Phase 2
tioguanine	purine antagonist		Phase 2
tiotidine	histamine receptor antagonist	HRH2	Phase 2
tiprenolol	adrenergic receptor antagonist	ADRB1, ADRB2, ADRB3	Phase 2
TMC-353121	RSV fusion inhibitor		Phase 2
TMC647055	RNA polymerase inhibitor		Phase 2
TNP-470	methionine aminopeptidase inhibitor		Phase 2
tonabersat	gap junction modulator, nitric oxide production inhibitor		Phase 2
torcitabine	DNA polymerase inhibitor	DCK, TK2	Phase 2
tosedostat	peptidase inhibitor	ANPEP, LAP3, NPEPPS	Phase 2
tozasertib	Aurora kinase inhibitor, Bcr-Abl kinase inhibitor, FLT3 inhibitor, JAK inhibitor	AURKA, AURKB, AURKC, LCK	Phase 2
traxoprodil	glutamate receptor antagonist	GRIN2B	Phase 2
tretazicar	DNA replication inhibitor	NQO2	Phase 2
triapine	ribonucleotide reductase inhibitor	RRM1, RRM2	Phase 2
trofinetide	cytokine production inhibitor	IFNG, IL6, TNF	Phase 2
tucatinib	EGFR inhibitor	ERBB2	Phase 2
uprosertib	AKT inhibitor	AKT1, AKT2, AKT3	Phase 2
ursodeoxycholyltaurine	cholesterol inhibitor		Phase 2
VE-822	ATR kinase inhibitor	ATM, ATR, MTOR, PIK3CG	Phase 2
velneperit	neuropeptide receptor antagonist	NPY5R	Phase 2
verinurad	urate transporter inhibitor	SLC22A12	Phase 2
verubulin	tubulin polymerization inhibitor	TUBB	Phase 2
voxtalisib	mTOR inhibitor, PI3K inhibitor	MTOR, PIK3CA	Phase 2
VT-464	cytochrome P450 inhibitor	CYP17A1	Phase 2
VX-222	HCV inhibitor		Phase 2
VX-702	p38 MAPK inhibitor	MAPK11, MAPK12, MAPK14	Phase 2
VX-745	p38 MAPK inhibitor	MAPK11, MAPK12, MAPK14	Phase 2
VX-765	caspase inhibitor	CASP1	Phase 2
XL-147	PI3K inhibitor	PIK3CA, PIK3CD, PIK3CG	Phase 2
Y-39983	rho associated kinase inhibitor	ROCK1, ROCK2	Phase 2
YM-155	survivin inhibitor	BIRC5	Phase 2
YM-511	aromatase inhibitor	CYP19A1	Phase 2
YM022	CCK receptor antagonist	CCKBR	Phase 2
zacopride	serotonin receptor antagonist	HTR3A, HTR3B, HTR4, HTR5A	Phase 2
zaprinast	phosphodiesterase inhibitor	GPR35, PDE1A, PDE4D, PDE5A, PDE9A	Phase 2
zardaverine	phosphodiesterase inhibitor	PDE4D	Phase 2
ZD-7288	HCN channel blocker	HCN1, HCN2, HCN3, HCN4	Phase 2
zindotrine	phosphodiesterase inhibitor		Phase 2
ZK-200775	kainate receptor antagonist		Phase 2
ZK811752	CC chemokine receptor antagonist	CCR1	Phase 2
Z160	N-type calcium channel blocker	CACNA2D1	Phase 2
1,12-Besm	polyamine biosynthesis inhibitor		Phase 2
2,4-dinitrochlorobenzene	thioredoxin inhibitor	TXN	Phase 2
2-deoxyglucose	glycolysis inhibitor	SLC2A1, SLC2A2, SLC2A3, SLC2A4	Phase 2
2-iminobiotin	nitric oxide synthase inhibitor	NOS1, NOS2	Phase 2
2-methoxyestradiol	hypoxia inducible factor inhibitor	COMT, CYP19A1, CYP1A1, CYP1B1, HIF1A, TUBB	Phase 2
3-amino-benzamide	PARP inhibitor	PARP1	Phase 2
3-deazaadenosine	adenosylhomocysteinase inhibitor	AHCY	Phase 2
6-aminochrysene	transferase inhibitor		Phase 2
7-hydroxystaurosporine	CDK inhibitor, CHK inhibitor, PKC inhibitor	CHEK1, MARK3, PDPK1	Phase 2
7-methoxytacrine	acetylcholinesterase inhibitor	ACHE	Phase 2
7-methylxanthine	adenosine receptor antagonist		Phase 2
9-aminocamptothecin	topoisomerase inhibitor	TOP1	Phase 2
alagebrium	glycosylation inhibitor		Phase 2/Phase 3
anlotinib	VEGFR inhibitor, PDGFR tyrosine kinase receptor inhibitor	KDR, PDGFRB	Phase 2/Phase 3
arbutin	melanin inhibitor	TYR	Phase 2/Phase 3
AZD4547	FGFR inhibitor	FGFR1, FGFR2, FGFR3, FGFR4, IGF1R, KDR	Phase 2/Phase 3
barasertib	Aurora kinase inhibitor	AURKA, AURKB	Phase 2/Phase 3
barasertib-HQPA	Aurora kinase inhibitor	AURKB	Phase 2/Phase 3
cabotegravir	HIV integrase inhibitor		Phase 2/Phase 3
decernotinib	JAK inhibitor	JAK3	Phase 2/Phase 3
ebselen	cyclooxygenase inhibitor, glutathione peroxidase agonist, H+/K+-ATPase inhibitor, nitric oxide synthase inhibitor	ALB	Phase 2/Phase 3
epigallocatechin-gallate-(-)	bacterial DNA gyrase inhibitor	ELANE, EP300, FASN, KAT2B, MMP14, MMP2	Phase 2/Phase 3
genistein	tyrosine kinase inhibitor	CFTR, ESR1, ESR2, ESRRA, ESRRB, ESRRG, NCOA1, NCOA2, PPARG, PTK2B, TOP2A, TRPC5	Phase 2/Phase 3
indirubin	CDK inhibitor, glycogen synthase kinase inhibitor	CDK1, CDK5, GSK3A	Phase 2/Phase 3
indole-3-carbinol	aryl hydrocarbon receptor agonist, indoleamine 2,3-dioxygenase inhibitor	AHR	Phase 2/Phase 3
L-NAME	nitric oxide synthase inhibitor	NOS3	Phase 2/Phase 3
liarozole	cytochrome P450 inhibitor	CYP19A1, CYP26A1	Phase 2/Phase 3
LY2157299	TGF beta receptor inhibitor	TGFBR1	Phase 2/Phase 3
meclinertant	neurotensin receptor antagonist	NTSR1, NTSR2	Phase 2/Phase 3
narlaprevir	HCV inhibitor		Phase 2/Phase 3
oxaloacetate	glutamate release inhibitor	CS, SPR	Phase 2/Phase 3
oxypurinol	xanthine oxidase inhibitor	XDH	Phase 2/Phase 3
pterostilbene	cyclooxygenase inhibitor, PPAR receptor agonist	PTGS2	Phase 2/Phase 3
saracatinib	src inhibitor	ABL1, LCK, SRC, YES1	Phase 2/Phase 3
selinexor	exportin antagonist	XPO1	Phase 2/Phase 3
tanshinone-iia	anti-inflammatory agent, interleukin inhibitor	IL1B, NR1I2, TNF	Phase 2/Phase 3
tetraethylenepentamine	superoxide dismutase inhibitor	SOD1, SOD2	Phase 2/Phase 3
verbascoside	PKC inhibitor, NFkB pathway inhibitor		Phase 2/Phase 3
vitamin-E	PKC inhibitor, LDL oxidation inhibitor	ALOX5, DGKA, NR1I2, PPP2CA, PPP2CB, PRKCA, PRKCB, SEC14L2, SEC14L3, SEC14L4	Phase 2/Phase 3
abafungin	sterol methyltransferase inhibitor		Phase 3
abametapir	metalloproteinase inhibitor	MMP9	Phase 3
acalabrutinib	Bruton's tyrosine kinase (BTK) inhibitor	BTK	Phase 3
acecainide	polarization inhibitor	SCN5A	Phase 3
acifran	cholesterol inhibitor	HCAR2, HCAR3	Phase 3
adaprev	TGF beta receptor inhibitor	IGF2R, M6PR	Phase 3
agmatine	nitric oxide synthase inhibitor	ADRA2C, ASIC3, CACNA1B, CHRNA1, GRIN1, KCNJ1, NISCH	Phase 3
AGN-194310	retinoid receptor antagonist	RXRA, RXRB, RXRG	Phase 3
AKBA	lipoxygenase inhibitor	ALOX5	Phase 3
aldoxorubicin	topoisomerase inhibitor	TOP2A	Phase 3
alisertib	Aurora kinase inhibitor	AURKA	Phase 3
almorexant	orexin receptor antagonist	HCRTR1, HCRTR2	Phase 3
aloxistatin	protease inhibitor	CTSG	Phase 3
alpelisib	PI3K inhibitor	PIK3CA, PIK3CB, PIK3CD, PIK3CG	Phase 3
aminoguanidine	nitric oxide synthase inhibitor	NOS2	Phase 3
aminopterin	dihydrofolate reductase inhibitor	DHFR, SLC46A1	Phase 3
amiprilose	CD antagonist		Phase 3
amitifadine	serotonin transporter (SERT) inhibitor	SLC6A2, SLC6A3, SLC6A4	Phase 3
amonafide	topoisomerase inhibitor	TOP2A, TOP2B	Phase 3
anacetrapib	cholesteryl ester transfer protein inhibitor	CETP	Phase 3
anisodamine	lipid peroxidase inhibitor	ADRA1A	Phase 3
apafant	platelet activating factor receptor antagonist	PTAFR	Phase 3
apatinib	RET tyrosine kinase inhibitor	CSK, KDR, KIT, RET	Phase 3
apricitabine	nucleoside reverse transcriptase inhibitor		Phase 3
aptiganel	glutamate receptor antagonist	GRIN1	Phase 3
arofylline	phosphodiesterase inhibitor	PDE4A	Phase 3
ASA-404	angiogenesis inhibitor		Phase 3
asunaprevir	HCV inhibitor		Phase 3
atrasentan	endothelin receptor antagonist	EDNRA	Phase 3
avasimibe	ACAT inhibitor	CES1	Phase 3
azeliragon	RAGE receptor antagonist	AGER	Phase 3
azimilide	potassium channel blocker	KCNA5, KCNE1, KCNH2, KCNQ1	Phase 3
baricitinib	JAK inhibitor	JAK1, JAK2	Phase 3
batimastat	matrix metalloprotease inhibitor	ADAM28, ADAMTS5, MMP12, MMP16, MMP2, MMP8	Phase 3
bemesetron	serotonin receptor antagonist	HTR3A, HTR3B	Phase 3
BF2.649	histamine receptor antagonist	HRH3	Phase 3
bicifadine	serotonin receptor antagonist, dopamine reuptake inhibitor	DRD2, SLC6A2, SLC6A4	Phase 3
bitopertin	glycine transporter inhibitor, GlyT-1 inhibitor	SLC6A5, SLC6A9	Phase 3
BMS-626529	HIV attachment inhibitor		Phase 3
brivanib	FGFR inhibitor, VEGFR inhibitor	CYP3A4, FGFR1, FLT1, KCNH2, KDR	Phase 3
brivanib-alaninate	FGFR inhibitor, VEGFR inhibitor	FGFR3	Phase 3
buparlisib	PI3K inhibitor	PIK3CA, PIK3CG	Phase 3
camptothecin	topoisomerase inhibitor	TOP1	Phase 3
canertinib	EGFR inhibitor	AKT1, EGFR, ERBB2, ERBB4	Phase 3
carboxyamidotriazole	calcium channel blocker	CXCL8	Phase 3
cariporide	sodium/hydrogen exchanger inhibitor	SLC9A1	Phase 3
CB-03-01	androgen receptor antagonist	AR	Phase 3
cediranib	KIT inhibitor, VEGFR inhibitor	CSF1R, FLT1, FLT3, FLT4, KDR, KIT, PDGFRA, PDGFRB	Phase 3
centpropazine	inositol monophosphatase inhibitor		Phase 3
cetilistat	triacylglycerol lipase inhibitor	PNLIP	Phase 3
cilengitide	integrin antagonist	ITGAV, ITGB3	Phase 3
cilomilast	phosphodiesterase inhibitor	PDE4A, PDE4B, PDE4D	Phase 3
cipemastat	metalloproteinase inhibitor	ADAM17, MMP1, MMP13, MMP2, MMP3, MMP8, MMP9	Phase 3
clinafloxacin	bacterial DNA gyrase inhibitor		Phase 3
cortodoxone	androgen receptor antagonist	AR	Phase 3
CP-945,598	cannabinoid receptor antagonist	CNR1	Phase 3
crisaborole	phosphodiesterase inhibitor	PDE4B	Phase 3
dacomitinib	EGFR inhibitor	EGFR, ERBB2, ERBB4	Phase 3
dalcetrapib	cholesteryl ester transfer protein inhibitor	CETP	Phase 3
daltroban	thromboxane receptor antagonist	TBXA2R	Phase 3
dapivirine	non-nucleoside reverse transcriptase inhibitor	CYP3A4, CYP3A5	Phase 3
daprodustat	hypoxia inducible factor inhibitor	EGLN1	Phase 3
darapladib	phospholipase inhibitor	PLA2G7	Phase 3
darusentan	endothelin receptor antagonist	EDNRA	Phase 3
deforolimus	mTOR inhibitor	MTOR	Phase 3
dehydrocorydaline	acetylcholinesterase inhibitor	ACHE	Phase 3
dexloxiglumide	CCK receptor antagonist	CCKAR	Phase 3
dichloroacetate	pyruvate dehydrogenase kinase inhibitor	PDK1	Phase 3
diclofensine	dopamine reuptake inhibitor	DRD1, MAOA, MAOB	Phase 3
dimesna	tubulin polymerization inhibitor		Phase 3
dinaciclib	CDK inhibitor	CDK1, CDK2, CDK5, CDK9	Phase 3
dofequidar	MRP inhibitor, P glycoprotein inhibitor	ABCB1	Phase 3
dovitinib	EGFR inhibitor, FGFR inhibitor, FLT3 inhibitor, PDGFR tyrosine kinase receptor inhibitor, VEGFR inhibitor	CSF1R, EGFR, FGFR1, FGFR2, FGFR3, FLT1, FLT3, FLT4, INSR, KDR, KIT, PDGFRA, PDGFRB	Phase 3
DPPE	histamine receptor antagonist	ABCB1, HRH1	Phase 3
elagolix	gonadotropin releasing factor hormone receptor antagonist	GNRHR	Phase 3
eliprodil	glutamate receptor antagonist	GRIN1, GRIN2B	Phase 3
eltanolone	membrane integrity inhibitor	GABRA1, GABRB2, GABRG2	Phase 3
eniluracil	dihydropyrimidine dehydrogenase inhibitor	AOX1, DPYD, XDH	Phase 3
enprofylline	phosphodiesterase inhibitor	ADORA1, ADORA2A, ADORA2B, ADORA3, PDE4A, PDE4B	Phase 3
entinostat	HDAC inhibitor	HDAC1, HDAC2, HDAC3, HDAC9	Phase 3
enzastaurin	PKC inhibitor	AKT1, GSK3B, PRKCA, PRKCB, PRKCD, PRKCG	Phase 3
epacadostat	indoleamine 2,3-dioxygenase inhibitor	IDO1	Phase 3
epothilone-b	microtubule stabilizing agent, tubulin polymerization inhibitor	TUBA1A, TUBA1B, TUBA1C, TUBA3C, TUBA4A, TUBA8, TUBB, TUBB1, TUBB3, TUBB4A, TUBB4B	Phase 3
eprodisate	antiamyloidogenic agent, amyloid protein inhibitor	SAA1	Phase 3
etanidazole	bacterial cell wall synthesis inhibitor		Phase 3
ETC-1002	AMPK inhibitor	ACLY	Phase 3
evacetrapib	cholesteryl ester transfer protein inhibitor	CETP	Phase 3
exatecan-mesylate	topoisomerase inhibitor	TOP1	Phase 3
exisulind	phosphodiesterase inhibitor	PDE5A	Phase 3
favipiravir	RNA polymerase inhibitor		Phase 3
FG-4592	hypoxia inducible factor prolyl hydroxylase inhibitor	EGLN2	Phase 3
fidarestat	aldose reductase inhibitor	AKR1B1	Phase 3
filanesib	kinesin inhibitor, kinesin-like spindle protein inhibitor	KIF11	Phase 3
flumatinib	Bcr-Abl kinase inhibitor	ABL1, PDGFRB	Phase 3
flurizan	gamma secretase inhibitor	APH1B, BACE1, IKBKG, PSEN1, PSEN2, PTGS1, PTGS2	Phase 3
foropafant	platelet activating factor receptor antagonist	PTAFR	Phase 3
fosbretabulin	tubulin polymerization inhibitor, VE-cadherin antagonist	CDH5	Phase 3
fruquintinib	VEGFR inhibitor	KDR	Phase 3
ganetespib	HSP inhibitor	HSP90AA1	Phase 3
gavestinel	glutamate receptor antagonist	GLRB	Phase 3
gilteritinib	FLT3 inhibitor	FLT3	Phase 3
ginkgolide-b	platelet activating factor receptor antagonist	GLRA1, GLRA2, GLRA3, GLRB, HTR3A, HTR3B	Phase 3
ginsenoside-rd	calcium channel blocker		Phase 3
glycitein	tumor necrosis factor release inhibitor	TNF	Phase 3
harringtonine	protein synthesis inhibitor		Phase 3
honokiol	AKT inhibitor	ALOX5, PTGS1, PTGS2	Phase 3
icariin	phosphodiesterase inhibitor	PDE5A	Phase 3
idalopirdine	serotonin receptor antagonist	HTR6	Phase 3
idasanutlin	MDM inhibitor	MDM2, TP53	Phase 3
idazoxan	adrenergic receptor antagonist	ADRA2A	Phase 3
idronoxil	XIAP inhibitor	ENOX2, SPHK1	Phase 3
ilomastat	matrix metalloprotease inhibitor	ACAN, ADAM28, MMP1, MMP12, MMP13, MMP14, MMP2, MMP3, MMP8, MMP9	Phase 3
iniparib	PARP inhibitor	PARP1	Phase 3
IPI-145	PI3K inhibitor	PIK3CA, PIK3CB, PIK3CD, PIK3CG	Phase 3
ipidacrine	acetylcholinesterase inhibitor	ACHE	Phase 3
isavuconazole	cytochrome P450 inhibitor	CYP3A4	Phase 3
KW-3902	adenosine receptor antagonist	ADORA1, ADORA2A, ADORA2B, ADORA3	Phase 3
L-monomethylarginine	nitric oxide synthase inhibitor	NOS1, NOS2	Phase 3
latrepirdine	glutamate receptor antagonist	HRH1, HTR6	Phase 3
lazabemide	monoamine oxidase inhibitor	MAOB	Phase 3
LCQ908	diacylglycerol O acyltransferase inhibitor	DGAT1	Phase 3
lemborexant	orexin receptor antagonist	HCRTR1, HCRTR2	Phase 3
lerisetron	serotonin receptor antagonist	HTR3A	Phase 3
lestaurtinib	FLT3 inhibitor, growth factor receptor inhibitor, JAK inhibitor	FLT3, NTRK1	Phase 3
letermovir	CMV terminase inhibitor		Phase 3
leucomethylene-blue	nitric oxide production inhibitor, tau aggregation inhibitor	MAPT	Phase 3
LGX818	RAF inhibitor	BRAF	Phase 3
licarbazepine	voltage-gated sodium channel blocker	SCN5A	Phase 3
licochalcone-a	topoisomerase inhibitor	PTPN1	Phase 3
licofelone	cyclooxygenase inhibitor, lipoxygenase inhibitor	ALOX5, PLA2G2E, PTGS2	Phase 3
linifanib	PDGFR tyrosine kinase receptor inhibitor, VEGFR inhibitor	CSF1, CSF1R, FLT1, FLT3, FLT4, KDR, KIT, PDGFRB, RET, TEK	Phase 3
linopirdine	potassium channel blocker	KCNQ2, KCNQ3, KCNQ4, KCNQ5	Phase 3
linsitinib	IGF-1 inhibitor	IGF1R, INSR, INSRR	Phase 3
lixivaptan	vasopressin receptor antagonist	AVPR2	Phase 3
lofemizole	cyclooxygenase inhibitor		Phase 3
lonafarnib	farnesyltransferase inhibitor	FNTA, HRAS, KRAS, NRAS	Phase 3
losmapimod	p38 MAPK inhibitor	MAPK14	Phase 3
lumateperone	serotonin receptor antagonist, dopamine receptor modulator	DRD2, HTR2A	Phase 3
maribavir	cytomegalovirus inhibitor, protein kinase inhibitor	PYGM	Phase 3
marimastat	matrix metalloprotease inhibitor	MMP1, MMP10, MMP11, MMP12, MMP13, MMP14, MMP15, MMP16, MMP17, MMP19, MMP2, MMP20, MMP21, MMP23A, MMP24, MMP25, MMP26, MMP27, MMP28, MMP3, MMP7, MMP8, MMP9	Phase 3
meisoindigo	STAT inhibitor	STAT3	Phase 3
MEK162	MEK inhibitor	MAP2K1, MAP2K2	Phase 3
metrifonate	acetylcholinesterase inhibitor	ACHE	Phase 3
midafotel	glutamate receptor antagonist	GRIN2A, GRIN2B, GRIN2C, GRIN2D	Phase 3
milacemide	monoamine oxidase inhibitor	MAOB	Phase 3
MLN9708	proteasome inhibitor		Phase 3
motesanib	KIT inhibitor, PDGFR tyrosine kinase receptor inhibitor, VEGFR inhibitor	FLT1, FLT4, KDR, KIT	Phase 3
napabucasin	STAT inhibitor	STAT3	Phase 3
neratinib	EGFR inhibitor	EGFR, ERBB2, KDR	Phase 3
nerbacadol	cyclooxygenase inhibitor		Phase 3
nolatrexed	thymidylate synthase inhibitor	TYMS	Phase 3
obatoclax	BCL inhibitor	BCL2	Phase 3
odanacatib	cathepsin inhibitor	CTSK	Phase 3
ODM-201	androgen receptor antagonist	AR	Phase 3
omadacycline	bacterial 30S ribosomal subunit inhibitor		Phase 3
opicapone	catechol O methyltransferase inhibitor	COMT	Phase 3
orantinib	FGFR inhibitor, PDGFR tyrosine kinase receptor inhibitor, VEGFR inhibitor	AURKA, AURKB, EGFR, FGFR1, FGFR2, KDR, PDGFRA, PDGFRB	Phase 3
orteronel	androgen biosynthesis inhibitor, androgen receptor antagonist, cytochrome P450 inhibitor	CYP17A1	Phase 3
otamixaban	coagulation factor inhibitor	F10	Phase 3
otenzepad	acetylcholine receptor antagonist	CHRM1, CHRM2, CHRM3, CHRM4, CHRM5	Phase 3
O6-Benzylguanine	O6-alkylguanine-DNA alkyltransferase inhibitor	MGMT	Phase 3
pacritinib	FLT3 inhibitor, JAK inhibitor	FLT3, JAK1, JAK2, JAK3	Phase 3
pafuramidine	DNA synthesis inhibitor		Phase 3
peficitinib	JAK inhibitor	JAK1, JAK2, JAK3	Phase 3
perifosine	AKT inhibitor	AKT1	Phase 3
pexidartinib	tyrosine kinase inhibitor	CSF1R, FLT3, KIT	Phase 3
phenserine	acetylcholinesterase inhibitor, beta amyloid synthesis inhibitor	ACHE, BCHE	Phase 3
physostigmine-salicylate	acetylcholinesterase inhibitor		Phase 3
plinabulin	tubulin polymerization inhibitor		Phase 3
preladenant	adenosine receptor antagonist	ADORA1, ADORA2A, ADORA2B, ADORA3	Phase 3
priralfinamide	sodium channel blocker	CACNA1B	Phase 3
pyridoxamine	AGE inhibitor		Phase 3
quizartinib	FLT3 inhibitor	CSF1R, FLT3, KIT, PDGFRA, PDGFRB, RET	Phase 3
ranirestat	aldose reductase inhibitor	AKR1B1	Phase 3
relebactam	beta lactamase inhibitor		Phase 3
remacemide	glutamate receptor antagonist	GRIN1	Phase 3
reparixin	CC chemokine receptor antagonist	CXCR1, CXCR2	Phase 3
resatorvid	toll-like receptor antagonist	TLR4	Phase 3
retaspimycin	HSP inhibitor	HSP90AA1	Phase 3
rifamycin-sv	RNA synthesis inhibitor		Phase 3
rigosertib	cell cycle inhibitor, PLK inhibitor	PLK1	Phase 3
ritanserin	serotonin receptor antagonist	ADRA1A, ADRA1B, ADRA1D, HTR1A, HTR1B, HTR1D, HTR2A, HTR2B, HTR2C, HTR5A, HTR6, HTR7	Phase 3
rociletinib	EGFR inhibitor	EGFR	Phase 3
rolipram	phosphodiesterase inhibitor		Phase 3
roquinimex	angiogenesis inhibitor, tumor necrosis factor production inhibitor		Phase 3
rubitecan	topoisomerase inhibitor	TOP1	Phase 3
rucaparib	PARP inhibitor	PARP1, PARP2	Phase 3
SB-742457	serotonin receptor antagonist	HTR6	Phase 3
schisandrol-b	lipid peroxidase inhibitor		Phase 3
selexipag	platelet aggregation inhibitor, IP1 prostacyclin receptor agonist	PTGIR	Phase 3
selfotel	glutamate receptor antagonist	GRIN2A, GRIN2B, GRIN2C, GRIN2D	Phase 3
selumetinib	MEK inhibitor	MAP2K1	Phase 3
semagacestat	gamma secretase inhibitor	PSEN1	Phase 3
semaxanib	VEGFR inhibitor	FGFR1, FLT1, KDR, KIT, PDGFRA, PDGFRB, RET	Phase 3
senicapoc	intermediate conductance potassium channel blocker	KCNN4	Phase 3
setipiprant	prostaglandin inhibitor	PTGDR2	Phase 3
solamargine	apoptosis inhibitor		Phase 3
solithromycin	protein synthesis inhibitor		Phase 3
sorbinil	aldose reductase inhibitor	AKR1B1	Phase 3
sotagliflozin	sodium/glucose cotransporter inhibitor	SLC5A1, SLC5A2	Phase 3
sparfosate	aspartate carbamoyltransferase inhibitor	CA2, CA4, CAD	Phase 3
SPP301	endothelin receptor antagonist	EDNRA	Phase 3
SQ-109	bacterial cell wall synthesis inhibitor	FDFT1	Phase 3
tacedinaline	HDAC inhibitor	HDAC1	Phase 3
tagatose	phosphorylase inhibitor	PYGL	Phase 3
talabostat	dipeptidyl peptidase inhibitor, fibroblast activation protein inhibitor	DPP4	Phase 3
talazoparib	PARP inhibitor	PARP2	Phase 3
tanespimycin	HSP inhibitor	HSP90AA1	Phase 3
targinine	nitric oxide synthase inhibitor	NOS3	Phase 3
tariquidar	P glycoprotein inhibitor	ABCB1	Phase 3
taselisib	PI3K inhibitor	PIK3CA	Phase 3
tasquinimod	angiogenesis inhibitor, S100A9 inhibitor	HDAC4	Phase 3
tecastemizole	histamine receptor antagonist	KCNH2	Phase 3
tecovirimat	orthopoxvirus egress inhibitor		Phase 3
tegobuvir	HCV inhibitor, protease inhibitor		Phase 3
telcagepant	calcitonin antagonist	CALCRL, RAMP1	Phase 3
telenzepine	acetylcholine receptor antagonist	CHRM1	Phase 3
tenidap	cyclooxygenase inhibitor	KCNJ4, PTGS1	Phase 3
tenilsetam	AGE inhibitor		Phase 3
terodiline	cholinergic receptor antagonist		Phase 3
terutroban	prostanoid receptor antagonist	TBXA2R	Phase 3
tetrindole	monoamine oxidase inhibitor	MAOA	Phase 3
TG-101348	FLT3 inhibitor, JAK inhibitor	BRD4, JAK1, JAK2, JAK3, TYK2	Phase 3
TGR-1202	PI3K inhibitor		Phase 3
tipifarnib	farnesyltransferase inhibitor	FNTA, FNTB	Phase 3
tirapazamine	DNA inhibitor		Phase 3
tivantinib	tyrosine kinase inhibitor	MET	Phase 3
tivozanib	VEGFR inhibitor	FLT1, FLT4, KDR, KIT, PDGFRA, PDGFRB	Phase 3
tolamolol	adrenergic receptor antagonist	ADRB1, ADRB2, ADRB3	Phase 3
tomelukast	leukotriene receptor antagonist	CYSLTR1	Phase 3
torcetrapib	cholesteryl ester transfer protein inhibitor	CETP	Phase 3
tozadenant	adenosine receptor antagonist	ADORA2A	Phase 3
tramiprosate	beta amyloid protein neurotoxicity inhibitor	APP	Phase 3
triptolide	RNA polymerase inhibitor	RELA	Phase 3
valnoctamide	arachidonic acid acylation inhibitor, benzodiazepine receptor agonist		Phase 3
valspodar	P glycoprotein inhibitor	ABCB1	Phase 3
vanoxerine	dopamine uptake inhibitor	SLC6A3	Phase 3
varespladib	secretory phospholipase inhibitor	PLA2G2A	Phase 3
vatalanib	KIT inhibitor, PDGFR tyrosine kinase receptor inhibitor, VEGFR inhibitor	EGFR, FLT1, FLT4, KDR, PDGFRB	Phase 3
veliflapon	leukotriene synthesis inhibitor	ALOX5AP	Phase 3
veliparib	PARP inhibitor	PARP1, PARP2	Phase 3
vercirnon	CC chemokine receptor antagonist	CCR9	Phase 3
vicriviroc	CC chemokine receptor antagonist	CCR5	Phase 3
volasertib	PLK inhibitor	PLK1	Phase 3
volinanserin	serotonin receptor antagonist	HTR2A, HTR2B, HTR2C, KCNH2	Phase 3
voreloxin	topoisomerase inhibitor	TOP2A	Phase 3
xibenolol	adrenergic receptor antagonist		Phase 3
XL-647	EGFR inhibitor, VEGFR inhibitor	EGFR, EPHB4, ERBB2, FLT4, KDR	Phase 3
zaldaride	calmodulin antagonist	CALM1	Phase 3
zaltidine	histamine receptor antagonist	HRH2	Phase 3
ZAMI-633	urease inhibitor		Phase 3
zamifenacin	acetylcholine receptor antagonist	CHRM3	Phase 3
zatebradine	HCN channel blocker	HCN1, HCN2, HCN3, HCN4	Phase 3
zibotentan	endothelin receptor antagonist	EDNRA	Phase 3
zoniporide	sodium/hydrogen exchanger inhibitor	SLC9A1	Phase 3
zosuquidar	P glycoprotein inhibitor	ABCB1, ABCB4	Phase 3
3,3'-diindolylmethane	CHK inhibitor, cytochrome P450 activator, indoleamine 2,3-dioxygenase inhibitor	AR, HIF1A, IFNG, PI3	Phase 3
[sar9,met(o2)11]-substance-p	tachykinin antagonist	TACR1	Preclinical
A-1070722	glycogen synthase kinase inhibitor	GSK3A, GSK3B	Preclinical
A-317491	purinergic receptor antagonist	P2RX3	Preclinical
A-366	histone lysine methyltransferase inhibitor	EHMT1, EHMT2	Preclinical
A-438079	purinergic receptor antagonist	P2RX7	Preclinical
A-674563	AKT inhibitor	AKT1, PKIA, PRKACA	Preclinical
A-7	calmodulin antagonist		Preclinical
A-784168	transient receptor potential channel antagonist	TRPV1	Preclinical
A-803467	sodium channel blocker	SCN10A	Preclinical
A-804598	purinergic receptor antagonist	P2RX7	Preclinical
A-839977	purinergic receptor antagonist	P2RX7	Preclinical
A-887826	sodium channel blocker	SCN10A	Preclinical
A-922500	diacylglycerol O acyltransferase inhibitor	DGAT1	Preclinical
A-939572	stearoyl-CoA desaturase inhibitor	SCD	Preclinical
A-967079	transient receptor potential channel antagonist	TRPA1	Preclinical
A-987306	histamine receptor antagonist	ADORA1, AVPR1A, CCR1, CHRM1, CHRM2, CHRM3, CHRM4, DRD3, HTR1A, HTR1B, HTR2A, HTR2B, HTR3A, TACR2	Preclinical
ABT-702	adenosine kinase inhibitor	ADK	Preclinical
AC-55541	PARP inhibitor	PARP2	Preclinical
AC-710	PDGFR tyrosine kinase receptor inhibitor	CSF1R, FLT3, KIT, PDGFRA, PDGFRB	Preclinical
ACDPP	glutamate receptor antagonist	GRM5	Preclinical
acetanilide	hydrogen peroxide decomposition inhibitor		Preclinical
acetylsalicylsalicylic-acid	cyclooxygenase inhibitor		Preclinical
adipic-acid	solute carrier family member inhibitor	SLC22A6	Preclinical
adrenosterone	11-beta hydroxysteroid dehydrogenase inhibitor	HSD11B1, HSD11B2	Preclinical
AF38469	sortilin inhibitor	SORT1	Preclinical
AG-1024	insulin growth factor receptor inhibitor	IGF1R	Preclinical
AG-14361	PARP inhibitor	PARP1	Preclinical
AG-490	EGFR inhibitor, JAK inhibitor	EGFR, JAK2, JAK3	Preclinical
AG-555	tyrosine kinase inhibitor	CDK2	Preclinical
AG-556	tyrosine kinase inhibitor		Preclinical
AGI-5198	isocitrate dehydrogenase inhibitor	IDH1	Preclinical
AGI-6780	isocitrate dehydrogenase inhibitor	IDH2	Preclinical
AH-7614	free fatty acid receptor antagonist	FFAR4	Preclinical
AH6809	prostanoid receptor antagonist	PTGDR, PTGER1, PTGER2, PTGER3	Preclinical
AI-10-49	core binding factor inhibitor	CBFB	Preclinical
AIM-100	tyrosine kinase inhibitor	TNK2	Preclinical
AJ76-(+)	dopamine receptor antagonist	DRD2, DRD3, DRD4	Preclinical
AK-7	SIRT inhibitor	SIRT2	Preclinical
AL-8697	p38 MAPK inhibitor	MAPK14	Preclinical
alantolactone	apoptosis stimulant, STAT inhibitor	STAT3	Preclinical
alexidine	phosphatidylglycerophosphatase inhibitor	PTPMT1	Preclinical
allylthiourea	nitrification inhibitor		Preclinical
aloin	angiogenesis inhibitor		Preclinical
alpha-Asarone	cytochrome P450 inhibitor, HMGCR inhibitor	HMGCR	Preclinical
alrestatin	aldose reductase inhibitor	AKR1B1	Preclinical
AM-251	cannabinoid receptor antagonist	CNR1, GPR18, GPR55	Preclinical
AM-281	cannabinoid receptor antagonist	CNR1, CNR2, GPR55	Preclinical
AM-404	cyclooxygenase inhibitor, FAAH inhibitor, TRPV antagonist	CNR1, CNR2, FAAH, TRPV1	Preclinical
AM-630	cannabinoid receptor antagonist	CNR1, CNR2	Preclinical
AM-92016	potassium channel blocker	GRIN1	Preclinical
AMD-3465	CC chemokine receptor antagonist	CXCR4	Preclinical
AMG-PERK-44	PERK inhibitor	EIF2AK4	Preclinical
AMG-9810	TRPV antagonist	TRPV1	Preclinical
AMG458	MET inhibitor	MET	Preclinical
AMI-1	protein arginine N-methyltransferase inhibitor	PRMT1	Preclinical
aminomethyltransferase	nitric oxide synthase inhibitor	NOS2	Preclinical
aminopurvalanol-a	CDK inhibitor, tyrosine kinase inhibitor	CDK1, CDK2, CDK5, CDK6	Preclinical
aminothiazole	cyclin D inhibitor	NOS2	Preclinical
ampyrone	cyclooxygenase inhibitor		Preclinical
AMZ30	protein phosphatase inhibitor		Preclinical
AM679	cannabinoid receptor agonist, lipoxygenase inhibitor	ALOX5AP, CNR1, CNR2	Preclinical
ANA-12	tropomyosin receptor kinase inhibitor	NTRK2	Preclinical
anisomycin	DNA synthesis inhibitor	NHP2L1, RPL10L, RPL11, RPL13A, RPL15, RPL19, RPL23, RPL23A, RPL26L1, RPL3, RPL37, RPL8, RSL24D1	Preclinical
ANR-94	A1 adenosine receptor antagonist	ADORA2A	Preclinical
antalarmin	corticosteroid releasing factor receptor antagonist	CRHR1	Preclinical
anthraquinone	CDC inhibitor	CDC25B	Preclinical
antimycin-a	ATP synthase inhibitor	CYCS	Preclinical
AP-18	transient receptor potential channel antagonist	TRPA1	Preclinical
APcK-110	KIT inhibitor	KIT, STAT3	Preclinical
API-1	AKT inhibitor	AKT1, AKT2, AKT3	Preclinical
apigenin	casein kinase inhibitor, cell proliferation inhibitor	AKR1B1, AR, CDK6, CFTR, CYP19A1, CYP1B1, HSD17B1	Preclinical
apoptosis-activator-II	carboxylesterase inhibitor	BCHE, CES1	Preclinical
APY-29	serine/threonine kinase inhibitor	ERN1	Preclinical
APY0201	phosphoinositide dependent kinase inhibitor	IL12A, IL12B, PIKFYVE	Preclinical
AQ-RA741	acetylcholine receptor antagonist	CHRM2	Preclinical
AR-A014418	glycogen synthase kinase inhibitor	GSK3B	Preclinical
AR-C155858	monocarboxylate transporter inhibitor	SLC16A1, SLC16A7	Preclinical
ARC-239	adrenergic receptor antagonist	ADRA2A, ADRA2B, ADRA2C	Preclinical
arctigenin	MEK inhibitor	CHUK, MAP2K1	Preclinical
arcyriaflavin-a	CDK inhibitor	CCND1, CDK4	Preclinical
ARV-825	bromodomain inhibitor	BRD4	Preclinical
AS-1892802	rho associated kinase inhibitor	ROCK1	Preclinical
AS-1949490	SHIP2 phosphatase inhibitor	INPP5D	Preclinical
AS-2444697	interleukin inhibitor	IRAK4	Preclinical
AS-252424	PI3K inhibitor	PIK3CG	Preclinical
AS-604850	PI3K inhibitor	PIK3CA, PIK3CG	Preclinical
AS-77	potassium channel blocker	KCNA3, KCNA5, KCNN4	Preclinical
asaraldehyde	cyclooxygenase inhibitor	PTGS2	Preclinical
ascomycin	calcineurin inhibitor	FKBP1A	Preclinical
AT-1015	serotonin receptor antagonist	HTR2A	Preclinical
atenolol-(+)	adrenergic receptor antagonist		Preclinical
atglistatin	adipose triglyceride lipase inhibitor		Preclinical
atropine-oxide	acetylcholine receptor antagonist		Preclinical
AT7867	AKT inhibitor	AKT2, GSK3B, PKIA, PRKACA	Preclinical
aurora-a-inhibitor-i	Aurora kinase inhibitor	AURKA	Preclinical
autotaxin-modulator-1	autotaxin inhibitor	ENPP2	Preclinical
AZ-10417808	caspase inhibitor	CASP3	Preclinical
AZ-10606120	purinergic receptor antagonist	P2RX7	Preclinical
AZ-12080282	hedgehog pathway inhibitor	DHH	Preclinical
AZ-628	RAF inhibitor	BRAF, RAF1	Preclinical
azacyclonol	histamine receptor antagonist	HRH1	Preclinical
azaguanine-8	purine antagonist	PNP	Preclinical
azalomycin-b	bacterial 50S ribosomal subunit inhibitor		Preclinical
azaserine	purine antagonist		Preclinical
AZD1283	purinergic receptor antagonist	P2RY12	Preclinical
AZD2858	glycogen synthase kinase inhibitor	GSK3B	Preclinical
AZD3264	IKK inhibitor	IKBKB	Preclinical
AZD3463	ALK tyrosine kinase receptor inhibitor, insulin growth factor receptor inhibitor	ALK, IGF1R	Preclinical
AZD3988	diacylglycerol kinase inhibitor	DGAT1	Preclinical
AZD5582	XIAP inhibitor	BIRC2, BIRC3, XIAP	Preclinical
AZD9272	glutamate receptor antagonist	GRM5	Preclinical
AZM-475271	src inhibitor	SRC	Preclinical
azomycin-(2-nitroimidazole)	protein synthesis inhibitor		Preclinical
AZ191	DYRK inhibitor	DYRK1B	Preclinical
AZ20	ATR kinase inhibitor	ATR, MTOR	Preclinical
AZ3146	monopolar spindle 1 kinase inhibitor		Preclinical
AZ505	histone lysine methyltransferase inhibitor	SMYD2	Preclinical
AZ5104	EGFR inhibitor	EGFR	Preclinical
AZ960	JAK inhibitor	JAK2	Preclinical
A12B4C3	polynucleotide kinase/phosphatase inhibitor	PNKP	Preclinical
A205804	ICAM1 expression inhibitor	ICAM1, SELE	Preclinical
A66	PI3K inhibitor	PIK3CA	Preclinical
A740003	purinergic receptor antagonist	P2RX7	Preclinical
A922500	diacylglycerol O acyltransferase inhibitor	DGAT1	Preclinical
BADGE	PPAR receptor antagonist	PPARG	Preclinical
BAG-956	phosphoinositide dependent kinase inhibitor	PIK3CG	Preclinical
baicalein	lipoxygenase inhibitor	ALOX5, GLO1, PREP, SELL, SELP, TNF, XDH	Preclinical
BAN-ORL-24	nociceptin/orphanin FQ receptor antagonist	OPRL1	Preclinical
BAX-channel-blocker	cytochrome C release inhibitor	BAX	Preclinical
BAY-11-7082	NFkB pathway inhibitor	RELA	Preclinical
BAY-11-7085	NFkB pathway inhibitor	NFKBIA	Preclinical
bay-60-7550	phosphodiesterase inhibitor	PDE2A	Preclinical
BAY-61-3606	syk inhibitor	SYK	Preclinical
BAZ2-ICR	bromodomain inhibitor	ZNF215	Preclinical
BC-11	urokinase inhibitor	PLAU	Preclinical
BCTC	TRPV antagonist	TRPV1	Preclinical
BD-1008	sigma receptor antagonist		Preclinical
BD-1047	adrenergic receptor antagonist	SIGMAR1	Preclinical
BD-1063	sigma receptor antagonist	SIGMAR1	Preclinical
benzoquinonium-dibromide	cholinergic receptor antagonist	CHRNA1	Preclinical
benzyl-isothiocyanate	methylazoxymethanol acetate inhibitor		Preclinical
bergenin	interleukin inhibitor	IL1B, TNF	Preclinical
BET-BAY-002	bromodomain inhibitor		Preclinical
beta-amyloid-synthesis-inhibitor	beta amyloid synthesis inhibitor	APP	Preclinical
beta-funaltrexamine	opioid receptor antagonist	OPRD1, OPRK1, OPRM1	Preclinical
BHQ	ATPase inhibitor	ATP2A1	Preclinical
BI-D1870	ribosomal protein inhibitor	RPS6KA1, RPS6KA2, RPS6KA3, RPS6KA6	Preclinical
BI-78D3	JNK inhibitor	MAPK8	Preclinical
BIBR-1532	telomerase inhibitor	TERT	Preclinical
BIBU-1361	EGFR inhibitor	EGFR	Preclinical
bicuculline-(+)	GABA receptor antagonist	GABRA1, GABRA2, GABRA3, GABRA4, GABRA5, GABRA6, KCNN1	Preclinical
bicuculline-methochloride-(-)	GABA receptor antagonist		Preclinical
BIO-5192	integrin inhibitor	ITGA4, ITGB1	Preclinical
bisindolylmaleimide-ix	PKC inhibitor	AKT1, GSK3B, LCK, MAPK1, MAPK11, MAPK12, MAPK14, MAPK8, PRKCA, ROCK1, RPS6KB1, SIRT1	Preclinical
BIX-01294	histone lysine methyltransferase inhibitor	EHMT1, EHMT2	Preclinical
BIX-02188	MEK inhibitor	MAP2K5	Preclinical
BIX-02189	MEK inhibitor	MAP2K5, MAPK7	Preclinical
blebbistatin-(+/-)	ATPase inhibitor	MYH2	Preclinical
blebbistatin-(-)	ATPase inhibitor		Preclinical
BLU9931	FGFR inhibitor	FGFR4	Preclinical
BMS-CCR2-22	CC chemokine receptor antagonist	CCR2	Preclinical
BMS-265246	CDK inhibitor	CDK1, CDK2	Preclinical
BMS-309403	fatty acid binding protein inhibitor	FABP4	Preclinical
BMS-345541	IKK inhibitor	CHUK, IKBKB	Preclinical
BMS-536924	IGF-1 inhibitor	AKT1, CCNE1, CDK2, CYP3A4, ERBB2, IGF1R, KDR, LCK, MAPK1, MET, PDGFRA, PDGFRB	Preclinical
BMS-566419	inosine monophosphate dehydrogenase inhibitor	IMPDH1, IMPDH2	Preclinical
BMS-688521	leukocyte function-associated antigen receptor antagonist, ICAM1 antagonist	ICAM1	Preclinical
BMY-7378	adrenergic receptor antagonist, serotonin receptor antagonist	ADRA1A, ADRA1B, ADRA1D, HTR1A	Preclinical
BNTX	opioid receptor antagonist	OPRD1, OPRK1, OPRM1	Preclinical
BQU57	Ras GTPase inhibitor	RALA, RALB	Preclinical
BRD-7389	ribosomal protein inhibitor	RPS6KA1, RPS6KA2, RPS6KA3	Preclinical
BRD-9876	kinesin inhibitor	KIF11	Preclinical
BRD4770	histone lysine methyltransferase inhibitor	EHMT2	Preclinical
brefeldin-a	protein synthesis inhibitor	ARF1, CYTH2	Preclinical
BRL-15572	serotonin receptor antagonist	HTR1A, HTR1B, HTR1D, HTR1E, HTR1F, HTR2A, HTR2B, HTR2C, HTR6	Preclinical
BRL-44408	adrenergic receptor antagonist	ADRA2A, ADRA2B, ADRA2C	Preclinical
BRL-50481	phosphodiesterase inhibitor	PDE7A, PDE7B	Preclinical
bromebric-acid	purine antagonist, DNA synthesis inhibitor		Preclinical
bromosporine	bromodomain inhibitor		Preclinical
brucine	glycine receptor antagonist	CHRM1, CHRM2, CHRM3, CHRM4, CHRM5	Preclinical
BS-181	CDK inhibitor	CDK7	Preclinical
BTB06584	ATPase inhibitor	ATP5F1	Preclinical
BTB1	mitotic kinesin inhibitor	KIF18A	Preclinical
BTT-3033	integrin inhibitor	ITGA2, ITGB1	Preclinical
BTZ043-racemate	DPRE1 inhibitor		Preclinical
butabindide	tripeptidyl peptidase inhibitor	TPP2	Preclinical
butein	EGFR inhibitor, src inhibitor	ACE	Preclinical
butyl-paraben	DNA synthesis inhibitor		Preclinical
BVT-2733	11-beta hydroxysteroid dehydrogenase inhibitor	HSD17B1	Preclinical
BVT-948	tyrosine phosphatase inhibitor	PTPN1, PTPN11, PTPN2	Preclinical
BW-B70C	lipoxygenase inhibitor	ALOX5	Preclinical
BW-616U	monoamine oxidase inhibitor	MAOA	Preclinical
BX-795	IKK inhibitor	CDK2, CHEK1, GSK3B, KDR, PDK1, PDPK1	Preclinical
BX-912	pyruvate dehydrogenase kinase inhibitor	CDK2, CHEK1, GSK3B, KDR, PDK1, PDPK1	Preclinical
BYK-204165	PARP inhibitor	PARP1	Preclinical
C-021	CC chemokine receptor antagonist	CCR4	Preclinical
C-1	protein kinase inhibitor	PRKCA	Preclinical
CaCCinh-A01	calcium-activated chloride channel inhibitor	CLCA1	Preclinical
caffeic-acid	HIV integrase inhibitor, lipoxygenase inhibitor, nitric oxide production inhibitor, tumor necrosis factor production inhibitor	ALOX5, MIF	Preclinical
caffeic-acid-phenethyl-ester	HIV integrase inhibitor	RELA	Preclinical
calpeptin	calpain inhibitor		Preclinical
CaMKII-IN-1	calcium/calmodulin dependent protein kinase inhibitor	AKT1, CAMK2A, CAMK4, MYLK	Preclinical
cardionogen-1	WNT signaling inhibitor	CTNNB1	Preclinical
casin	GTPase inhibitor	CDC42	Preclinical
catharanthine	tubulin polymerization inhibitor		Preclinical
cathepsin-inhibitor-1	cathepsin inhibitor	CTSB, CTSL, CTSV	Preclinical
CAY10505	PI3K inhibitor	PIK3CG	Preclinical
CCG-50014	G protein signaling inhibitor	RGS4, RGS8	Preclinical
CCG-63802	G protein signaling inhibitor	RGS4	Preclinical
CCG-63808	G protein signaling inhibitor	RGS4	Preclinical
CCMQ	homoquinolinic acid binding inhibitor		Preclinical
CCT-031374	WNT signaling inhibitor	CTNNB1	Preclinical
CCT018159	HSP inhibitor	HSP90AA1, HSP90AB1	Preclinical
CCT128930	AKT inhibitor	PKIA, PRKACA	Preclinical
CCT129202	Aurora kinase inhibitor	AURKA, AURKB, AURKC	Preclinical
CCT137690	Aurora kinase inhibitor	AURKA, AURKB, AURKC	Preclinical
CDK1-5-inhibitor	CDK inhibitor, glycogen synthase kinase inhibitor	CDK1, CDK5, GSK3B	Preclinical
CDK9-IN-6	CDK inhibitor	CDK9	Preclinical
CEP-33779	JAK inhibitor	JAK2	Preclinical
cephalomannine	DNA polymerase inhibitor		Preclinical
cephalosporin-c-zn	bacterial cell wall synthesis inhibitor		Preclinical
CE3F4	rap guanine nucleotide exchange factor inhibitor	RAPGEF3	Preclinical
CFM-2	glutamate receptor antagonist		Preclinical
CFTRinh-172	chloride channel blocker	CFTR	Preclinical
CGH2466	adenosine receptor antagonist	ADORA1, ADORA2B, ADORA3	Preclinical
CGK-733	ATM kinase inhibitor, ATR kinase inhibitor	ATM, ATR	Preclinical
CGP-20712A	adrenergic receptor antagonist	ADRB1, ADRB3	Preclinical
CGP-37157	mitochondrial Na+/Ca2+ exchanger antagonist, sodium/calcium exchange inhibitor	SLC8A1	Preclinical
CGP-52411	EGFR inhibitor	EGFR	Preclinical
CGP-53353	EGFR inhibitor, PKC inhibitor	EGFR, PRKCB	Preclinical
CGP-54626	GABA receptor antagonist	GABBR1, GABBR2, KCTD12, KCTD16, KCTD8	Preclinical
CGP-55845	GABA receptor antagonist	GABBR1, GABBR2, KCTD12, KCTD16, KCTD8	Preclinical
CGP-57380	MAP kinase inhibitor	AURKB, LCK, MKNK1, MKNK2, SGK1	Preclinical
CGP-60474	CDK inhibitor	CDK1, CDK2	Preclinical
CGP-71683	neuropeptide receptor antagonist	NPY5R	Preclinical
CGP-74514	CDK inhibitor	CDK1	Preclinical
CGP-78608	glutamate receptor antagonist		Preclinical
CGS-15943	adenosine receptor antagonist	ADORA1, ADORA2A, ADORA2B, ADORA3	Preclinical
CGS-9896	GABA receptor antagonist	GABRA1, GABRB2, GABRG2	Preclinical
CHC	monocarboxylate transporter inhibitor	SLC16A1	Preclinical
chicago-sky-blue-6b	glutamate inhibitor, macrophage migration inhibiting factor inhibitor	MIF	Preclinical
CHIR-124	CHK inhibitor	CHEK1	Preclinical
CHIR-98014	glycogen synthase kinase inhibitor	GSK3A, GSK3B	Preclinical
CHIR-99021	glycogen synthase kinase inhibitor	CDK1, GSK3A, GSK3B, MAPK1	Preclinical
chlorisondamine-diiodide	acetylcholine receptor antagonist	CHRNA1	Preclinical
CHR-6494	serine/threonine kinase inhibitor	GSG2	Preclinical
chromanol-(+/-)	potassium channel blocker		Preclinical
chromanol-293B-(-)-[3R,4S]	potassium channel blocker		Preclinical
chrysophanic-acid	EGFR inhibitor	EGFR, MTOR	Preclinical
CH223191	aryl hydrocarbon receptor antagonist	AHR	Preclinical
cicloprofen	cyclooxygenase inhibitor	PTGS1, PTGS2	Preclinical
CID-16020046	G protein-coupled receptor antagonist	GPR55	Preclinical
CID-2011756	protein kinase inhibitor	PKD1	Preclinical
CID-2745687	G protein-coupled receptor antagonist	GPR35	Preclinical
CID-5458317	MAP kinase phosphatase inhibitor	MAPK3	Preclinical
cilostamide	phosphodiesterase inhibitor	PDE3A, PDE3B	Preclinical
cinanserin	serotonin receptor antagonist	HTR2A	Preclinical
cinchonine	P glycoprotein inhibitor	CYP2D6	Preclinical
cinnamaldehyde	aldose reductase inhibitor, TRPV agonist	TRPA1	Preclinical
CINPA-1	CAR antagonist	NR1H4, NR1I3, PPARG	Preclinical
ciproxifan	histamine receptor antagonist	ADRA2A, ADRA2C, HRH3, HRH4, HTR3A	Preclinical
citric-acid	coagulation factor inhibitor	AKR1B1, ANG, APRT, BHMT, C8G, CA4, CPB1, CS, CTDSP1, GNMT, HGS, HS3ST3A1, IL4I1, ITPA, LSM6, MDH2, MIF, PDE5A, PKD2L1, PLEKHA1, RNASE1, RNASE3, SRC, TNFSF13B, UCK2	Preclinical
CK-636	actin related protein inhibitor	ACTR2, ACTR3, ARPC1B, ARPC2, ARPC3, ARPC4, ARPC5	Preclinical
CKI-7	casein kinase inhibitor	CSNK1G2	Preclinical
clobenpropit	histamine receptor antagonist	HRH1, HRH2, HRH3, HRH4	Preclinical
CMPD-1	p38 MAPK inhibitor	GNRHR, MAPK14	Preclinical
CNX-2006	EGFR inhibitor	EGFR	Preclinical
CNX-774	Bruton's tyrosine kinase (BTK) inhibitor	BTK	Preclinical
CO-101244	glutamate receptor antagonist	GRIN2B	Preclinical
compound-w	beta-secretase inhibitor	BACE1	Preclinical
compound-401	DNA dependent protein kinase inhibitor	MTOR, PRKDC	Preclinical
costunolide	telomerase inhibitor		Preclinical
cot-inhibitor-1	MAPK-interacting kinase inhibitor	MAP3K8	Preclinical
cot-inhibitor-2	MAPK-interacting kinase inhibitor	MAP3K8	Preclinical
coumophos	cholinesterase inhibitor		Preclinical
CP-316819	glycogen phosphorylase inhibitor	PYGL	Preclinical
CP-339818	potassium channel blocker	KCNA3	Preclinical
CP-471474	matrix metalloprotease inhibitor	MMP1, MMP13, MMP2, MMP3, MMP9	Preclinical
CP-640186	acetyl-CoA carboxylase inhibitor	ACACA, ACACB	Preclinical
CP-673451	PDGFR tyrosine kinase receptor inhibitor	KIT, PDGFRA, PDGFRB	Preclinical
CP-91149	glycogen phosphorylase inhibitor	PYGL	Preclinical
CPA-inhibitor	carboxypeptidase inhibitor	CPA1, CPA2	Preclinical
CPCCOEt	glutamate receptor antagonist	GRM1	Preclinical
CPI-169	histone lysine methyltransferase inhibitor	EZH2	Preclinical
CPI-203	bromodomain inhibitor	BRD4	Preclinical
CPI-360	histone lysine methyltransferase inhibitor	EZH2	Preclinical
CPSI-1306-(+/-)	macrophage migration inhibiting factor inhibitor	MIF	Preclinical
crizotinib-(S)	MTH1 inhibitor	NUDT1	Preclinical
cryptotanshinone	acetylcholinesterase inhibitor, STAT inhibitor	STAT3	Preclinical
CR8-(R)	CDK inhibitor	CCNA2	Preclinical
CTEP	glutamate receptor antagonist	GRM5	Preclinical
CU-CPT-4a	toll-like receptor inhibitor	TLR3	Preclinical
cyclocytidine	DNA synthesis inhibitor, RNA synthesis inhibitor		Preclinical
cycloheximide	protein synthesis inhibitor	RPL3	Preclinical
cyclopiazonic-acid	ATPase inhibitor	ATP2A1	Preclinical
CYM-50358	sphingosine 1-phosphate receptor antagonist	S1PR4	Preclinical
CYM-50769	neuropeptide receptor antagonist	NPBWR1	Preclinical
CZC-54252	leucine rich repeat kinase inhibitor	LRRK2	Preclinical
CZC24832	PI3K inhibitor	PIK3CG	Preclinical
C34	toll-like receptor inhibitor	TLR4	Preclinical
C646	histone acetyltransferase inhibitor	EP300	Preclinical
D-Phenylalanine	enkephalinase inhibitor	CCBL1, CRH, HCAR3	Preclinical
D-4476	TGF beta receptor inhibitor	CSNK1A1, CSNK1D, TGFB1	Preclinical
D-64131	microtubule inhibitor	TUBB	Preclinical
daminozide	KDM2A inhibitor	KDM2A, KDM7A, PHF8	Preclinical
daphnetin	protein kinase inhibitor		Preclinical
DAPT	gamma secretase inhibitor		Preclinical
DAU-5884	acetylcholine receptor antagonist	CHRM3	Preclinical
DBeQ	ATPase inhibitor	CASP3	Preclinical
DC-260126	free fatty acid receptor antagonist	FFAR1	Preclinical
DCPIB	chloride channel blocker, gap junction modulator, glutamate inhibitor	SLC1A2	Preclinical
DDR1-IN-1	discoidin domain receptor inhibitor	DDR1, DDR2	Preclinical
deltarasin	phosphodiesterase inhibitor	KRAS	Preclinical
deoxyarbutin	tyrosinase inhibitor		Preclinical
deptropine	histamine receptor antagonist	HRH1	Preclinical
dexfosfoserine	membrane integrity inhibitor	CFTR, GRM4, GRM6, GRM7, GRM8, KCNC4, PDPK1, PIM1, PRKACA, PRKCQ, PYGL, PYGM, REG1A, RHO, SERPINB3, SMAD2, TAOK2	Preclinical
DH-97	melatonin receptor antagonist	MTNR1B	Preclinical
DHBP	ryanodine receptor blocker		Preclinical
dibenzepine	norepinephrine reputake inhibitor		Preclinical
digitoxigenin	ATPase inhibitor	ATP1A1	Preclinical
dimethindene-(S)-(+)	acetylcholine receptor antagonist	HRH1	Preclinical
diphenyleneiodonium	nitric oxide synthase inhibitor	NOS2, NOS3	Preclinical
dizocilpine-(+)	glutamate receptor antagonist	GRIN1, GRIN2A, GRIN2B, GRIN2C, GRIN2D	Preclinical
DMH1	ALK tyrosine kinase receptor inhibitor	ACVR1	Preclinical
DMH4	VEGFR inhibitor	KDR	Preclinical
DMNB	DNA dependent protein kinase inhibitor		Preclinical
DNQX	glutamate receptor antagonist	GRIA1, GRIA2, GRIK1, GRIN1, GRIN2A, GRIN2B	Preclinical
dorsomorphin	AMPK inhibitor	ACVR1, BMPR1A, BMPR1B, EPHA2, FKBP1A, FLT1, FLT3, KDR, LCK, MKNK1, PRKAA1, RPS6KA1, SRC	Preclinical
DPO-1	potassium channel blocker	KCNA5	Preclinical
DQP-1105	glutamate receptor antagonist	GRIN2C, GRIN2D	Preclinical
DR-2313	PARP inhibitor	PARP1, PARP3	Preclinical
DR-4485	serotonin receptor antagonist	HTR7	Preclinical
DRF053-(R)	CDK inhibitor	CSNK1A1	Preclinical
droxinostat	HDAC inhibitor	HDAC6, HDAC8	Preclinical
dynasore	dynamin inhibitor	DNM1, DNM1L, DNM2	Preclinical
dynole-34-2	dynamin inhibitor	DNM1	Preclinical
D609	phospholipase inhibitor		Preclinical
E-64	cysteine protease inhibitor, calpain inhibitor	CTSS	Preclinical
eact	calcium-activated chloride channel inhibitor	ANO1	Preclinical
EB-47	PARP inhibitor	PARP1	Preclinical
EBPC	aldose reductase inhibitor	AKR1B1	Preclinical
EC-144	HSP inhibitor	HSP90AA1, HSP90AB1	Preclinical
EED226	polycomb protein inhibitor	EED	Preclinical
EG00229	neuropilin receptor antagonist	NRP1	Preclinical
EHop-016	Ras GTPase inhibitor	RAC1, RAC3	Preclinical
EIPA	transient receptor potential polycystic inhibitor, sodium/hydrogen exchanger inhibitor	ADRA2A, ASIC1, PKD2L1	Preclinical
EIT-hydrobromide	nitric oxide synthase inhibitor	NOS2, NOS3	Preclinical
EI1	histone lysine methyltransferase inhibitor	EZH2	Preclinical
ELN-441958	bradykinin receptor antagonist	BDKRB1	Preclinical
embelin	HCV inhibitor, XIAP inhibitor	XIAP	Preclinical
EMD-66684	angiotensin receptor antagonist	AGTR1	Preclinical
emodin	11-beta hydroxysteroid dehydrogenase inhibitor	CSNK2A1	Preclinical
endo-IWR-1	PARP inhibitor	TNKS, TNKS2	Preclinical
EN460	endoplasmic reticulum oxidation inhibitor	ERO1A	Preclinical
EO-1428	p38 MAPK inhibitor	MAPK11, MAPK14	Preclinical
EPPTB	trace amine associated receptor antagonist	TAAR1	Preclinical
EPZ004777	histone lysine methyltransferase inhibitor	DOT1L	Preclinical
EPZ005687	histone lysine methyltransferase inhibitor	EZH2	Preclinical
EPZ011989	histone lysine methyltransferase inhibitor	EZH2	Preclinical
EPZ015666	protein arginine N-methyltransferase inhibitor	PRMT5	Preclinical
EPZ020411	protein arginine N-methyltransferase inhibitor	PRMT6	Preclinical
ER-27319	mediator release inhibitor, SYK inhibitor	SYK	Preclinical
ER-50891	retinoid receptor antagonist	RARA	Preclinical
erastin	ion channel antagonist	VDAC2	Preclinical
erbstatin-analog	EGFR inhibitor, tyrosine kinase inhibitor	EGFR	Preclinical
ERK5-IN-1	MAP kinase inhibitor	MAPK7	Preclinical
eseroline-(-)	acetylcholinesterase inhibitor	OPRD1, OPRM1	Preclinical
ESI-09	EPAC inhibitor	RAPGEF3, RAPGEF4	Preclinical
etebenecid	uricosuric blocker		Preclinical
eticlopride	dopamine receptor antagonist	DRD2, DRD3, DRD4	Preclinical
ETP-45658	PI3K inhibitor	PIK3CA, PIK3CB, PIK3CD, PIK3CG	Preclinical
ETP-46464	ATR kinase inhibitor		Preclinical
eucatropine	acetylcholine receptor antagonist		Preclinical
evodiamine	ATPase inhibitor, TRPV agonist	TRPV1	Preclinical
EVP4593	NFkB pathway inhibitor		Preclinical
exo-IWR-1	WNT signaling inhibitor negative control	TNKS	Preclinical
EXO-1	ARF inhibitor		Preclinical
famprofazone	cyclooxygenase inhibitor		Preclinical
fenclonine-(+/-)	tryptophan hydroxylase inhibitor	PAH, TPH1, TPH2	Preclinical
fendiline	calcium channel blocker	HTR2B	Preclinical
FERb-033	EGFR inhibitor	ERBB2	Preclinical
ferrostatin-1	ferroptosis inhibitor		Preclinical
FGIN-1-27	inositol monophosphatase inhibitor	TSPO	Preclinical
FH-535	PPAR receptor antagonist, WNT signaling inhibitor	PPARD, PPARG	Preclinical
FIPI	phospholipase inhibitor	PLD1, PLD2	Preclinical
fisetin	Aurora kinase inhibitor	CDK6, FASN	Preclinical
FLI-06	notch signaling inhibitor		Preclinical
flufenamic-acid	chloride channel blocker	AKR1C3, ANO1, AR, GJA1, GJA10, GJA3, GJA4, GJA5, GJA8, GJA9, GJB1, GJB2, GJB3, GJB4, GJB5, GJB6, GJB7, GJC1, GJC2, GJC3, GJD2, GJD3, GJD4, GJE1, PANX1, PANX2, PANX3, PKD2L1, PTGS1, PTGS2, TRPC5, TRPM2, TRPM5	Preclinical
flurofamide	urease inhibitor		Preclinical
formononetin	alcohol dehydrogenase inhibitor	ADH1C, SLC5A2	Preclinical
FPA-124	AKT inhibitor		Preclinical
FPS-ZM1	RAGE receptor antagonist	AGER	Preclinical
FR-122047	cyclooxygenase inhibitor		Preclinical
FR-180204	MAP kinase inhibitor	MAPK1, MAPK3	Preclinical
FRAX486	serine/threonine kinase inhibitor	PAK1, PAK2, PAK3, PAK4	Preclinical
furamidine	protein arginine N-methyltransferase inhibitor	PRMT1	Preclinical
g-caryophyllene	acetylcholinesterase inhibitor	ACHE	Preclinical
G-15	estrogen receptor antagonist	GPER1	Preclinical
gabazine	GABA receptor antagonist	GABRA1, GABRA2, GABRA3, GABRA4, GABRA5, GABRA6, GABRG2	Preclinical
gallic-acid	beta amyloid protein neurotoxicity inhibitor, PPAR receptor agonist	CA1, CA12, CA14, CA2, CA4, CA6, CA9, SELP	Preclinical
GANT-58	GLI antagonist	GLI1	Preclinical
GANT-61	GLI antagonist	GLI1, GLI2	Preclinical
GBR-12783	dopamine uptake inhibitor		Preclinical
GBR-12935	dopamine uptake inhibitor	AGTR1, SLC6A3	Preclinical
GBR-13069	dopamine uptake inhibitor	SLC6A3	Preclinical
GDC-0879	RAF inhibitor	BRAF	Preclinical
gedunin	HSP inhibitor	HSP90AA1	Preclinical
geldanamycin	HSP inhibitor	HSP90AA1, HSP90AB1	Preclinical
geniposidic-acid	cyclooxygenase inhibitor		Preclinical
genz-123346	glucosylceramidase inhibitor	UGCG	Preclinical
GF109203X	PKC inhibitor	PDPK1, PIM1, PRKCI, PRKCZ	Preclinical
GGsTop	gamma glutamyltransferase Inhibitors	GGT1	Preclinical
GGTI-298	GGTase inhibitor	CDKN1A	Preclinical
ginkgolide-a	GABA receptor antagonist	GLRA1, GLRB	Preclinical
ginsenoside-c-k	NFkB pathway inhibitor, nitric oxide synthase inhibitor	PTGS2	Preclinical
GK921	transglutaminase inhibitor	TGM2	Preclinical
GNF-2	Bcr-Abl kinase inhibitor	ABL1, BCR	Preclinical
GNF-5	Bcr-Abl kinase inhibitor	ABL1, BCR	Preclinical
GNF-5837	growth factor receptor inhibitor	NTRK1, NTRK2, NTRK3	Preclinical
GNF-7	protein kinase inhibitor, glucokinase inhibitor	GCK, TNK2	Preclinical
GNTI	opioid receptor antagonist	OPRK1, OPRM1	Preclinical
go-6983	protein kinase inhibitor	PRKCA, PRKCB, PRKCD, PRKCG, PRKCZ	Preclinical
golgicide-a	ARF inhibitor	GBF1	Preclinical
GPI-1046	FKBP inhibitor	FKBP1A	Preclinical
GPi-688	glycogen phosphorylase inhibitor		Preclinical
GPP-78	NAMPT inhibitor	NAMPT	Preclinical
GR-103691	dopamine receptor antagonist	DRD3	Preclinical
GR-113808	serotonin receptor antagonist	HTR4	Preclinical
GR-127935	serotonin receptor antagonist	HTR1A, HTR1B, HTR1D, HTR1E, HTR1F, HTR2A, HTR2B, HTR2C, HTR6	Preclinical
GR-144053	integrin antagonist	ITGA2B, ITGB3	Preclinical
GR-159897	tachykinin antagonist	TAC1, TACR2	Preclinical
gramine	norepinephrine reputake inhibitor		Preclinical
GR125487	serotonin receptor antagonist	HTR4	Preclinical
GS-143	ubiquitin ligase inhibitor	BTRC, NFKBIA	Preclinical
GSK-J1	histone demethylase inhibitor	KDM6B	Preclinical
GSK-J2	histone demethylase inhibitor		Preclinical
GSK-J4	histone lysine demethylase inhibitor	KDM6A, KDM6B	Preclinical
GSK-LSD-1	histone lysine demethylase inhibitor	KDM1A	Preclinical
GSK-0660	PPAR receptor antagonist	PPARD	Preclinical
GSK-1562590	urotensin receptor antagonist	UTS2R	Preclinical
GSK-2193874	transient receptor potential channel antagonist	TRPV4	Preclinical
GSK-2837808A	lactate dehydrogenase inhibitor	LDHA	Preclinical
GSK-3-inhibitor-IX	glycogen synthase kinase inhibitor, lipoxygenase inhibitor	GSK3A, GSK3B	Preclinical
GSK1838705A	insulin growth factor receptor inhibitor	ALK, IGF1R, INSR, RPS6KA1	Preclinical
GSK1904529A	IGF-1 inhibitor, insulin growth factor receptor inhibitor, insulin receptor ligand	IGF1R, INSR	Preclinical
GSK2194069	fatty acid synthase inhibitor	FASN	Preclinical
GSK2334470	phosphoinositide dependent kinase inhibitor	AURKA, AURKB, PDPK1	Preclinical
GSK2578215A	leucine rich repeat kinase inhibitor	LRRK2	Preclinical
GSK2606414	protein kinase inhibitor	EIF2AK3, MYLK2	Preclinical
GSK2656157	PERK inhibitor		Preclinical
GSK269962	rho associated kinase inhibitor	ROCK1, ROCK2	Preclinical
GSK2801	bromodomain inhibitor	BAZ2A, BAZ2B	Preclinical
GSK2830371	protein phosphatase inhibitor	PPM1D	Preclinical
GSK3787	PPAR receptor antagonist	PPARD	Preclinical
GSK429286A	rho associated kinase inhibitor	ROCK1	Preclinical
GSK503	histone lysine methyltransferase inhibitor	EZH2	Preclinical
GSK650394	serum/glucocorticoid regulated kinase inhibitor	SGK1, SGK2	Preclinical
GTP-14564	FLT3 inhibitor, tyrosine kinase inhibitor	CSF1R, FLT3, KIT, PDGFRB	Preclinical
guvacine	GABA uptake inhibitor	SLC6A1, SLC6A11, SLC6A12, SLC6A13	Preclinical
GW-2580	cFMS kinase inhibitor	CSF1R	Preclinical
GW-438014A	neuropeptide receptor antagonist	NPY5R	Preclinical
GW-441756	growth factor receptor inhibitor	NTRK1	Preclinical
GW-5074	RAF inhibitor, leucine rich repeat kinase inhibitor	NTRK1, RAF1	Preclinical
GW-583340	EGFR inhibitor	EGFR, ERBB2	Preclinical
GW-627368	prostanoid receptor antagonist	PTGER4	Preclinical
GW-6471	PPAR receptor antagonist	PPARA	Preclinical
GW-788388	ALK tyrosine kinase receptor inhibitor	LCK, MAPK14, TGFBR1	Preclinical
GW-843682X	PLK inhibitor	PLK1, PLK3	Preclinical
GW-9662	PPAR receptor antagonist	NCOA2, PPARG, RXRA	Preclinical
GYKI-52466	glutamate receptor antagonist	GRIA1, GRIA2, GRIA3, GRIA4	Preclinical
GZD824	Bcr-Abl kinase inhibitor	ABL1, BCR	Preclinical
G007-LK	tankyrase inhibitor	TNKS, TNKS2	Preclinical
H-89	PKA inhibitor	GSG2, PKIA, PRKACA	Preclinical
HA-130	autotaxin inhibitor	ENPP2	Preclinical
HA-14-1	BCL inhibitor	BCL2	Preclinical
HA-966-(S)-(-)	glutamate receptor antagonist	GRIA1	Preclinical
harmane	monoamine oxidase inhibitor	MAOA, MAOB	Preclinical
HA14-1	BCL inhibitor	BCL2	Preclinical
HC-067047	transient receptor potential channel antagonist	TRPV4	Preclinical
heclin	ubiquitin ligase inhibitor	NEDD4, SMURF2, WWP1	Preclinical
HER2-Inhibitor-1	EGFR inhibitor		Preclinical
hesperadin	Aurora kinase inhibitor	AURKB	Preclinical
hexamethonium	cholinergic receptor antagonist	CHRNA2, CHRNA3, CHRNA4, CHRNA6	Preclinical
HJC-0350	GTPase inhibitor	RAPGEF4	Preclinical
HLCL-61	protein arginine N-methyltransferase inhibitor	PRMT5	Preclinical
HTH-01-015	protein kinase inhibitor	NUAK1	Preclinical
hydrastine-(1r,-9s)	tyrosine hydroxylase inhibitor		Preclinical
hydroxyfasudil	rho associated kinase inhibitor	PKIA, PRKACA, ROCK1	Preclinical
hydroxytacrine-maleate-(r,s)	cholinesterase inhibitor	ACHE	Preclinical
hygromycin-b	polypeptide synthesis inhibitor		Preclinical
hyperin	aldose reductase inhibitor	ACE, AKR1B1	Preclinical
hypoxanthine	PARP inhibitor	PNP	Preclinical
H2L-5765834	lysophosphatidic acid receptor antagonist	LPAR1, LPAR3	Preclinical
I-BET151	bromodomain inhibitor	BRD2, BRD3, BRD4	Preclinical
I-BRD9	bromodomain inhibitor	BRD9	Preclinical
I-CBP-112	bromodomain inhibitor	CREBBP, EP300	Preclinical
IBMX	phosphodiesterase inhibitor	ADORA1, PDE2A, PDE3B, PDE4D, PDE5A, PDE6G, PDE7A, PDE8A, PDE9A	Preclinical
ibuprofen-(s)	cyclooxygenase inhibitor	ASIC1, BCL2, CFTR, FABP2, PLAT, PPARG, PTGS1, PTGS2, SLC5A8, THBD	Preclinical
ICA-121431	sodium channel blocker	SCN1A, SCN3A	Preclinical
ICG-001	beta-catenin inhibitor	CTNNB1	Preclinical
ICI-63197	phosphodiesterase inhibitor		Preclinical
iCRT-14	WNT signaling inhibitor, beta catenin inhibitor	CTNNB1, TCF4	Preclinical
IC261	casein kinase inhibitor	CSNK1A1, CSNK1D, CSNK1E, CSNK1G2	Preclinical
idazoxane	adrenergic receptor antagonist	ADRA2A, ADRA2B, ADRA2C	Preclinical
IDO5L	indoleamine 2,3-dioxygenase inhibitor	IDO1	Preclinical
IEM1460	glutamate receptor antagonist	GRIA2	Preclinical
IEM1754	glutamate receptor antagonist	GRIA1	Preclinical
IKK-16	IKK inhibitor	IKBKB	Preclinical
IKK-2-inhibitor	IKK inhibitor, SYK inhibitor	IKBKB	Preclinical
impentamine	histamine receptor antagonist	HRH3	Preclinical
INCA-6	calcineurin inhibitor	NFATC1	Preclinical
indatraline	norepinephrine transporter inhibitor	MAOA, MAOB	Preclinical
indirubin-3-monoxime	CDK inhibitor, glycogen synthase kinase inhibitor	CDK1, CDK2, CDK5, CDK5R1, GSK3B	Preclinical
INH1	Hec1 inhibitor	NDC80	Preclinical
iodophenpropit	histamine receptor antagonist	HRH3, HRH4	Preclinical
iopanic-acid	thyroid hormone inhibitor		Preclinical
IOX1	histone demethylase inhibitor	EGLN1, KDM3A, KDM4C, KDM6B	Preclinical
IOX2	hypoxia inducible factor inhibitor	EGLN1, KDM2A, KDM5C	Preclinical
IPA-3	p21 activated kinase inhibitor	PAK1	Preclinical
IRL-2500	endothelin receptor antagonist	EDNRB	Preclinical
ISO-1	macrophage migration inhibiting factor inhibitor	MIF	Preclinical
ISRIB	eukaryotic translation initiation factor inhibitor, PERK inhibitor	EIF2A, EIF2AK3	Preclinical
ITD-1	TGF beta receptor inhibitor	TGFBR2	Preclinical
ITX3	GEF inhibitor	TRIO	Preclinical
IT1t	CC chemokine receptor antagonist	CXCR4	Preclinical
IU1	ubiquitin C-terminal hydrolase inhibitor	USP14	Preclinical
IWP-L6	porcupine inhibitor	PORCN	Preclinical
JAK3-inhibitor-V	JAK inhibitor	JAK3	Preclinical
JHW-007	dopamine uptake inhibitor	SLC6A3	Preclinical
JIB04	histone lysine demethylase inhibitor	KDM4E	Preclinical
JK-184	hedgehog pathway inhibitor		Preclinical
JLK-6	gamma secretase inhibitor	PSEN1	Preclinical
JNJ-10191584	histamine receptor antagonist	HRH4	Preclinical
JNJ-10397049	orexin receptor antagonist	HCRTR1, HCRTR2	Preclinical
JNJ-16259685	glutamate receptor antagonist	GRM1	Preclinical
JNJ-1661010	FAAH inhibitor	FAAH	Preclinical
JNJ-17203212	TRPV antagonist	TRPV1	Preclinical
JNJ-27141491	CC chemokine receptor antagonist	CCR2	Preclinical
JNJ-42041935	hypoxia inducible factor prolyl hydroxylase inhibitor	PDK2	Preclinical
JNJ-47965567	purinergic receptor antagonist	P2RX7	Preclinical
JNJ-7706621	CDK inhibitor	AURKA, AURKB, CDK1, CDK2	Preclinical
JNJ-7777120	histamine receptor antagonist	HRH4	Preclinical
JQ1-(+)	bromodomain inhibitor	BRD4, BRDT	Preclinical
JTE-013	lysophospholipid receptor antagonist	P2RY10, S1PR2	Preclinical
JW-55	tankyrase inhibitor	TNKS, TNKS2	Preclinical
JW-642	monoacylglycerol lipase inhibitor	MGLL	Preclinical
JW-67	Wnt pathway inhibitor	APC, AXIN1, GSK3B	Preclinical
JW-74	WNT signaling inhibitor, tankyrase inhibitor	TNKS, TNKS2	Preclinical
JX-401	p38 MAPK inhibitor	MAPK14	Preclinical
JZL-184	monoacylglucerol lipase inhibitor	MGLL	Preclinical
JZL-195	FAAH inhibitor, monoacylglycerol lipase inhibitor	FAAH, MGLL	Preclinical
K-Ras(G12C)-inhibitor-12	K-ras inhibitor	KRAS	Preclinical
K-Ras(G12C)-inhibitor-6	K-ras inhibitor		Preclinical
K-858	kinesin-like spindle protein inhibitor	KIF11	Preclinical
kaempferol	bone resorption inhibitor, estrogen-related receptor inverse agonist	AKR1B1, ALOX15B, ALOX5, AR, CYP1B1, GLO1, HSD17B1, UGT3A1	Preclinical
KB-R7943	sodium/calcium exchange inhibitor	SLC8A1, TRPC3, TRPC5, TRPC6	Preclinical
KB-SRC-4	src inhibitor	SRC	Preclinical
kenpaullone	CDK inhibitor, glycogen synthase kinase inhibitor	CCNB1, CDK1, CDK5, GSK3B	Preclinical
KF-38789	P selectin inhibitor	SELP	Preclinical
KG-5	RAF inhibitor	BRAF, FLT3, KIT, PDGFRB	Preclinical
KH-CB19	CDC inhibitor	CLK1, CLK3, DYRK1A	Preclinical
KHK-IN-1	hexokinase inhibitor	KHK	Preclinical
KI-16425	lysophosphatidic acid receptor antagonist	LPAR1, LPAR3	Preclinical
KI-20227	c-Fms inhibitor	CSF1R, KDR, KIT, PDGFRB	Preclinical
KI-8751	KIT inhibitor, PDGFR tyrosine kinase receptor inhibitor, VEGFR inhibitor	KDR	Preclinical
ki16198	lipoprotein antagonist	LPA	Preclinical
KL-001	proteasome inhibitor	CRY1, CRY2	Preclinical
KML29	monoacylglucerol lipase inhibitor	MGLL	Preclinical
KN-62	calcium/calmodulin dependent protein kinase inhibitor, purinergic receptor antagonist	AKT1, CAMK2A, CHEK1, LCK, MAPK1, MAPK11, MAPK12, MAPK14, MAPK8, P2RX7, PRKCA, ROCK1, RPS6KB1, SGK1	Preclinical
KN-93	calcium/calmodulin dependent protein kinase inhibitor	CAMK2A	Preclinical
Ko143	BCRP inhibitor	ABCB1, ABCC1	Preclinical
KPT-185	exportin antagonist	XPO1	Preclinical
KPT-276	exportin antagonist	XPO1	Preclinical
KRN-633	VEGFR inhibitor	FLT1, FLT4, KDR	Preclinical
KS-176	BCRP inhibitor	ABCG2	Preclinical
ku-0063794	mTOR inhibitor	MTOR	Preclinical
KU-55933	ATM kinase inhibitor	ATM, PRKDC	Preclinical
KU-60019	ATM kinase inhibitor	ATM	Preclinical
kuromanin	ribosyl cyclase inhibitor	CD38	Preclinical
KU14R	imidazoline receptor antagonist		Preclinical
kynurenic-acid	glutamate receptor antagonist	GPR35, GRIN1, GRIN2A, GRIN2B	Preclinical
KY02111	Wnt pathway inhibitor	DKK1	Preclinical
K02288	bone morphogenic protein inhibitor	BMP1	Preclinical
K145	sphingosine kinase inhibitor	SPHK2	Preclinical
L-mimosine	dopamine beta hydroxylase inhibitor, eukaryotic translation initiation factor inhibitor	DBH, EIF5A	Preclinical
L-NIL	nitric oxide synthase inhibitor	NOS1, NOS2, NOS3	Preclinical
L-152804	neuropeptide receptor antagonist	NPY5R	Preclinical
L-161982	prostanoid receptor antagonist	PTGER4	Preclinical
L-168049	glucagon receptor antagonist	GCGR	Preclinical
L-670596	prostanoid receptor antagonist		Preclinical
L-689560	glutamate receptor antagonist	GRIN1, GRIN2A, GRIN2B, GRIN2C, GRIN2D	Preclinical
L-690330	inositol monophosphatase inhibitor	IMPA1	Preclinical
L-693403	sigma receptor agonist, sigma receptor antagonist	DRD2, SIGMAR1	Preclinical
L-701252	glutamate receptor antagonist	GRIN1	Preclinical
L-701324	glutamate receptor antagonist	GRIN1, GRIN2A, GRIN2B, GRIN2C, GRIN2D	Preclinical
L-732,138	tachykinin antagonist	TACR1, TACR2	Preclinical
L-733060	tachykinin antagonist	TACR1	Preclinical
L-741742	dopamine receptor antagonist	DRD3, DRD4, SCN1A, SCN3A	Preclinical
L-745870	dopamine receptor antagonist	DRD1, DRD2, DRD3, DRD4, HTR1A, HTR2A, HTR6, HTR7	Preclinical
L-760735	tachykinin antagonist	TACR1	Preclinical
L-798,106	prostanoid receptor antagonist	PTGER3	Preclinical
LB42708	farnesyltransferase inhibitor		Preclinical
LDC1267	protein tyrosine kinase inhibitor	AXL, MERTK, TYRO3	Preclinical
LDN-209929	haspin kinase inhibitor	GSG2	Preclinical
LDN-212854	bone morphogenic protein inhibitor	ABL1, ACVR1, RIPK2	Preclinical
LDN-27219	tissue transglutaminase inhibitor	TGM2	Preclinical
LDN-57444	ubiquitin C-terminal hydrolase inhibitor		Preclinical
LDN193189	bone morphogenic protein inhibitor	ACVR1, BMPR1A	Preclinical
levobunolol-(+)	adrenergic receptor antagonist		Preclinical
levobunolol-(+/-)	adrenergic receptor antagonist		Preclinical
LFM-A13	Bruton's tyrosine kinase (BTK) inhibitor	BTK	Preclinical
LH846	casein kinase inhibitor	CSNK1D	Preclinical
ligustilide	tumor necrosis factor production inhibitor	TNF	Preclinical
LIMKi-3	LIM kinase inhibitor	LIMK1	Preclinical
limonin	HIV protease inhibitor		Preclinical
lithocholic-acid	FXR antagonist, vitamin D receptor agonist	GPBAR1, NR1H4, NR1I2, VDR	Preclinical
LM-22A4	tropomyosin receptor kinase inhibitor	NTRK2	Preclinical
LMK-235	HDAC inhibitor	HDAC4, HDAC5	Preclinical
loxistatin-acid	cysteine peptidase inhibitor	CTSB	Preclinical
LPA2-antagonist-1	lysophosphatidic acid receptor antagonist	LPAR2	Preclinical
LRRK2-IN-1	leucine rich repeat kinase inhibitor	LRRK2	Preclinical
luzindole	melatonin receptor antagonist	MTNR1A, MTNR1B	Preclinical
LY2109761	TGF beta receptor inhibitor	TGFBR1, TGFBR2	Preclinical
LY2183240	FAAH inhibitor, FAAH reuptake inhibitor	FAAH	Preclinical
LY225910	CCK receptor antagonist	CCKBR	Preclinical
LY231617	lipid peroxidase inhibitor		Preclinical
LY2365109	Glycine transporter 1 inhibitor	SLC6A9	Preclinical
LY255283	leukotriene receptor antagonist	LTB4R, LTB4R2	Preclinical
LY266097	serotonin receptor antagonist	HTR2B	Preclinical
LY2857785	CDK inhibitor	CDK9	Preclinical
LY288513	CCK receptor antagonist	CCKBR	Preclinical
LY294002	mTOR inhibitor, PI3K inhibitor, DNA dependent protein kinase inhibitor, phosphodiesterase inhibitor, PLK inhibitor	AKT1, CHEK1, GSK3B, LCK, MAPK1, MAPK11, MAPK12, MAPK14, MAPK8, MTOR, PIK3CA, PIK3CB, PIK3CD, PIK3CG, PLK1, PRKCA, PRKDC, ROCK1, RPS6KB1, SGK1	Preclinical
LY303511	casein kinase inhibitor, mTOR inhibitor, PI3K inhibitor	BRD2, BRD3, BRD4	Preclinical
LY310762	serotonin receptor antagonist	HTR1D	Preclinical
LY320135	cannabinoid receptor antagonist	CNR1	Preclinical
LY364947	TGF beta receptor inhibitor, p38 MAPK inhibitor	TGFBR1	Preclinical
LY393558	serotonin receptor antagonist	HTR1B, HTR1D, HTR2A, HTR2B	Preclinical
LY411575	gamma secretase inhibitor		Preclinical
LY456236	glutamate receptor antagonist	GRM1	Preclinical
M-25	smoothened receptor antagonist	DHH, IHH, SMO	Preclinical
M-344	HDAC inhibitor		Preclinical
madrasin	cell splicing inhibitor		Preclinical
MCC950	NOD like receptor inhibitor	NLRP3	Preclinical
McN-5652-(+/-)	selective serotonin reuptake inhibitor (SSRI)		Preclinical
MC1568	HDAC inhibitor	HDAC2	Preclinical
mdivi-1	dynamin inhibitor	DNM1	Preclinical
MDL-29951	glutamate receptor antagonist	FBP1	Preclinical
ME-0328	PPAR receptor antagonist	PARP3	Preclinical
MEK1-2-inhibitor	MEK inhibitor	MAP2K2	Preclinical
methylatropine-nitrate	acetylcholine receptor antagonist	CHRM1	Preclinical
methyllycaconitine	acetylcholine receptor antagonist	CHRNA7	Preclinical
mevastatin	HMGCR inhibitor	HMGCR	Preclinical
ME0328	PARP inhibitor	PARP3	Preclinical
MG-132	proteasome inhibitor	PSMB1	Preclinical
MG-624	acetylcholine receptor antagonist	CHRNA7	Preclinical
MGCD-265	VEGFR inhibitor	AXL, MET	Preclinical
MI-14	PI4K inhibitor	PI4KB	Preclinical
mimosine	DNA replication inhibitor	CCL2, SHMT1, SHMT2, TYR	Preclinical
mirin	MRE11A exonuclease inhibitor	MRE11A	Preclinical
mivobulin	microtubule inhibitor		Preclinical
MJ-15	cannabinoid receptor antagonist	CNR1	Preclinical
MK-2048	HIV integrase inhibitor		Preclinical
MK-2894	prostaglandin inhibitor	PTGER4	Preclinical
MK-8745	Aurora kinase inhibitor	AURKA	Preclinical
MK2-IN-1	MAP kinase inhibitor	MAPKAPK2	Preclinical
ML-141	GTPase inhibitor	CDC42	Preclinical
ML-193	G protein-coupled receptor antagonist	GPR55	Preclinical
ML-281	serine/threonine kinase inhibitor	STK33	Preclinical
ML-298	phospholipase inhibitor	PLD2	Preclinical
ML-323	ubiquitin specific protease inhibitor	USP1	Preclinical
ML-3403	MAP kinase inhibitor	CYP3A4, MAPK11, MAPK12, MAPK14	Preclinical
ML-348	lysophospholipase inhibitor	LYPLA1	Preclinical
ML-365	potassium channel blocker	KCNK3, KCNK9	Preclinical
ML-786	RAF inhibitor	BRAF, RAF1	Preclinical
ML-9	myosin light chain kinase inhibitor	TRPC6	Preclinical
ML130	NOD1 inhibitor		Preclinical
ML133	potassium channel blocker		Preclinical
ML161	protease-activated receptor inhibitor		Preclinical
ML167	CLK inhibitor, DYRK inhibitor	CLK4, DYRK1B	Preclinical
ML204	transient receptor potential channel antagonist	TRPC4, TRPC5	Preclinical
ML324	histone lysine demethylase inhibitor	KDM4A	Preclinical
ML347	ALK tyrosine kinase receptor inhibitor	ACVR1, ACVRL1, BMPR1A	Preclinical
MM-102	WDR5/MLL interaction inhibitor		Preclinical
MM-11253	retinoid receptor antagonist	RARG	Preclinical
MMPX	phosphodiesterase inhibitor		Preclinical
MM77	serotonin receptor antagonist	HTR1A	Preclinical
MN-64	tankyrase inhibitor	TNKS	Preclinical
MNITMT	lymphocyte inhibitor		Preclinical
MNS-(3,4-Methylenedioxy-nitrostyrene)	src inhibitor, syk inhibitor	SRC, SYK	Preclinical
monastrol	kinesin inhibitor	KIF11	Preclinical
morin	cytochrome P450 inhibitor	ADORA2A, ESR2, FASN, MCL1, SLC22A12	Preclinical
MPEP	glutamate receptor antagonist	GRM1, GRM4, GRM5	Preclinical
MPI-0479605	mitotic kinase inhibitor	TTK	Preclinical
Mps-BAY-2a	monopolar spindle 1 kinase inhibitor	TTK	Preclinical
Mps1-IN-1	monopolar spindle 1 kinase inhibitor	TTK	Preclinical
Mps1-IN-5	protein kinase inhibitor		Preclinical
MRK-560	gamma secretase inhibitor	APP	Preclinical
MRS-1220	adenosine receptor antagonist	ADORA2B, ADORA3	Preclinical
MRS-3777	adenosine receptor antagonist	ADORA1, ADORA2A, ADORA2B, ADORA3	Preclinical
MRS1334	adenosine receptor antagonist	ADORA3	Preclinical
MRS1845	calcium channel blocker		Preclinical
MRS2578	purinergic receptor antagonist	P2RY6	Preclinical
MRS3777	adenosine receptor antagonist	ADORA2A	Preclinical
MTPG	glutamate receptor antagonist	GRM2, GRM3	Preclinical
MY-5445	phosphodiesterase inhibitor, platelet aggregation inhibitor	PDE5A	Preclinical
myricetin	androgen receptor agonist, cytochrome P450 inhibitor	PIK3CG	Preclinical
myricitrin	PKC inhibitor	NOS1, PRKCA	Preclinical
M8-B	transient receptor potential channel antagonist	TRPM8	Preclinical
N-benzylnaltrindole	opioid receptor antagonist		Preclinical
N-salicoylaminophenol	ribonucleotide reductase inhibitor		Preclinical
nafadotride	dopamine receptor antagonist	DRD2, DRD3, HTR1A	Preclinical
naloxone-benzoylhydrazone	opioid receptor antagonist	OPRK1, OPRM1	Preclinical
naltriben	opioid receptor antagonist	OPRD1, OPRK1, OPRM1	Preclinical
naltrindole	opioid receptor antagonist	OPRD1, OPRK1, OPRM1	Preclinical
naringin	cytochrome P450 inhibitor	SLCO1A2	Preclinical
naringin-dihydrochalcone	cytochrome P450 inhibitor		Preclinical
NAV-26	voltage-gated sodium channel blocker	SCN9A	Preclinical
NBI-27914	corticosteroid releasing factor receptor antagonist	CRHR1	Preclinical
NBI-74330-(+/-)	CC chemokine receptor antagonist	CXCR3	Preclinical
NBQX	glutamate receptor antagonist	GRIA1, GRIA2, GRIA3, GRIA4, GRIK1, GRIN1, GRIN2A, GRIN2B	Preclinical
NCS-382	GABA receptor antagonist	GABBR1, GABBR2, SLC52A2	Preclinical
NDT-9513727	complement antagonist	C5AR1	Preclinical
necrostatin-1	RIPK inhibitor	RIPK1	Preclinical
necrostatin-2	necroptosis inhibitor, RIPK inhibitor	RIPK2	Preclinical
nexturastat-a	HDAC inhibitor	HDAC1, HDAC6	Preclinical
NFKB-activation-inhibitor-II	NFkB pathway inhibitor	RELA	Preclinical
NGB-2904	dopamine receptor antagonist	DRD3	Preclinical
NGD-98-2	corticosteroid releasing factor receptor antagonist	CRHR1	Preclinical
NHI-2	lactate dehydrogenase inhibitor	LDHA	Preclinical
NH125	eukaryotic translation elongation factor 2 inhibitor		Preclinical
NI-57	bromodomain inhibitor	BRD1, BRPF1, BRPF3	Preclinical
NIDA-41020	cannabinoid receptor antagonist	CNR1	Preclinical
niguldipine-(S)-(+)	adrenergic receptor antagonist	ADRA1A	Preclinical
nithiamide	bacterial DNA inhibitor		Preclinical
nitrocaramiphen	cholinergic receptor antagonist	CHRM1	Preclinical
nitrosodimethylurea	DNA synthesis inhibitor		Preclinical
NKY-80	adenylyl cyclase inhibitor	ADCY5	Preclinical
NMS-E973	HSP inhibitor		Preclinical
NMS-P715	protein kinase inhibitor		Preclinical
NMS-873	ATPase inhibitor	VCP	Preclinical
NNC-05-2090	GABA uptake inhibitor, GAT inhibitor	SLC6A12	Preclinical
NNC-55-0396	T-type calcium channel blocker	CATSPER1, CATSPER2, CATSPER3, CATSPER4	Preclinical
NNC-711	GABA uptake inhibitor	SIGMAR1, SLC6A1	Preclinical
nobiletin	MEK inhibitor	MAP2K1	Preclinical
nocodazole	tubulin polymerization inhibitor	HPGDS	Preclinical
nor-Binaltorphimine-dihydrochloride	opioid receptor antagonist	OPRD1, OPRK1, OPRM1	Preclinical
norcyclobenzaprine	adrenergic receptor agonist, serotonin receptor antagonist		Preclinical
NPPB	chloride channel blocker	ANO1, CLCN2, CLCN7, TRPA1	Preclinical
NPS-2143	calcium receptor antagonist	CASR	Preclinical
NPY-5RA972	neuropeptide receptor antagonist	NPY5R	Preclinical
NQDI-1	caspase inhibitor	CASP3	Preclinical
NSC-23766	Ras GTPase inhibitor		Preclinical
NSC-3852	HDAC inhibitor	HDAC1	Preclinical
NSC-405020	matrix metalloprotease inhibitor	MMP1	Preclinical
NSC-625987	CDK inhibitor	CDK2, CDK4	Preclinical
NSC-632839	ubiquitin specific protease inhibitor	SENP2, USP1, USP2, USP7	Preclinical
NSC-663284	CDC inhibitor	CDC25A, CDC25B, CDC25C	Preclinical
NSC-697923	ubiquitin-conjugating enzyme inhibitor	UBE2N	Preclinical
NSC-95397	CDC inhibitor	CDC25A, CDC25B	Preclinical
NSC-9965	acetylcholine receptor antagonist	CHRNA4, CHRNB2	Preclinical
NSC636819	histone demethylase inhibitor	KDM4A, KDM4B	Preclinical
NTNCB	neuropeptide receptor antagonist	NPY5R	Preclinical
NTRC-824	neurotensin receptor antagonist	NTSR2	Preclinical
NT157	IGF-1 inhibitor	IGF1R	Preclinical
NU-1025	PARP inhibitor	PARP1	Preclinical
NU-2058	cyclin D inhibitor	CCNA2, CDK2	Preclinical
NU-7026	DNA dependent protein kinase inhibitor, mTOR inhibitor, PI3K inhibitor	PRKDC	Preclinical
NU-7441	DNA dependent protein kinase inhibitor	PRKDC	Preclinical
nutlin-3	MDM inhibitor	MDM2, TP53	Preclinical
NU6027	CDK inhibitor	CCNA2, CDK2	Preclinical
NVP-ADW742	insulin growth factor receptor inhibitor	IGF1R	Preclinical
NVP-AEW541	IGF-1 inhibitor	IGF1R, INSR	Preclinical
NVP-BHG712	ephrin inhibitor	EPHB4	Preclinical
NVP-BSK805	JAK inhibitor	JAK2	Preclinical
NVP-BVU972	MET inhibitor	MET	Preclinical
NVP-TAE226	protein tyrosine kinase inhibitor	PTK2	Preclinical
NVP-TAE684	ALK tyrosine kinase receptor inhibitor	ALK, INSR	Preclinical
NVP-TNKS656	tankyrase inhibitor	TNKS2	Preclinical
NVP-231	ceramidase inhibitor	CERK	Preclinical
NVS-PAK1-1	p21 activated kinase inhibitor	PAK1	Preclinical
N20C	glutamate receptor antagonist		Preclinical
O-1918	cannabinoid receptor antagonist		Preclinical
ODQ	guanylyl cyclase inhibitor	GUCY1A2, GUCY1A3, GUCY1B3	Preclinical
OF-1	bromodomain inhibitor	BRD1	Preclinical
OG-L002	histone lysine demethylase inhibitor	KDM1A	Preclinical
OICR-9429	WDR5/MLL interaction inhibitor	WDR5	Preclinical
oleoylethanolamide	cannabinoid receptor agonist, glucose dependent insulinotropic receptor agonist, potassium channel blocker, PPAR receptor agonist	CNR1, GPR119, GPR55, PPARA	Preclinical
oligomycin-a	ATP synthase inhibitor, ATPase inhibitor	ATP5A1	Preclinical
olomoucine	CDK inhibitor	CDK1, CDK2, CDK5, MAPK1	Preclinical
OMDM-2	FAAH inhibitor	GPR119	Preclinical
ONO-AE3-208	prostanoid receptor antagonist	PTGER4	Preclinical
ONO-8130	prostanoid receptor antagonist	PTGER1	Preclinical
ONX-0914	proteasome inhibitor		Preclinical
ON123300	CDK inhibitor	CDK4, NUAK1, PDGFRB	Preclinical
OR-486	catechol O methyltransferase inhibitor	COMT	Preclinical
Org-25543	glycine transporter inhibitor	GLRB, SLC6A5	Preclinical
oridonin	BCL inhibitor	BCL2	Preclinical
OSI-420	EGFR inhibitor	EGFR	Preclinical
osthol	calcium channel blocker		Preclinical
OT-R-antagonist-1	oxytocin receptor antagonist	AVPR1A, OXTR	Preclinical
OTS514	TOPK inhibitor		Preclinical
OXA-06	rho associated kinase inhibitor	ROCK1, ROCK2	Preclinical
oxacyclohexadecan-2-one	protein kinase inhibitor		Preclinical
OXF-BD-02	bromodomain inhibitor	BRD4	Preclinical
oxolinic-acid	bacterial DNA gyrase inhibitor		Preclinical
oxonic-acid	uricase inhibitor		Preclinical
PA-452	retinoid receptor antagonist	RXRA	Preclinical
PACOCF3	phospholipase inhibitor	PLA2G4A	Preclinical
palmatine-chloride	dopamine synthesis inhibitor	CYP3A4	Preclinical
palmitoylcarnitine	protein kinase inhibitor		Preclinical
parbendazole	tubulin polymerization inhibitor	TUBB	Preclinical
parthenolide-(-)	NFkB pathway inhibitor	HDAC1	Preclinical
parthenolide-(alternate-stereo)	NFkB pathway inhibitor	IKBKB, RELA	Preclinical
PCI-29732	Bruton's tyrosine kinase (BTK) inhibitor	BTK	Preclinical
PCI-34051	HDAC inhibitor	HDAC1, HDAC10, HDAC6, HDAC8	Preclinical
PD-102807	acetylcholine receptor antagonist	CHRM4	Preclinical
PD-156707	endothelin receptor antagonist	EDNRA, EDNRB	Preclinical
PD-158780	EGFR inhibitor	EGFR	Preclinical
PD-160170	neuropeptide receptor antagonist	NPY1R	Preclinical
PD-161570	FGFR inhibitor	FGFR1	Preclinical
PD-166285	src inhibitor	EGFR, FGFR1, PDGFRB, PKMYT1, SRC, WEE1	Preclinical
PD-166793	collagenase inhibitor, metalloproteinase inhibitor	MMP13, MMP2, MMP3	Preclinical
PD-168393	EGFR inhibitor	EGFR, ERBB2, SRC	Preclinical
PD-168568	dopamine receptor antagonist	DRD2, DRD4	Preclinical
PD-173074	FGFR inhibitor, VEGFR inhibitor	FGFR1, FGFR2, FGFR3, FGFR4, FLT1, FLT4, KDR, PDGFRA, PDGFRB	Preclinical
PD-173212	calcium channel blocker	CACNA1B	Preclinical
PD-198306	MAP kinase inhibitor, MEK inhibitor	MAP2K1, MAP2K2	Preclinical
PD-318088	MEK inhibitor	MAP2K1	Preclinical
PD-407824	PKC inhibitor	WEE1	Preclinical
PD-98059	MEK inhibitor	AKT1, CHEK1, GSK3B, LCK, MAP2K1, MAPK1, MAPK11, MAPK12, MAPK14, MAPK8, PRKCA, RAF1, ROCK1, RPS6KB1, SGK1	Preclinical
PDE10-IN-1	phosphodiesterase inhibitor	PDE10A	Preclinical
PD1-PDL-inhibitor-1	programmed death ligand inhibitor	CD274	Preclinical
pepstatin	aspartic protease inhibitor	CTSB, CTSD, CTSL, REN	Preclinical
PF-04885614	voltage-gated sodium channel blocker	SCN10A	Preclinical
PF-06447475	serine/threonine kinase inhibitor	LRRK2	Preclinical
PF-3845	FAAH inhibitor	FAAH	Preclinical
PF-429242	SREBP inhibitor	MBTPS1	Preclinical
PF-431396	focal adhesion kinase inhibitor	PTK2, PTK2B	Preclinical
PF-4708671	ribosomal protein inhibitor	RPS6KB1	Preclinical
PF-4800567	casein kinase inhibitor	CSNK1D, CSNK1E	Preclinical
PF-4981517	cytochrome P450 inhibitor	CYP3A4	Preclinical
PF-5274857	smoothened receptor antagonist	SMO	Preclinical
PF-573228	focal adhesion kinase inhibitor	CDK1, CDK2, CDK7, GSK3B, IKBKB	Preclinical
PF-670462	casein kinase inhibitor	CSNK1D, CSNK1E	Preclinical
PF-750	FAAH inhibitor	FAAH	Preclinical
PF-8380	autotaxin inhibitor	ENPP2	Preclinical
PFI-1	bromodomain inhibitor	BRD4	Preclinical
PFI-3	bromodomain inhibitor	PBRM1, SMARCA4	Preclinical
PFI-4	bromodomain inhibitor	BRPF1	Preclinical
PHA-665752	c-Met inhibitor	MET	Preclinical
PHA-680632	Aurora kinase inhibitor	AURKA, AURKB, AURKC	Preclinical
PHA-767491	CDC inhibitor	CDK1, RPS6KB1	Preclinical
phenothiazine	dopamine receptor antagonist		Preclinical
phenylmethylsulfonyl-fluoride	serine protease inhibitor		Preclinical
phlorizin	sodium/glucose cotransporter inhibitor	SLC5A1, SLC5A11, SLC5A2, SLC5A3	Preclinical
PHP-501	GABA receptor antagonist	GABRA1, GABRB2, GABRG2	Preclinical
PHT-427	AKT inhibitor, pyruvate dehydrogenase inhibitor	AKT2, PDPK1	Preclinical
PHTPP	estrogen receptor antagonist	ESR2	Preclinical
PI-103	mTOR inhibitor, PI3K inhibitor	MTOR, PIK3CA, PIK3CB, PIK3CD, PIK3CG, PRKDC	Preclinical
PI-828	PI3K inhibitor		Preclinical
piceatannol	SYK inhibitor	ATP5A1, ATP5B, ATP5C1, IRF3	Preclinical
picrotoxinin	GABA receptor antagonist	GLRA1, GLRA2, GLRA3, GLRB, HTR3A, HTR3B	Preclinical
pifithrin-alpha	TP53 inhibitor	TP53	Preclinical
pifithrin-cyclic	TP53 inhibitor	TP53	Preclinical
pifithrin-mu	HSP inhibitor	HSPA1A, TP53	Preclinical
PIK-293	PI3K inhibitor	PIK3CA, PIK3CB, PIK3CD, PIK3CG	Preclinical
PIK-294	PI3K inhibitor	PIK3CB, PIK3CD, PIK3CG	Preclinical
PIK-75	DNA protein kinase inhibitor, PI3K inhibitor	PIK3CA, PIK3CB, PIK3CD, PIK3CG, PRKDC	Preclinical
PIK-93	PI3K inhibitor	PI4KB, PIK3C3, PIK3CG	Preclinical
PIM-1-Inhibitor-2	Pim kinase inhibitor	PIM1	Preclinical
pindolol-(-)	adrenergic receptor antagonist, serotonin receptor antagonist	HTR1A	Preclinical
pirenperone	serotonin receptor antagonist	HTR2A, HTR7	Preclinical
PIT	purinergic receptor antagonist	P2RY1	Preclinical
PI4KIII-beta-inhibitor-1	PI4K inhibitor	PI4K2B	Preclinical
PJ-34	PARP inhibitor	EEF2, PARP1, PARP15, PARP3	Preclinical
PK-THPP	potassium channel blocker	KCNK9	Preclinical
PK-44	dipeptidyl peptidase inhibitor	DPP4	Preclinical
plurisin-#1	stearoyl-CoA desaturase inhibitor	SCD	Preclinical
PLX-4720	RAF inhibitor	BRAF, KDR	Preclinical
PLX-647	receptor tyrosine protein kinase inhibitor	CSF1R, KIT	Preclinical
PMPA	glutamate receptor antagonist	FOLH1	Preclinical
PNU-177864	dopamine receptor antagonist	DRD3	Preclinical
PNU-37883	ATP-sensitive potassium channel antagonist		Preclinical
PNU-74654	beta-catenin inhibitor	CTNNB1, TCF4	Preclinical
PP-1	src inhibitor	HCK, RET	Preclinical
PP-121	protein tyrosine kinase inhibitor	ABL1, EGFR, HCK, KDR, MTOR, PDGFRA, PIK3CA, PIK3CB, PIK3CD, PIK3CG, PRKDC, SRC	Preclinical
PP-2	src inhibitor	ABL1, LCK, LYN, RIPK2, SRC	Preclinical
PPY-A	Abl kinase inhibitor	ABL1, BCR	Preclinical
PP242	mTOR inhibitor	MTOR, PASK	Preclinical
PQ-401	IGF-1 inhibitor	IGF1R	Preclinical
PR-619	DUB inhibitor		Preclinical
pravadoline	cyclooxygenase inhibitor	CNR1, CNR2	Preclinical
PRIMA1	TP53 inhibitor	ACHE	Preclinical
proadifen	nitric oxide synthase inhibitor	NOS1	Preclinical
propranolol-(R)	adrenergic receptor antagonist	ADRB2, ADRB3	Preclinical
propranolol-(S)	adrenergic receptor antagonist	ADRB1, ADRB2, ADRB3, HTR1A, HTR1B, HTR5A, SLC10A1	Preclinical
protoporphyrin-ix	heme oxygenase inhibitor	HMOX1	Preclinical
PRT4165	polycomb repressive complex inhibitor	PRC1	Preclinical
PSB-06126	NTPDase inhibitor	ENTPD3	Preclinical
PSB-11	adenosine receptor antagonist	ADORA1, ADORA2A, ADORA3	Preclinical
PSB-1115	adenosine receptor antagonist	ADORA1, ADORA2B, ADORA3	Preclinical
PSB-36	adenosine receptor antagonist	ADORA1, ADORA2A, ADORA2B, ADORA3	Preclinical
PSB-603	adenosine receptor antagonist	ADORA1, ADORA2A, ADORA2B, ADORA3	Preclinical
PSI-7976	HCV inhibitor		Preclinical
PTC-209	BMI-1 inhibitor		Preclinical
puromycin	protein synthesis inhibitor	NHP2L1, RPL10L, RPL11, RPL13A, RPL15, RPL19, RPL23, RPL23A, RPL26L1, RPL3, RPL37, RPL8, RSL24D1	Preclinical
purvalanol-a	CDK inhibitor	CDK1, CDK2, CDK4, CDK5, CSNK1G3, RPS6KA1, SRC	Preclinical
purvalanol-b	tyrosine kinase inhibitor	CDK2, CDK4, CDK5, MAPK1, MAPK3, SRPK2	Preclinical
PYR-41	ubiquitin activating enzyme inhibitor		Preclinical
pyrazolanthrone	JNK inhibitor	MAPK10, MAPK8, MAPK8IP1, MAPK9, TTK	Preclinical
pyrrolidine-dithiocarbamate	NFkB pathway inhibitor	HSD11B1, RELA	Preclinical
P22077	ubiquitin specific protease inhibitor	USP7	Preclinical
P5091	ubiquitin specific protease inhibitor	USP7	Preclinical
P7C3	NAMPT inhibitor	NAMPT	Preclinical
QX-222	sodium channel blocker		Preclinical
QX-314	sodium channel blocker	MAPK14, TGFBR1	Preclinical
R-268712	serine/threonine kinase inhibitor	TGFBR1	Preclinical
R-59022	diacylglycerol kinase inhibitor, protein kinase inhibitor	DGKA	Preclinical
R-96544	serotonin receptor antagonist	HTR2A	Preclinical
rauwolscine	adrenergic receptor antagonist	ADRA2A, ADRA2B, ADRA2C, HTR1B, HTR1D, HTR1E, HTR2B	Preclinical
RBC8	Ral GTPase inhibitor	RALA, RALB	Preclinical
remodelin	transferase inhibitor	NAT10	Preclinical
repsox	TGF beta receptor inhibitor	TGFBR1	Preclinical
reversan	MRP inhibitor	ABCC1	Preclinical
reversine	Aurora kinase inhibitor	AURKB, INCENP, MAP2K1	Preclinical
RGFP966	HDAC inhibitor	HDAC3	Preclinical
RG108	DNA methyltransferase inhibitor	DNMT1, DNMT3B	Preclinical
RHC-80267	triacylglycerol lipase inhibitor	DAGLA, DAGLB	Preclinical
rheochrysidin	protein tyrosine kinase inhibitor	PTPN1	Preclinical
RITA	MDM inhibitor	MDM2	Preclinical
RKI-1447	rho associated kinase inhibitor	CDC42BPA, DMPK, LIMK1, MYLK, PAK1, PKN1, ROCK1, ROCK2	Preclinical
RN-1	histone demethylase inhibitor	KDM1A	Preclinical
RN-1734	TRPV antagonist	TRPV4	Preclinical
Ro-106-9920	NFkB pathway inhibitor		Preclinical
Ro-1138452	prostanoid receptor antagonist	PTGIR	Preclinical
Ro-20-1724	phosphodiesterase inhibitor	PDE3A, PDE4A, PDE4B, PDE4C, PDE4D	Preclinical
RO-3	purinergic receptor antagonist	P2RX3	Preclinical
Ro-3306	CDK inhibitor	CDK1	Preclinical
Ro-48-8071	oxidosqualene cyclase inhibitor	LSS	Preclinical
Ro-61-8048	kynurenine 3-monooxygenase inhibitor	KMO	Preclinical
Ro-9187	HCV inhibitor		Preclinical
rolipram-R(-)	phosphodiesterase inhibitor	PDE4A, PDE4B, PDE4C, PDE4D, PDE5A	Preclinical
rolipram-S(+)	phosphodiesterase inhibitor		Preclinical
RQ-00203078	transient receptor potential channel antagonist	TRPM8	Preclinical
RS-100329	adrenergic receptor antagonist	ADRA1A, ADRA1D	Preclinical
RS-102221	serotonin receptor antagonist	HTR2A, HTR2B, HTR2C	Preclinical
RS-102895	CCR antagonist	CCR2	Preclinical
RS-16566	serotonin receptor antagonist		Preclinical
RS-17053	adrenergic receptor antagonist	ADRA1A, ADRA1D	Preclinical
RS-23597-190	serotonin receptor antagonist	HTR4	Preclinical
RS-39604	serotonin receptor antagonist	HTR4	Preclinical
RS-504393	CC chemokine receptor antagonist	CCL2, CCR2	Preclinical
RS-79948	adrenergic receptor antagonist	ADRA2A	Preclinical
RU-SKI-43	hedgehog pathway inhibitor	HHAT	Preclinical
rutaecarpine	cyclooxygenase inhibitor	PTGS2	Preclinical
ruxolitinib-(S)	JAK inhibitor	JAK1, JAK2	Preclinical
RWJ-50271	integrin inhibitor	ICAM1	Preclinical
RX-821002	adrenergic receptor antagonist	ADRA1A, ADRA1B, ADRA1D, ADRA2A, ADRA2B, ADRA2C	Preclinical
ryuvidine	histone lysine methyltransferase inhibitor	CDK2, CDK4	Preclinical
R112	syk inhibitor	SYK	Preclinical
S-Isopropylisothiourea	nitric oxide synthase inhibitor	NOS3	Preclinical
S-Trityl-L-cysteine	mitotic kinesin inhibitor		Preclinical
S-07662	CAR antagonist	NR1I3	Preclinical
SA-47	FAAH inhibitor	FAAH	Preclinical
saclofen	GABA receptor antagonist	GABBR1, GABBR2, KCTD12, KCTD16, KCTD8	Preclinical
salidroside	beta amyloid protein neurotoxicity inhibitor	APP	Preclinical
salubrinal	eukaryotic translation initiation factor inhibitor	EIF2S1	Preclinical
sal003	eukaryotic translation initiation factor inhibitor	EIF2A	Preclinical
SANT-1	smoothened receptor antagonist	SHH, SMO	Preclinical
SANT-2	smoothened receptor antagonist	SHH, SMO	Preclinical
SAR131675	VEGFR inhibitor	FLT4	Preclinical
SAR405	PI3K inhibitor	PIK3C3	Preclinical
SB-200646	serotonin receptor antagonist	HTR2B, HTR2C	Preclinical
SB-202190	p38 MAPK inhibitor	AKT1, ALOX5, CHEK1, GSK3B, LCK, MAPK1, MAPK11, MAPK12, MAPK14, MAPK8, PRKCA, ROCK1, RPS6KB1, SGK1	Preclinical
SB-203186	serotonin receptor antagonist	HTR4	Preclinical
SB-203580	p38 MAPK inhibitor	AKT1, ALOX5, CHEK1, CYP2D6, CYP3A4, GAK, GSK3B, LCK, MAPK1, MAPK10, MAPK11, MAPK12, MAPK14, MAPK8, MAPK9, PRKCA, RAF1, RIPK2, ROCK1, RPS6KB1, SGK1, SRC, TNF	Preclinical
SB-206553	serotonin receptor antagonist	HTR2A, HTR2B, HTR2C	Preclinical
SB-216641	serotonin receptor antagonist	HTR1A, HTR1B, HTR1D, HTR2A, HTR2B, HTR2C	Preclinical
SB-216763	glycogen synthase kinase inhibitor	CCNA2, CDK2, GSK3A, GSK3B	Preclinical
SB-218078	CHK inhibitor	CHEK1	Preclinical
SB-218795	tachykinin antagonist	TACR3	Preclinical
SB-221284	serotonin receptor antagonist	HTR2A, HTR2B, HTR2C	Preclinical
SB-222200	tachykinin antagonist	TACR3	Preclinical
SB-225002	CC chemokine receptor antagonist	CXCR2	Preclinical
SB-228357	serotonin receptor antagonist	HTR2A, HTR2B, HTR2C	Preclinical
SB-239063	p38 MAPK inhibitor	MAPK11, MAPK14, PTGS2	Preclinical
SB-258585	serotonin receptor antagonist	HTR6	Preclinical
SB-268262	calcitonin antagonist	CALCA	Preclinical
SB-269970	serotonin receptor antagonist	HTR7	Preclinical
SB-297006	CC chemokine receptor antagonist	CCR3	Preclinical
SB-328437	CCR antagonist		Preclinical
SB-334867	orexin receptor antagonist	HCRTR1, HCRTR2	Preclinical
SB-366791	TRPV antagonist	TRPV1	Preclinical
SB-399885	serotonin receptor antagonist	HTR6	Preclinical
SB-408124	orexin receptor antagonist	HCRTR1, HCRTR2	Preclinical
SB-415286	glycogen synthase kinase inhibitor	GSK3A, GSK3B, RPS6KB1	Preclinical
SB-431542	TGF beta receptor inhibitor	ACVR1C, TGFBR1	Preclinical
SB-452533	TRPV antagonist	TRPV1	Preclinical
SB-505124	ALK tyrosine kinase receptor inhibitor	TGFBR1	Preclinical
SB-525334	TGF beta receptor inhibitor	TGFBR1	Preclinical
SB-590885	RAF inhibitor	BRAF	Preclinical
SB-612111	nociceptin/orphanin FQ (NOP) receptor antagonist	OPRL1	Preclinical
SB-657510	urotensin receptor antagonist	UTS2R	Preclinical
SB-706375	urotensin receptor antagonist	UTS2R	Preclinical
SB-747651A	kinase inhibitor	AKT1, AKT3, ROCK1, RPS6KA5, RPS6KB1	Preclinical
SB-772077B	rho associated kinase inhibitor	ROCK1, ROCK2	Preclinical
SBE-13	PLK inhibitor	PLK1	Preclinical
SBHA	HDAC inhibitor	HDAC1, HDAC3	Preclinical
SC-144	P glycoprotein inhibitor		Preclinical
SC-19220	prostanoid receptor antagonist	PTGER1	Preclinical
SC-236	cyclooxygenase inhibitor	PTGS2	Preclinical
SC-51089	prostanoid receptor antagonist	PTGER1	Preclinical
SC-560	cyclooxygenase inhibitor	PTGS1	Preclinical
SCH-23390	dopamine receptor antagonist	DRD1, DRD5, HTR2C, KCNJ4, KCNJ6	Preclinical
SCH-51344	MTH1 inhibitor	NUDT1	Preclinical
SCH-58261	adenosine receptor antagonist	ADORA1, ADORA2A, ADORA2B, ADORA3	Preclinical
scopolamine-n-oxide	acetylcholine receptor antagonist	CHRM1, CHRM2, CHRM3, CHRM4, CHRM5, SI	Preclinical
scriptaid	HDAC inhibitor	HDAC1, HDAC2, HDAC3, HDAC4, HDAC5, HDAC6, HDAC7, HDAC8, HDAC9	Preclinical
SD-169	p38 MAPK inhibitor	MAPK14	Preclinical
SD-208	TGF beta receptor inhibitor	TGFBR1	Preclinical
SD-2590	matrix metalloprotease inhibitor	MMP1, MMP13, MMP2	Preclinical
SDM25N	opioid receptor antagonist	OPRD1	Preclinical
SDZ-SER-082	serotonin receptor antagonist	HTR2A, HTR2B, HTR2C	Preclinical
SDZ-205-557	serotonin receptor antagonist	HTR3A, HTR3B	Preclinical
SDZ-21009	adrenergic receptor antagonist, serotonin receptor antagonist	HTR1A, HTR1B	Preclinical
SDZ-220-040	glutamate receptor antagonist	GRIN1	Preclinical
SDZ-220-581	glutamate receptor antagonist	GRIN1	Preclinical
securinine	GABA receptor antagonist, TP53 activator	GABRA1	Preclinical
SEN-1269	beta amyloid inhibitor	APP	Preclinical
sesamin	NFkB pathway inhibitor		Preclinical
SF-11	neuropeptide receptor antagonist	MCOLN3, NPY2R	Preclinical
SGC-CBP30	bromodomain inhibitor	CREBBP, EP300	Preclinical
SGC-0946	histone lysine methyltransferase inhibitor		Preclinical
SGC-707	protein arginine N-methyltransferase inhibitor	PRMT3	Preclinical
SGI-1027	DNA methyltransferase inhibitor	DNMT1, DNMT3A, DNMT3B	Preclinical
SHA-68	neuropeptide receptor antagonist	NPSR1	Preclinical
SHP099	protein tyrosine kinase inhibitor	PTPN11	Preclinical
SIB-1757	glutamate receptor antagonist	GRM5	Preclinical
SIB-1893	glutamate receptor antagonist	GRM4, GRM5	Preclinical
SID-7969543	steroidogenic factor antagonist	NR5A1	Preclinical
sinefungin	DNA methyltransferase inhibitor, RNA synthesis inhibitor	CARM1	Preclinical
sinomenine	angiogenesis inhibitor		Preclinical
SirReal-2	SIRT inhibitor	SIRT2	Preclinical
sirtinol	SIRT inhibitor	SIRT1, SIRT2	Preclinical
SIS3	serine/threonine kinase inhibitor	SMAD3, TGFBR1	Preclinical
SJ-172550	MDM inhibitor	MDM4	Preclinical
skepinone-l	p38 MAPK inhibitor	MAPK14	Preclinical
SKF-83566	dopamine receptor antagonist	DRD1, DRD5	Preclinical
SKF-86002	p38 MAPK inhibitor	ALOX5, MAPK14	Preclinical
SKF-89976A	GABA uptake inhibitor	SLC6A1	Preclinical
SKF-91488	histamine N-methyltransferase inhibitor	HNMT	Preclinical
SKF-96365	calcium channel blocker	CYP3A4, PKD2, TRPC1, TRPC3, TRPC4, TRPC5, TRPV2	Preclinical
SKI-II	sphingosine kinase inhibitor	SPHK1	Preclinical
SKLB1002	VEGFR inhibitor	KDR	Preclinical
SM-164	XIAP inhibitor	BIRC2, BIRC3, XIAP	Preclinical
SM-21	sigma receptor antagonist	PGRMC1	Preclinical
SMI-4a	Pim kinase inhibitor	PIM1	Preclinical
SN-6	sodium/calcium exchange inhibitor		Preclinical
SNAP-5089	adrenergic receptor antagonist	ADRA1A, ADRA1B, ADRA1D, ADRA2A, ADRA2B, ADRA2C, CACNA1C, CACNA1D	Preclinical
SP-100030	NFkB pathway inhibitor	JUN, NFKB1	Preclinical
SP-141	ubiquitin ligase inhibitor	MDM2	Preclinical
spautin-1	deubiquitinase inhibitor	USP10, USP13	Preclinical
spiroxatrine	serotonin receptor antagonist	ADRA1A, ADRA1B, ADRA1D, ADRA2A, ADRA2B, ADRA2C, HTR1A, HTR2B	Preclinical
splitomycin	SIRT inhibitor	SIRT1	Preclinical
SPP-86	receptor tyrosine protein kinase inhibitor	RET	Preclinical
SQ-22536	adenylyl cyclase inhibitor	ADCY1	Preclinical
SR-3306	JNK inhibitor	MAPK10, MAPK8, MAPK9	Preclinical
SR-3576	JNK inhibitor	MAPK10	Preclinical
SR-3677	rho associated kinase inhibitor	ROCK2	Preclinical
SR-59230A	adrenergic receptor antagonist	ADRB1, ADRB2, ADRB3	Preclinical
SRC-kinase-inhibitor-I	src inhibitor	CSK, LCK, RIPK2	Preclinical
SRPIN340	serine arginine protein kinase inhibitor	SRPK1, SRPK2	Preclinical
ST-2825	myeloid differentiation primary response inhibitor	MYD88	Preclinical
STAT3-inhibitor-VI	STAT inhibitor	STAT3	Preclinical
stemregenin-1	aryl hydrocarbon receptor antagonist	AHR	Preclinical
STF-083010	serine/threonine kinase inhibitor	ERN1	Preclinical
STF-118804	NAMPT inhibitor	NAMPT	Preclinical
STF-31	NAMPT inhibitor	NAMPT, SLC2A1	Preclinical
strychnine	acetylcholine receptor antagonist	CHRM1, CHRM2, CHRM3, CHRM4, CHRM5, CHRNA10, CHRNA9, GLRA1, GLRA2, GLRA3, GLRB	Preclinical
SU-11274	hepatocyte growth factor receptor inhibitor, tyrosine kinase inhibitor	MET	Preclinical
SU-16f	PDGFR tyrosine kinase receptor inhibitor	PDGFRB	Preclinical
SU-4312	PDGFR tyrosine kinase receptor inhibitor, tyrosine kinase inhibitor, VEGFR inhibitor	KDR, PDGFRB	Preclinical
SU3327	JNK inhibitor	MAPK8	Preclinical
SU9516	CDK inhibitor	CDK1, CDK2, CDK4, CDK5	Preclinical
SX-011	MAP kinase inhibitor	MAPK14	Preclinical
SYM-2081	kainate receptor antagonist	GRIK1, GRIK2, GRIK3, GRIK4, GRIK5, SLC1A2	Preclinical
SYM-2206	glutamate receptor antagonist	GRIA1, GRIA2, GRIA3, GRIA4	Preclinical
S1P1-agonist-III	sphingosine kinase inhibitor	S1PR1	Preclinical
S4	carbonic anhydrase inhibitor	CA12, CA9	Preclinical
T-0070907	PPAR receptor antagonist	PPARG	Preclinical
T-0156	phosphodiesterase inhibitor	PDE5A	Preclinical
T-5601640	LIM kinase inhibitor	LIMK2	Preclinical
TA-01	casein kinase inhibitor, MAP kinase inhibitor	CSNK1D, CSNK1E, MAPK14	Preclinical
TAK-632	RAF inhibitor	BRAF	Preclinical
tangeritin	cell cycle inhibitor		Preclinical
TBOA-(DL)	excitatory amino acid transporter inhibitor	SLC1A1, SLC1A2, SLC1A3, SLC1A6, SLC1A7	Preclinical
TC-A-2317	Aurora kinase inhibitor	AURKA	Preclinical
TC-ASK-10	MAP kinase inhibitor	MAP3K5, MAP3K6	Preclinical
TC-E-5002	histone demethylase inhibitor	KDM2A, KDM4A, KDM4C, KDM5A, KDM6A, KDM7A, PHF8	Preclinical
TC-F-2	FAAH inhibitor	FAAH	Preclinical
TC-G-1004	adenosine receptor antagonist	ADORA2A	Preclinical
TC-H-106	HDAC inhibitor	HDAC1, HDAC2, HDAC3, HDAC8	Preclinical
TC-I-15	integrin inhibitor	ITGA2, ITGB1	Preclinical
TC-I-2000	transient receptor potential channel antagonist	TRPM8	Preclinical
TC-I-2014	transient receptor potential channel antagonist	TRPM8	Preclinical
TC-LPA5-4	lysophosphatidic acid receptor antagonist	LPAR5	Preclinical
TC-Mps1-12	monopolar spindle 1 kinase inhibitor	TTK	Preclinical
TC-N-1752	sodium channel blocker	SCN9A	Preclinical
TC-S-7003	src inhibitor	LCK	Preclinical
TC-S-7004	DYRK inhibitor	DYRK1A, DYRK1B	Preclinical
TC-S-7005	PLK inhibitor	PLK2	Preclinical
TC-S-7006	MAP kinase inhibitor	MAP3K8	Preclinical
TC-S-7009	hypoxia inducible factor inhibitor	EPAS1	Preclinical
TCN201	glutamate receptor antagonist	GRIN2A	Preclinical
TCS-HDAC6-20b	HDAC inhibitor	HDAC6	Preclinical
TCS-OX2-29	orexin receptor antagonist	HCRTR2	Preclinical
TCS-PIM-1-1	Pim kinase inhibitor	PIM1	Preclinical
TCS-21311	JAK inhibitor	JAK3	Preclinical
TCS-2314	integrin inhibitor	ITGA4, ITGB1	Preclinical
TCS-359	FLT3 inhibitor	FLT3	Preclinical
TCS-5861528	transient receptor potential channel antagonist	TRPA1	Preclinical
TCS2002	glycogen synthase kinase inhibitor	GSK3B	Preclinical
TC1	beta-secretase inhibitor	BACE1	Preclinical
Teijin-compound-1	CC chemokine receptor antagonist	CCR2	Preclinical
tenofovir-alafenamide	nucleoside reverse transcriptase inhibitor		Preclinical
tenovin-1	SIRT inhibitor, TP53 activator	SIRT1	Preclinical
tenovin-6	SIRT inhibitor	SIRT1, SIRT2, SIRT3	Preclinical
terreic-acid-(-)	Bruton's tyrosine kinase (BTK) inhibitor	BTK	Preclinical
tetrandrine	calcium channel blocker	SLC6A3	Preclinical
TFC-007	prostaglandin inhibitor	HPGDS	Preclinical
TG-003	CLK inhibitor	CLK1, CLK4, DYRK1A, DYRK1B	Preclinical
TG-100572	src inhibitor, VEGFR inhibitor	KDR, SRC	Preclinical
TG-100713	PI3K inhibitor		Preclinical
TG-101209	JAK inhibitor	JAK2, JAK3	Preclinical
TGX-221	PI3K inhibitor	PIK3CB, PIK3CD	Preclinical
thiamet-g	GLCNAC phosphotransferase inhibitor	MGEA5	Preclinical
thiazovivin	rho associated kinase inhibitor		Preclinical
thioperamide	histamine receptor antagonist	HRH3, HRH4	Preclinical
THZ1	CDK inhibitor	CDK7	Preclinical
THZ1-R	CDK inhibitor	CDK7	Preclinical
THZ2	CDK inhibitor	CDK7	Preclinical
TH588	MTH1 inhibitor	NUDT1	Preclinical
tie2-kinase-inhibitor	TIE tyrosine kinase inhibitor	KDR, MAPK14	Preclinical
tioxolone	carbonic anhydrase inhibitor	CA2	Preclinical
TMN-355	cyclophilin inhibitor	PPIA	Preclinical
torin-1	mTOR inhibitor	MTOR	Preclinical
torin-2	mTOR inhibitor	MTOR	Preclinical
TP-0903	AXL kinase inhibitor	AXL	Preclinical
TPCA-1	IKK inhibitor	IKBKB	Preclinical
TRAM-34	potassium channel antagonist	KCNN4	Preclinical
trap-101	nociceptin/orphanin FQ receptor antagonist, opioid receptor antagonist	OPRL1	Preclinical
trichostatin-a	HDAC inhibitor	HDAC1, HDAC10, HDAC2, HDAC3, HDAC4, HDAC5, HDAC6, HDAC7, HDAC8, HDAC9	Preclinical
tropanyl-3,5-dimethylbenzoate	serotonin receptor antagonist	HTR3A, HTR3B	Preclinical
tryptanthrin	cyclooxygenase inhibitor	IDO1	Preclinical
TTP-22	casein kinase inhibitor	CSNK2A1	Preclinical
tubastatin-a	HDAC inhibitor	HDAC6	Preclinical
TW-37	BCL inhibitor	BCL2, BCL2L1, MCL1	Preclinical
TWS-119	glycogen synthase kinase inhibitor	GSK3B, JUN, MYC	Preclinical
TY-52156	sphingosine 1-phosphate receptor antagonist	S1PR3	Preclinical
tyrphostin-AG-1296	FLT3 inhibitor	FLT3	Preclinical
tyrphostin-AG-1478	EGFR inhibitor	EGFR, MAPK14	Preclinical
tyrphostin-AG-18	EGFR inhibitor, tyrosine kinase inhibitor	EGFR	Preclinical
tyrphostin-AG-494	EGFR inhibitor	EGFR	Preclinical
tyrphostin-AG-825	protein tyrosine kinase inhibitor	ERBB2	Preclinical
tyrphostin-AG-835	protein tyrosine kinase inhibitor	EGFR	Preclinical
tyrphostin-AG-879	tyrosine kinase inhibitor	ERBB2, KDR, NTRK1	Preclinical
tyrphostin-AG-99	tyrosine kinase inhibitor	EGFR	Preclinical
tyrphostin-A9	protein tyrosine kinase inhibitor, tyrosine kinase inhibitor		Preclinical
U-0124	MEK inhibitor		Preclinical
U-0126	MEK inhibitor	AKT1, CHEK1, GSK3B, LCK, MAP2K1, MAP2K2, MAP2K7, MAPK1, MAPK11, MAPK12, MAPK14, MAPK8, PRKCA, RAF1, ROCK1, RPS6KB1, SGK1	Preclinical
U-0521	catechol O methyltransferase inhibitor	COMT	Preclinical
U-104	carbonic anhydrase inhibitor	CA1, CA12, CA2, CA9	Preclinical
U-18666A	oxidosqualene cyclase inhibitor		Preclinical
U-99194	dopamine receptor antagonist	DRD3	Preclinical
UAMC-00039	dipeptidyl peptidase inhibitor	DPP4, DPP7	Preclinical
UBP-296	glutamate receptor antagonist	GRIK1	Preclinical
UBP-302	glutamate receptor antagonist	GRIK1	Preclinical
UBP-310	glutamate receptor antagonist	GRIK1, GRIK5	Preclinical
UC-112	XIAP inhibitor	XIAP	Preclinical
UCL-2077	slow afterhyperpolarization channel blocker		Preclinical
UF-010	HDAC inhibitor	HDAC1, HDAC2, HDAC3, HDAC8	Preclinical
UH-232-(+)	dopamine receptor antagonist	DRD2, DRD3, DRD4, HTR1A	Preclinical
UK-356618	metalloproteinase inhibitor	MMP13, MMP14, MMP2, MMP3, MMP9	Preclinical
UK-5099	monocarboxylate transporter inhibitor	SLC16A1	Preclinical
UNC-2327	protein arginine N-methyltransferase inhibitor	PRMT3	Preclinical
UNC-926	MBT inhibitor	L3MBTL1	Preclinical
UNC0224	histone lysine methyltransferase inhibitor	EHMT1, EHMT2	Preclinical
UNC0321	histone lysine methyltransferase inhibitor	EHMT2	Preclinical
UNC0631	histone lysine methyltransferase inhibitor	EHMT2	Preclinical
UNC0638	histone lysine methyltransferase inhibitor	EHMT1, EHMT2	Preclinical
UNC0642	histone lysine methyltransferase inhibitor	EHMT1, EHMT2	Preclinical
UNC0646	histone lysine methyltransferase inhibitor	EHMT2	Preclinical
UNC0737	histone lysine methyltransferase inhibitor	EHMT1, EHMT2	Preclinical
UNC1215	L3MBTL antagonist	L3MBTL3	Preclinical
UNC1999	histone lysine methyltransferase inhibitor	EZH2	Preclinical
UNC2025	MER tyrosine kinase inhibitor, FLT3 inhibitor	FLT3, MERTK	Preclinical
UNC2250	MER tyrosine kinase inhibitor	MERTK	Preclinical
UNC669	L3MBTL antagonist	L3MBTL1	Preclinical
UPF-1069	PARP inhibitor	PARP2	Preclinical
URMC-099	mixed lineage kinase inhibitor	CDKL2, DAPK3, FLT3, LRRK2, MAP3K10, MAP3K11, MAP3K2, MAP3K9, SRPK2	Preclinical
VBY-825	cathepsin inhibitor	CTSB, CTSL, CTSS	Preclinical
VE-821	ATR kinase inhibitor	ATR	Preclinical
VER-155008	HSP inhibitor	HSPA1A	Preclinical
VER-49009	HSP inhibitor	HSP90AA1	Preclinical
vesamicol	acetylcholinesterase inhibitor	SLC18A3	Preclinical
VU-0240551	potassium/chloride cotransporter inhibitor	SLC12A5	Preclinical
VU-0364739	phospholipase inhibitor	PLD2	Preclinical
VUF10166	serotonin receptor antagonist	HTR3A, HTR3B	Preclinical
VU0155069	phospholipase inhibitor	PLD1	Preclinical
VU591	potassium channel blocker	KCNJ1	Preclinical
VX-11e	MAP kinase inhibitor	MAPK1	Preclinical
W-54011	anaphylatoxin chemotactic receptor antagonist	C5AR1	Preclinical
WAY-170523	metalloproteinase inhibitor	MMP13	Preclinical
WAY-207024	gonadotropin releasing factor hormone receptor antagonist	GNRHR, HRH2, TACR2	Preclinical
WAY-213613	glutamate inhibitor	SLC1A2	Preclinical
WAY-316606	secreted frizzled related protein inhibitor	SFRP1	Preclinical
WAY-600	mTOR inhibitor	MTOR	Preclinical
WB-4101	adrenergic receptor antagonist	ADRA1A, ADRA1B, ADRA1D, ADRA2A, ADRA2B, ADRA2C, HTR1A	Preclinical
WDR5-0103	histone lysine methyltransferase inhibitor	WDR5	Preclinical
WEHI-345-analog	src inhibitor		Preclinical
WH-4-023	src inhibitor	LCK, SRC	Preclinical
WHI-P154	JAK inhibitor	EGFR, JAK1, JAK2, JAK3	Preclinical
WIKI4	Wnt pathway inhibitor, tankyrase inhibitor	TNKS2	Preclinical
WIN-18446	aldehyde dehydrogenase inhibitor	ALDH1A2	Preclinical
WIN-64338	bradykinin receptor antagonist	BDKRB2	Preclinical
wiskostatin	neural Wiskott-Aldrich syndrome protein inhibitor, actin related protein inhibitor	WAS, WASL	Preclinical
wnt-c59	porcupine inhibitor	PORCN	Preclinical
wortmannin	PI3K inhibitor	PI4KA, PI4KB, PIK3CA, PIK3CD, PIK3CG, PIK3R1, PLK1, PRKDC	Preclinical
WP1130	deubiquitinase inhibitor	JAK2, UCHL5, USP14, USP9X	Preclinical
WR99210	dihydrofolate reductase inhibitor	TYMS	Preclinical
WWL-113	carboxylesterase inhibitor	CES3	Preclinical
WWL-123	monoacylglycerol lipase inhibitor	ABHD6	Preclinical
WYE-125132	mTOR inhibitor	MTOR	Preclinical
WYE-354	mTOR inhibitor	MTOR	Preclinical
WYE-687	mTOR inhibitor	MTOR	Preclinical
WZ-3146	EGFR inhibitor	EGFR	Preclinical
WZ-4002	EGFR inhibitor	EGFR, ERBB2	Preclinical
WZ4003	AMPK inhibitor	NUAK1, NUAK2	Preclinical
WZ8040	EGFR inhibitor	EGFR	Preclinical
WZ811	CC chemokine receptor antagonist	CXCR4	Preclinical
XAV-939	tankyrase inhibitor	TNKS, TNKS2	Preclinical
XD-14	bromodomain inhibitor	BRD2, BRD3, BRD4, BRDT	Preclinical
XE-991	potassium channel blocker	KCNQ1, KCNQ2, KCNQ3, KCNQ4, KCNQ5	Preclinical
XL388	mTOR inhibitor	MTOR	Preclinical
XMD17-109	MAP kinase inhibitor	MAPK7	Preclinical
XMD8-92	MAP kinase inhibitor	DCLK2, MAPK7, PLK4, TNK1	Preclinical
Y-11	focal adhesion kinase inhibitor	PTK2	Preclinical
Y-134	estrogen receptor antagonist	ESR1, ESR2	Preclinical
Y-27632	rho associated kinase inhibitor	PKIA, PKN2, PRKACA, PRKCE, ROCK1, ROCK2	Preclinical
Y-29794	prolyl endopeptidase inhibitor	PREP	Preclinical
Y-320	interleukin inhibitor	IL17A	Preclinical
YIL-781	ghrelin receptor antagonist	GHSR	Preclinical
YK-4-279	apoptosis inhibitor	EWSR1, FLI1	Preclinical
YM-201636	PI3K inhibitor		Preclinical
YM-244769	sodium/calcium exchange inhibitor		Preclinical
YM-298198	glutamate receptor antagonist	GRM1	Preclinical
YM-58483	calcium channel blocker	TRPC3, TRPC5, TRPM4	Preclinical
YM-90709	IL5 inhibitor	CSF2RB, IL5RA	Preclinical
YO-01027	gamma secretase inhibitor		Preclinical
YS-035	calcium channel blocker		Preclinical
YZ9	phosphofructokinase inhibitor	MIF, PFKFB3	Preclinical
Y16	rho associated kinase inhibitor	RHOA	Preclinical
ZCL-278	CDC inhibitor	CDC42	Preclinical
ZD-7155	angiotensin receptor antagonist	AGTR1	Preclinical
zebularine	DNA methyltransferase inhibitor	CDA, DNMT1	Preclinical
ZK-164015	estrogen receptor antagonist	ESR1, ESR2	Preclinical
ZM-241385	adenosine receptor antagonist	ADORA1, ADORA2A, ADORA2B, ADORA3	Preclinical
ZM-306416	Abl kinase inhibitor, src inhibitor, VEGFR inhibitor	EGFR, FLT1, FLT4, KDR	Preclinical
ZM-323881	VEGFR inhibitor	KDR	Preclinical
ZM-336372	RAF inhibitor	BRAF, LCK, MAPK14, RAF1	Preclinical
ZM-39923	JAK inhibitor	JAK1, JAK3	Preclinical
ZM-447439	Aurora kinase inhibitor	AURKA, AURKB	Preclinical
zolantidine	histamine receptor antagonist		Preclinical
1,2,3,4,5,6-hexabromocyclohexane	JAK inhibitor	JAK2	Preclinical
1,3-dipropyl-8-phenylxanthine	adenosine receptor antagonist		Preclinical
1-(1,2-Diphenylethyl)piperidine-(+/-)	glutamate receptor antagonist		Preclinical
1-azakenpaullone	glycogen synthase kinase inhibitor	CCNB1, CDK1, CDK5, GSK3B	Preclinical
1-deoxymannojirimycin	alpha mannosidase inhibitor	MAN2A1	Preclinical
1-naphthyl-PP1	src inhibitor	SRC	Preclinical
10-DEBC	AKT inhibitor	PIM1	Preclinical
10-hydroxycamptothecin	topoisomerase inhibitor	TOP1	Preclinical
10058-F4	c-Myc inhibitor		Preclinical
1400W	nitric oxide synthase inhibitor	NOS1, NOS2, NOS3	Preclinical
2'-c-methylguanosine	HCV inhibitor		Preclinical
2,4-dinitrophenol	ATP synthase inhibitor	APP	Preclinical
2-aminobenzenesulfonamide	carbonic anhydrase inhibitor	CA12, CA14, CA2, CA6, CA9	Preclinical
2-APB	1,4,5-trisphosphate inhibitor	TRPC1, TRPC3, TRPC4, TRPC5, TRPC6, TRPC7, TRPM2, TRPM3, TRPM6, TRPV1, TRPV6	Preclinical
2-CMDO	dopamine receptor antagonist	DRD2, DRD4	Preclinical
2-cyanopyrimidine	cathepsin inhibitor		Preclinical
2-hydroxysaclofen	GABA receptor antagonist	GABBR1, GABBR2	Preclinical
2-methylimidazole	cholesterol inhibitor		Preclinical
2-oxopropanoate	pyruvate dehydrogenase kinase inhibitor	ABAT, AGXT2, PC, PDHB, PKLR, PKM, SLC16A1, SLC16A2, SLC16A3, SLC16A4, SLC16A5, SLC16A6, SLC16A7, SLC16A8	Preclinical
2-PMDQ	adrenergic receptor antagonist	ADRA1A	Preclinical
2-TEDC	lipoxygenase inhibitor	ALOX12	Preclinical
3,4-DCPG-(R)	glutamate receptor antagonist		Preclinical
3-alpha-bis-(4-fluorophenyl)-methoxytropane	dopamine uptake inhibitor	CHRM1, SLC6A2, SLC6A3, SLC6A4	Preclinical
3-bromo-7-nitroindazole	nitric oxide synthase inhibitor	NOS1, NOS2, NOS3	Preclinical
3-bromopyruvate	hexokinase inhibitor	HK2	Preclinical
3-carboxy-4-hydroxyphenylglycine-(R)	glutamate receptor antagonist	GRIN1, GRIN2A, GRIN2B, GRIN2C	Preclinical
3-carboxy-4-hydroxyphenylglycine-(S)	glutamate receptor antagonist	GRM1, GRM5	Preclinical
3-CPMT	dopamine reuptake inhibitor		Preclinical
3-deazaneplanocin-A	histone lysine methyltransferase inhibitor	EZH2	Preclinical
3-deazauridine	cytidine deaminase inhibitor		Preclinical
3-methyladenine	PI3K inhibitor	PI3	Preclinical
3PO	phosphofructokinase inhibitor	PFKFB3	Preclinical
4,4-pentamethylenepiperidine	M2 channel blocker		Preclinical
4,5,6,7-tetrabromobenzotriazole	casein kinase inhibitor	AKT1, CHEK1, CSNK2A1, GSK3B, LCK, MAP2K1, MAPK1, MAPK11, MAPK12, MAPK14, MAPK8, PRKCA, ROCK1, RPS6KB1, SGK1	Preclinical
4-(4-fluorobenzoyl)-1-(4-phenylbutyl)-piperidine	serotonin receptor antagonist	HTR2A	Preclinical
4-carboxy-3-hydroxyphenylglycine-(RS)	glutamate receptor agonist, glutamate receptor antagonist	GRM1	Preclinical
4-carboxy-3-hydroxyphenylglycine-(S)	glutamate receptor agonist, glutamate receptor antagonist	GRM1, GRM2	Preclinical
4-chlorophenylguanidine	urokinase inhibitor	PLAUR	Preclinical
4-DAMP	cholinergic receptor antagonist	CHRM1, CHRM2, CHRM3, CHRM4, CHRM5	Preclinical
4-HQN	PARP inhibitor	PARP1	Preclinical
4-iodo-6-phenylpyrimidine	macrophage migration inhibiting factor inhibitor	MIF	Preclinical
4-methylgenistein	protein tyrosine kinase inhibitor	CYP19A1, ESRRA, ESRRB, ESRRG, FASN	Preclinical
4-mu-8C	IRE1 inhibitor	ERN1	Preclinical
4-P-PDOT	melatonin receptor antagonist	MTNR1A, MTNR1B	Preclinical
4-phenyl-1,2,3,4-tetrahydroisoquinoline	dopamine release inhibitor		Preclinical
4EGI-1	protein synthesis inhibitor	EIF4E	Preclinical
4E1RCat	protein synthesis inhibitor	EIF4E, EIF4G1	Preclinical
5,7-dichlorokynurenic-acid	glutamate receptor antagonist	GLRA2, GRIN1, GRIN2A, GRIN2B, GRIN2C, GRIN2D	Preclinical
5-BDBD	purinergic receptor antagonist	P2RX4	Preclinical
6-iodo-nordihydrocapsaicin	TRPV antagonist	TRPV1	Preclinical
7-aminocephalosporanic-acid	beta lactamase inhibitor		Preclinical
7-chlorokynurenic-acid	glutamate receptor antagonist	GRIN1, GRIN2A, GRIN2B, GRIN2C	Preclinical
7-nitroindazole	nitric oxide synthase inhibitor	NOS1, NOS2, NOS3	Preclinical

